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ABSTRACT
Orf is a highly contagious, eruptive skin disease of sheep and goats caused by a
parapox virus. The virus enters through abrasions in the skin, where it replicates in the
regenerating epidermal keratinocytes. Despite the generation of a specific antiviral
response, orf virus reinfections can be established easily, although the lesions are
milder and generally regress more rapidly than after primary exposure.
The cutaneous response to orf involves the formation of a dense network of MHC
class IT dendritic cells at the lesion. The primary aim of this project was to
characterise these dendritic cells and to identify the cytokines produced by orf infected
keratinocytes in vitro, that might be involved in the accumulation of the dendritic cells
in vivo.
In vivo studies of primary and secondary orf virus lesions identified the class IT
dendritic cells to be a population of CD1" cells, which are also found within the dermis
of normal ovine skin. A subpopulation of these cells also expressed the antigen,
coagulation factor Xllla. Factor Xnia+ dendritic cells comprised over half the
dendritic cells seen in the network of a primary orf lesion but were only observed in
small numbers, transiently, in the secondary orf lesion. All the dendritic cells lacked
the expression of ovine macrophage markers. The proliferative response of the
primary and secondary orf lesions also differed. High proliferative activity was
observed in the epidermis and dermis in the primary response to orf but not in the
secondary response. A few of the proliferating cells were identified as dendritic cells
but it would appear that the dendritic cell network in both primary and secondary orf
lesions does not arise by local cell division.
An in vitro model of orf virus infection of cultured ovine keratinocytes was
established. The kinetics of infection and the ability of the cells to support viral
replication was investigated. It was shown that viral antigen could be detected in the
infected cells 12h post-infection, prior to the onset of the viral cytopathic effect (CPE)
at 24h. The release of infectious virus particles into the culture supematants was
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observed only after the onset of CPE. Host cell protein synthesis was unaffected
within the first 12 hours post-infection as measured by incorporation of 35S
methionine by the cells.
Analysis of cytokine production by cultured ovine keratinocytes showed that
uninfected keratinocytes had the ability to secrete the cytokines Interleukin-8 (IL-8)
and Granulocyte-macrophage-colony stimulating factor (GM-CSF). Infection of
keratinocytes with orf virus stimulated the production of IL-8 but GM-CSF could not
be detected at any timepoint post-infection, despite the high level of mRNA present
within the infected cells. Exogenous ovine GM-CSF incubated with supematants from
infected cells rapidly disappeared. The addition of protease inhibitors to the
supernatants did not prevent the clearance of GM-CSF and so degradation of GM-
CSF by endogenous proteases produced by the infected cells is unlikely. The factors
involved in the clearance of GM-CSF have not been identified.
The results presented in this thesis indicate that orf virus may possess virulence
factors that interfere with the production of cytokines by keratinocytes. The
significance of these in vitro studies in relation to in vivo observations of infection has
yet to be determined but may relate to the unusual dendritic cell response in orf and to







Orf or contagious pustular dermatitis is a highly contagious, eruptive skin disease of
sheep and goats. It is caused by a parapoxvirus which can also infect man. The
condition has no systemic phase and is characterised by pustular lesions from which
scabs develop. Little has been published on the development of immunity and it is
known that protection against re-infections is incomplete and not long lasting, and the
available, live attenuated vaccine is only of limited use (Buddie 1984, Kitching,
1987).
Figure 1.1 Orf lesions around the mouth and nares lamb. Some of the
lesions are highlyproliferative, a feature which is more common to
natural infections as opposed to those that are experimentally induced.




Orf is a disease that is distributed worldwide wherever sheep and goats are raised.
The disease occurs all year round but is most common during the spring and summer
(Aynaud, 1923; Glover, 1928; Schmidt and Hardy, 1932). Although orf is regarded as
primarily affecting domestic sheep and goats, it has also been reported to occur
naturally in other animals (reviewed by Robinson and Lyttle, 1991) either in the wild,
in captivity or as farmed domesticated species. A feature of the poxviruses is their
lack of pathogenicity for the commonly used laboratory animals.
Orf virus is also transmissible to man, occurring usually as an occupational hazard
through the direct contact of man with animals or animal products. Thus it is a disease
associated with veterinary surgeons, farm workers, butchers and freezer workers
(Purdy, 1955). The lesions caused are found most commonly on the hands or face
and, although painful, they are seldom serious. In uncomplicated cases the lesion
resolves 5-8 weeks after infection (Hodgson-Jones, 1951, Leavell et al., 1968). The
lesion that develops is quite different from the lesion in sheep and will be described in
more detail below.
The traditional view of orf virus transmission is that the virus, shed into the
environment in the form of infectious scab material, is very hardy and will persist in
dust and wool which act as the source of new infections (Theiler, 1928; Glover,
1932; Boughton and Hardy, 1935). The virus then enters through epidermal
abrasions, a prerequisite for establishing an infection, caused by grazing in rough
pasture or by scratches from fencing materials contaminated with the virus. Thus
natural infections are normally localised around the mouth and nose or above the
hooves. Human infections are thought to occur in a similar manner through contact
with infected animals or contaminated fomites such as rails and wool hooks, and the
presence of wounds and abrasions on the arms and hands increase the risk of infection
(Pask et al., 1951). Person to person transmission of orf has also been reported (Lang,
1962).
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Typically outbreaks of orf are seen in susceptible animals (usually lambs) on a
property that does not vaccinate and, once the pasture becomes contaminated, it is
difficult to eradicate, the shed scabs of each infected animal contributing to the
environmental pool of infection. However this traditional view of transmission does
not account for virus getting into previously clean premises and surviving between
outbreaks. One explanation for the persistence of virus in infected premises is that orf
virus can survive for long periods in dry preparations, especially in scabs (Glover,
1930; Livingston and Hardy, 1960; Leavell et al., 1986; Jubb and Kennedy, 1970).
Although such persistence could occur in areas where animals are housed, infectious
virus is much less likely to be maintained in this way on pastures exposed to the
elements. Exposure to ultraviolet (UV) radiation reduces the infectivity of orf virus
(Manley, 1934; Sawhney, 1972) and Mckeever and Reid (1986) showed that wet
weather conditions in Scotland are not conducive for scab borne viral infectivity
indicating that the large number of orf virus outbreaks observed in the spring are
unlikely to be caused by orf virus that had wintered in scabs in this country.
The method of transmission of orf virus into new, clean premises remains to be
elucidated. It has been proposed that subclinical orf infections or animals suffering
from chronic or trivial orf virus infections act as carriers (Greig et al., 1984;
Mckeever, 1984). At present there is still insufficient evidence to support this view. It
is generally believed that the spread and maintenance of the infection is related to the
resistant nature of the virions in the environment and the short-lived immunity to re¬
infection.
1.1.3. The clinical pathology of the disease
Natural orf infections are established in, and generally restricted to, the site of
epidermal abrasions, commonly the lips, mouth and nose of lambs (see Figure 1.1) and
udders of nursing ewes. The virus is highly epitheliotropic and the lesions produced
are found generally on the epithelium and oral mucosa, although in some cases it may
affect other tissues of the body (reviewed in Robinson and Balassu, 1981 and Watt,
1983). Application of a viral suspension to scarified skin is the established method of
inducing orf experimentally (Glover, 1928; Wheeler and Cawley, 1956; Abdussalam,
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1957, Kluge et al, 1972). Skin lesions develop initially as reddening and swelling
around the sites of inoculation and the lesions progress through the stages of papules,
vesicles and pustules to scab formation. In uncomplicated cases the disease is afebrile
and self limiting. Secondary papules, vesicles and pustules often develop so that the
lesion involves 1-2 cm of skin surrounding the initial inoculation site. In a primary
experimental infection scabs form within one week and are shed within 4-6 weeks
without leaving a scar. Secondary infections are generally milder, the scab forms
within 3-4 days and complete resolution of infection is seen by 14 days (Robinson and
Balassu, 1981).
The effects of the disease on the animal are determined by the site and extent of the
lesions. Lesions around the mouth and nose interfere with feeding, retarding the
growth of young lambs. Teat lesions on the udders of nursing ewes can also interfere
with the suckling of young lambs. Complications such as mastitis can arise as a result
of opportunistic bacterial infections. Highly proliferative lesions that are not normally
observed in experimental orf infections are more common in natural orf infections (see
Figure 1.1). These proliferative papillomatous lesions form dense wart-like
outgrowths that together with secondary complications, become ulcerative and
necrotic without scab formation. The process of healing is delayed, resulting in much
more persistent infections (Glover et aL, 1928; Newsan and Cross, 1931; Selbie, 1944;
Darbyshire, 1961).
Orf virus infection of man produces a lesion that is significantly different from the
lesion observed in sheep. Whilst the human lesion progresses through the macular,
papular, vesicular and pustular stages seen in sheep, it is characterised by the dilation
and the extensive proliferation of the vascular endothelium of the dermal capillaries.
This results in a marked umbilication of the lesion that is not observed in sheep
(reviewed by Yirrell and Vestey, 1994). The cellular components involved in the
human response have not yet been identified.
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1.1.4. Orf virus structure
Orf virus is a member of the genus parapoxvirus belonging to the family Poxviridae.
The parapoxviruses are morphologically similar and can be distinguished from other
poxvirus genera by 3 main criteria: they are 1) more cylindrical, 2) have a higher axial
ratio and 3) the tubular threads on their outermost coat are arranged in a direct basket
weave fashion rather than the random arrangement observed for the orthopoxviruses
(see Figure 1.2). These viruses do however share a common antigens, such as the
nucleoprotein antigen, with the other poxvirus genera (Webster, 1958; Woodroofe
and Feiiner, 1962).
Figure 1.2 Electronmicrograph ofnegatively stained orf virus showing the outer
tubular coat ofthe viralparticles, the 'M'form. X 80,000.
Oif virus is oval in outline with a long axis of 260nm on average and a short axis of
160nm with an axial ratio of 1.6 (Nagington and Home, 1962; Abdussalam and
Cosslett, 1957). The viral coat comprises an inner and an outer envelope and cell
culture isolates of orf virus appear to have an additional membrane which, by analogy
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with vaccinia, is thought to be derived from the host cell Golgi body (Rosenbusch and
Reed, 1983; Mitchner, 1969). Electron microscopy of negatively stained orf virus
particles reveals two forms of orf virus; the 'M' or mulberry form, where the outer
tubular coat of the virus is highlighted (see Figure 1.2) or the 'C' or clear form,
where the stain has penetrated the viral coat to reveal the capsule of the virus
(Nagington and Home, 1962; Knocke, 1962; Buttner et al, 1964; Nagington et
al, 1964).
The internal structure of orf virus is similar to other poxviruses (Knocke 1962;
Nagington and Home, 1962; Peters et al, 1964). It consists of an internal S shaped
tubular structure surrounded by a lipoprotein envelope (Mitchner et al, 1969). Orf
virus contains linear double stranded DNA of approximately 137kb in size and in
common with the other parapoxviruses has a high guanine and cytosine (G + C)
content of up to 63% (Wittek et al, 1979). Like the DNA of vaccinia vims and
papular stomatitis vims, orf vims DNA has crosslinked ends.
1.1.5. Strain variation
Until relatively recently it was generally perceived that only one strain of orf virus
exists as cross protection trials between isolates from the UK, USA, France and
Australia did not show any strain variation (Glover, 1932 and 1933). The results
obtained from the different groups were however quite variable, indicating the
unreliable nature of the tests used. A wide range of methods employed by various
workers to measure antigenic variation between orf virus strains (reviewed by
Robinson and Balassu, 1981) also gave conflicting evidence. Buddie et al, (1984)
were able to organise different viral isolates into groups based on the electrophoretic
analysis of the structural polypeptides, whereas they had been unable to find
differences using serum neutralisation tests. More recent studies employing restriction
endonuclease analysis of orf vims DNA have indicated that there is considerable
heterogeneity between isolates, which could be related to antigenic diversity
(Robinson et al, 1987). The biological significance of this diversity is not known.
Antigenically the other poxviruses; bovine papular stomatitis virus, milker's nodule
virus and pseudocowpox virus appear to be closely related to each other and to orf
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virus, which would support the view that biologically significant diversity of orf virus
isolates is unlikely.
1.1.6. Vaccination
Orf is the only parapoxvirus disease where vaccination is practised routinely as a
control measure. Vaccination is by the use of a live virus vaccine in essentially the
same manner as that described by Aynaud (1923). The animal is inoculated at 3-4
weeks of age on the leg with unattenuated virus (Aynaud, 1923; Glover, 1928;
Schmidt, 1962; Howarth, 1929; Boughton and Hardy, 1935). A typical orf lesion
occurs at the site of the inoculation and after 12-13 days the animal is "immune" to
reinfection (Robertson, 1976). The animals are protected for approximately 5 months
after which infections can be contracted but they tend to be milder (Roberston, 1976).
The primary aim of vaccination is to protect the animal from developing the severe
disease during the crucial early growth stage or passing infection to the udder of the
ewe thereby reducing production losses in the lamb-meat industry. The disadvantages
of the vaccination protocol are that the vaccines are not fully protective (Buddie et
al, 1984) and, as the vaccine is a live virus preparation, the scabs that are formed
following vaccination contaminate the environment
1.1.7. The orf virus genome
Most of the work characterising pox virus genomes has been carried out on the
orthopoxviruses, particularly vaccinia virus. It would appear that all pox viruses are
related even at the genome level. However the distinctive morphology of the virions
and the high G+C content of the genome of the parapoxviruses have set them apart
from the orthopoxviruses (Robinson and Balassu, 1981; Robinson and Lyttle, 1991).
Vaccinia virus has a genome of 199kb and a G + C content of 36% compared with the
genome of orf virus which is 60kb smaller and has a higher G + C content of 63%.
Vaccinia virus has been extensively characterised and whilst orf and vaccinia differ in
their G + C content, recent studies have shown that, if their gene sequences are
translated into peptide sequences and compared, they share a number of putative
proteins in common (Fleming et al., 1993). Furthermore it was found that some of the
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proteins were in the same relative positions allowing a tentative alignment of the two
genomes (see Figure 1.3, Fleming et al., 1993).
Selected regions of the orf virus genome have been sequenced. A 4kb region at the
left end of the genome which includes the inverted terminal repeat (ITR) and 1.5kb of
unique sequence has revealed three genes transcribed early in infection, two of which
are unique to orf virus (Fraser et al., 1990, Fleming et al., 1991,1992). The third gene
shows homology at the amino acid level to a UTPase-like gene in vaccinia virus
(Mercer et al., 1989; Slabaugh and Roseman, 1989; McGeoch, 1990). Sequencing of
another fragment revealed a lOkDa polypeptide with homology to the 14k "fusion"
gene of vaccinia virus (Rodriguez and Esteban, 1987; Rodriguez et al., 1987, Naase et
al, 1991). The relative position on the genome and the orientation of the dUTPase-
like and 14kDa-like genes are similar in the two viruses suggesting that despite the
divergence in G + C content of the genomes and the differences in morphology, the
general arrangement of genes may have been conserved between orf virus and
vaccinia virus. A recent study has identified an orf virus homologue of the vaccinia
virus gene encoding the major envelope antigen P37K (Sullivan et al., 1994). The
protein produced also shows homology to the proteins encoded by molluscum
contagiosum virus and another encoded by fowlpox virus. When the orf virus gene
was expressed it was found to be one of a limited number of orf virus proteins to
which sheep mount a strong antibody response following a natural infection and
which stimulate lymphocytes derived from lymph nodes draining a site of infection.
Vaccinia virus gene products have recently been identified that interfere specifically
with a number of host defence mechanisms (discussed in more detail later). Some of
these genes confer resistance to the cytokines interferon (IFN) and interleukin-1.
(EL-1) (reviewed by Smith, 1993). It would be of great interest therefore if these
genes are conserved within the orf virus genome. However it is the genes closest to
the termini of the vaccinia virus genome that are the determinants of virus virulence,
tissue specificity and host range (Pickup et al., 1984; Kowtal and Moss, 1988,
Boursnell et al., 1988, Perkus et al., 1991) and when vaccinia is aligned with orf virus,
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1.1.8. Immune responses to orf virus infection
Orf virus has the ability to re-infect its host resulting in the development of clinical
lesions. The re-infected animal however suffers a milder, more rapid course of
infection. It is generally accepted that orf virus does confer immunity on the host. The
nature and duration of this immunity remains controversial. It was suggested that orf
virus induces lifelong and complete protection against re-infection, (Aynaud, 1923;
Altara, 1925; Jacotot, 1926; Glover, 1928; Abdussalam, 1958; Hardy, 1964; Jubb et
al., 1985) but there is ample evidence to the contrary. The susceptibility of the
recovered animals to re-infection and the fact that vaccinated animals are also
susceptible to infection would confirm the view that orf virus confers only partial
immunity on the animal (Schmidt, 1962 and 1967; Lopatnikov, 1968; Frerichs, 1980;
Kovalevef al., 1971; Osman, 1976; Buddie, 1981; McKeever, 1986 ;McKeever et
al, 1988). The duration of this immunity appears to be very variable. Secondary orf
infections in humans have also been recorded within 14 months of the first, indicating
that immunity in man may also be shortlived (Robinson and Petersen, 1983).
i). Humoral immunity
Early studies showed that serum from immune animals was not protective (Aynaud,
1923) and, although neutralising antibody present in colostrum is passed on to lambs
from their immune dams, it did not appear to be protective (Buddie and Pulford,
1984). This is consistent with reports that lambs born to immune dams are still fully
susceptible to infection within the first few days of life (Boughton and Hardy, 1935;
Schmidt, 1967; Richeter and Jansen, 1968). However in other experiments, the titre
of neutralising antibody in colostrum appeared to correlate directly with the degree of
protection transferred to the lambs (Poulain et al., 1972, Jan et al., 1978).
It was demonstrated, that following orf virus infection, viral neutralising,
agglutinating, precipitating and complement fixing antibodies were produced (Buddie
and Pulford, 1984; Poulain et al., 1972, Jan et al., 1978; Nagington and Whittle, 1961;
Abdussalam, 1958; Schmidt; 1967). Circulating antibody can be detected as early as 6
days after inoculation and Western blotting showed that the antibody from infected
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animals would bind to preparations of orf virus antigens (McKeever, 1987). Naturally
infected animals with chronic lesions showed responses to at least 13 virion
components, with some variation. Experimentally infected animals responded more
consistently but only to 3 or 4 viral antigens, one of which was a 40kDa protein
identified as the characteristic surface antigen Despite the production of virus specific
antibody however, there is no convincing evidence that humoral responses are
involved in protection against infection with orf virus or in the resolution of the
lesions as infections can be established in animals with pre-existing antibody. It seems
more likely, therefore that recovery from the disease is the result of cell mediated
immunity.
ii). Cell mediated immunity
The first attempt to demonstrate the role of cell mediated immunity in orf virus
infection was an adoptive transfer experiment carried out by Osman (1976). Naive
sheep were inoculated with sensitised splenic and thymic cells from immune sheep in
an attempt to transfer immunity to orf. However the sheep were not protected from
orf and developed lesions that could not be distinguished from the controls. As
identical twins were not used, the sheep were not major histocompatibility antigen
matched and thus the experiment has received some criticism. Other studies
successfully demonstrated the involvement of cell mediated immunity to orf virus by
indirect macrophage inhibition tests, direct leucocyte migration inhibition and
lymphocyte transformation tests (Maeda, 1979). Sheep previously exposed to orf
virus demonstrated a delayed type hypersensitivity (DTH) reaction when injected
intradermally with killed orf virus antigen (Buddie and Pulford, 1984). Furthermore
this DTH provided a way of distinguishing between lambs that had been actively
immunised and those that had been exposed to colostral antibodies, as only the
immunised lambs gave a positive DTH response. Peripheral blood lymphocytes
demonstrated proliferative activity to orf virus antigen that preceded the detection of
specific antibodies in the blood (Yirrell et al., 1989). This occurred approximately 7-
14 days after primary exposure to infection and higher proliferative responses could
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be detected following secondary infection although there was greater variation
between individual sheep than in the primary resonse.
The conclusions to be drawn from these experiments suggest that the humoral and
cellular responses to orf virus infection are typical of those following an acute
cutaneous viral infection. However, they provide little in the way of information about
the mechanisms of the protective response. More recently work has focused on the
local cellular immune response as being important in the control of, and protection
against, orf virus infections.
Before describing the local cutaneous response to orf virus, the cellular components
of the skin immune system that are important in the generation of a local cutaneous
immune response will be discussed.
1.2. THE SKIN IMMUNE SYSTEM (S.I.S)
The skin is the largest organ of the body and in addition to providing a protective
barrier, it also carries out a number of important physiological and immunological
functions. The skin contains a number of indigenous cell types that have the ability to
initiate both local inflammatory and systemic immune reactions. The concept of skin
associated lymphoid tissue (SALT) was introduced by Streilein (1978). Streilein used
this term to describe the specialised immune mechanisms of the skin including 1. the
recirculating population of T-lymphocytes that have skin seeking tendencies
(epidermotropic T cells), 2. the dedicated antigen presenting cells of the epidermis
(the Langerhans cells) and 3. the skin draining peripheral lymph nodes. Since then
other immunologically active cell types and their mediators have been recognised
within the skin and these cell types taken together with those comprising SALT, form
an intricate and complex immune system known as the skin immune system (SIS)
(Bos and Kapsenberg, 1986). These newly recognised cells include keratinocytes,
mast cells, polymorphonuclear neutrophils, yS-type T cells, indeterminate cells, veiled
cells, vascular endothelium cells, afferent lymphatic endothelium and most recently the
dendritic cells of the dermis.
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The cellular components of SIS have been extensively reviewed by Bos and
Kapsenberg (1986,1993), Bos (1990) and the major cell types involved in cutaneous
immunity have been highlighted and updated below.
1.2.1. The role of epidermal Langerhans/dendritic cells in cutaneous
immunity
Dendritic cells originally described by Steinman et al., (1979) are a system of bone
marrow derived antigen presenting cells that are widely distributed throughout
lymphoid and non-lymphoid tissues of the body (Table 1.1).
Table 1.1 The dendritic cell system-distribution and nomenclature
Tissue Area Name
Non-lymphoid organs
Skin Epidermal Langerhans cells
Dermal dendritic cells
Heart, Liver, Lung, Gut Interstitial cells
Lymphoid organs Spleen, Thymus Interdigitating cells
Lymph nodes - B cell area
- T cell area
Interdigitating cells
Follicular dendritic cells
The dendritic cells from the different locations of the body all share characteristic
features that distinguish them from other antigen presenting cells as they, 1) exhibit a
typical dendritic and 'veiled' morphology, 2) constitutively express high levels of
major histocompatibility (MHC) class II molecules on their surface, 3) lack or have
comparatively low amounts of markers of the monocyte-macrophage lineage, 4) have
a limited phagocytic potential in comparison with professional phagocytes and 5)
show strong stimulatory capacity for resting T lymphocytes in proliferation assays,
such as the mixed leucocyte reaction, with the ability to cluster in an antigen
independent manner.
14
i). Langerhans cells as immature dendritic cells
Langerhans cells (LC) are the best characterised of the dendritic cells. They represent
the most peripheral outpost of the immune system and function as a critical link
between the extracutaneous environment and the organism. The discovery of LC as
an antigen presenting cell led to numerous productive experimental studies (reviewed
by Romani and Schuler, 1992). Based on these studies the general consensus view on
the function of the LC is that they are the primary antigen presenting cell of the skin.
LC pick up antigen from the epidermis, process it and carry the antigen on the surface
of the cell in association with MHC class II molecules. The antigen laden cells travel
across the epidermal/dermal junction into the dermis and are then carried by the flow
of the afferent lymph to the draining lymph node. Once in the lymph node, LC are
believed to be the unique antigen presenting cells that can activate and prime naive,
antigen specific T lymphocytes.
In vivo and in vitro studies have revealed significant phenotypical and functional
differences between LC and the related lymphoid dendritic cells. Functionally,
lymphoid dendritic cells are poor antigen processing cells (Kapsenberg et al., 1991).
However they are potent antigen presenting cells and have the capacity to activate
resting lymphocytes in vitro and induce contact sensitisation in vivo (Cumberbatch et
al, 1991a). In contrast freshly isolated LC are very efficient at processing soluble
protein antigens (Romani et al., 1989) but they are relatively inefficient antigen
presenting cells and fail to form stable clusters with T cells (Cumberbatch et
al., 1991b). It has been hypothesised that freshly isolated LC are the in vitro functional
equivalents of the intra-epidermal LC, whereas cultured LC are equivalent to LC that
have already migrated to the draining lymph node. This proposal contains the concept
that the increase in LC antigen presenting cell function that occurs during culture
parallels the differentiaton programme of LC that have migrated to the lymph node.
A comparison between the populations of freshly isolated LC and cultured LC has
revealed phenotypical, morphological and functional differences that could be related
to the specific roles of LC and lymphoid dendritic cells (reviewed by Romani and
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Schulerl992). The main function of the LC is the uptake and processing of antigen.
The presence of acidic organelles and the high cellular synthesis rate of MHC class II
and the invariant chain (Brodsky, 1991; Becker, 1991) could be related to their
efficiency at processing and presenting antigen. These properties are lost on culture
(Streilein, 1989; Kampgen et al, 1991) and replaced by the increased ability of the cell
to present antigen in association with MHC class II and stimulate T cells. Associated
with this new-found ability of the cell is an increase in the expression of MHC class II
molecules (Romani et al., 1989; Schuler and Steinmann; 1985; Shimada et al., 1987;
Teunissen et al., 1990; Witmer-Pack et al., 1988) and adhesion molecules involved in
T cell interactions (Romani and Schuler, 1992), discussed in more detail below.
LC have very poor phagocytic activity compared with the professional phagocytes.
Birbeck granules and CD la surface antigen associated with LC have been implicated
in antigen uptake (Hanau et al., 1987). Birbeck granules are proposed to delay excess
degradation of antigens and this, togetherwith the slow turnover of the surface MHC
class II molecules, is thought to ensure that antigen presentation can still occur in the
time taken for LC to make contact with antigen-specific T cells (Kapsenberg et
al, 1990).
ii). Migration ofLC
The ability of LC to migrate is supported by a number of studies. Following skin
sensitisation there is a gradual reduction in LC, an increase in afferent lymph veiled
cells (many containing Birbeck granules) and an accumulation of dendritic cells in the
lymph nodes (Hoefsmit et al., 1982; Kripke, 1990; Knight et al., 1985a and b).
Following the topical application of the contact sensitiser fluoroscein isothiocyanate
(FTTC) to the skin of mice, dendritic cells were found in the draining lymph node that
were carrying FTTC and had the ability to stimulate FITC specific primary T cells
(Macatonia et al., 1987). In vitro, Larsen et al., (1990) created an organ culture skin
model and demonstrated the capacity of LC to leave the epidermis, accumulating as
MHC class IT dendritic cells within the dermis and subsequently migrating out from
the skin explant into the culture medium.
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Collectively, these studies make it very likely that LC migrate from the epidermis to
the lymph nodes. However the possibility that some of the migrating cells are dermal
dendritic cells has to be considered and will be discussed later.
iii). Antigen presentation
The primary site of sensitisation to antigen is the regional lymph node. There the
antigen laden dendritic cell stimulates the T cells through the interaction of the T cell
receptor TCR/CD3 complex on the T cell specific for the MHC/peptide complex on
the surface of the dendritic cell. These T cells are then stimulated to proliferate and
produce cytokines. A unique feature of dendritic cells is their capacity to form stable
aggregates with T cells in an antigen independent manner (Inaba and Steinman, 1986;
Inaba et al., 1986; Inaba et ah, 1989). This is irrespective of a fit between the antigen
specific T cell receptor on the T cell and the MHC class E/peptide on the dendritic
cell. This is thought to enhance the probability of the dendritic cell encountering the
specific T cell reactive for antigen/MHC II complex from large populations of non¬
specific T cells. The molecular basis for this aggregation is unknown but may involve
some of the surface markers described below.
Recent research over the last few years has convincingly demonstrated that a resting T
cell requires 2 signals for induction of cytokine gene expression and cellular
proliferation (reviewed by Schwarz, 1990 and Jenkins, 1992). The first signal is
provided by the ligation of the TCR/CD3 with the antigen/MHC complex described
above, and this confers the antigen specificity of the T cell. A second 'costimulatory
signal' is however required to activate the T cell. These costimulatory signals are
provided by the interaction of other surface molecules with their cognate ligands and
are described below.
iv). Modulation ofLCphenotype andfunction during migration
The mechanism of LC function in vivo is not fully understood although it appears to
be dependent upon granulocyte macrophage-colony stimulating factor (GM-CSF)
(Heufler et al., 1987, Witmer-Pack et al., 1988), which will be discussed in more detail
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below. During this maturation process in culture, a number of surface markers have
been found to be up or down regulated which could be related to the migration and
enhanced function of the LC in vivo.
E-cadherin
Cadherins are expressed in the normal, uninflamed epidermis (Nose et al., 1986), and
mediate cell to cell adhesion in the tissues by binding to identical cadherins on
adjacent cells (Takeichi, 1990 and 1991). A recent study by Tang et al., (1993)
demonstrated the expression of cadherins by freshly isolated LC and, in vitro these
LC adhered to keratinocytes through the molecule E-cadherin. Following LC culture
the expression of E-cadherin was down-regulated which was associated with a
decrease in the affinity of the LC for the keratinocytes. It was proposed that in vivo
under normal resting conditions LC persist in the epidermis through the interaction of
the E-cadherin molecule with keratinocytes. Following antigenic challenge, a change
in the local environment, possibly mediated by keratinocyte cytokine production
(discussed below) results in the down regulation of E-cadherin permitting the LC to
leave the epidermis and migrate to the local lymph node.
Intracellular adhesion molecule-1 (ICAM-1) andB7
ICAM-1 has been shown to be important in the presentation of antigen in association
with MHC class II (Dang et al., 1990) by inducing important costimulatory signals
through the lymphocyte function associated antigen 1 (LFA-1) of T cells (Seventer et
al., 1990). During LC culture, ICAM-1 expression is upregulated indicating its role in
the enhanced function of the cultured LC (Tang and Udey, 1991,1992; Simon et
al., 1991). There is also evidence to suggest that this ICAM-I/LFA-I interaction may
be involved in the antigen independent T cell clustering described previously (Lorenz
et al., 1993, Makegoba et al., 1989).
ICAM-1 is expressed by other cells that do not always function as antigen presenting
cells and it was recently shown that the presence of an additional molecule, B7 is
required for the functional maturation of the LC (Symington et al., 1993). The B7/BB-
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1 molecule is a member of the Ig supergene family (Yokochi et al., 1982; Freeman,
1989) expressed by B cells and other antigen presenting cells. The B7 molecule binds
to the CD28 and CTLA4 molecules expressed by 95% of the resting CD4 T cells and
is thought to mediate the co-stimulation of CD4+ T cells by regulating cytokine
production (Freedman et al., 1991; Razi-Wolf, 1992). Symington et al., (1993) showed
that cultured but not fresh LC express the molecule B7, and LC B7 co-stimulated the
proliferation of resting CD4+ T cells. A recent study by Larsen et al., (1994) has
shown that GM-CSF acts to upregulate the expression of the B7 molecules by
dendritic cells, confirming the importance of GM-CSF for dendritic cell maturation.
v). Summary ofLCfunction
Epidermal LC are highly specialised to initiate primary immune responses and the
antigen presenting pathway that has been described, i.e the processing of antigen in
the periphery and its presentation to dendritic cells in the draining lymph. A secondary
response is much more rapid and is unlikely to go through this whole sequence of
events, implicating a role for the LC in presenting antigen locally to the primed
antigen specific T cells present in the skin. In vitro studies have demonstrated the
ability of freshly isolated LC to present exogenous protein antigens to peptide specific
and primed T cells (Pure et al., 1990, Streilein et al., 1990). However the role of the
LC in a secondary response has not yet been defined.
An experiment carried out by Yoshikawa et al., (1992) showed that the depletion of
LC from the epidermis of ultra violet B (UVB) treated skin does not inhibit the
expression of pre-exisiting contact hypersensitivity, thereby implicating other antigen
presenting cells of the dermis in the expression of cutaneous immunity, discussed
below.
vi). Dermal dendritic cells
The epidermal LC was identified as the major antigen presenting cell in the original
formulation of SALT, where the dermis was thought to have only a passive role as the
route by which cells entered or exited the skin. However there is increasing evidence
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to suggest that the dendritic cells of the dermis play a part in the induction of
immunity. Dermal dendritic cells or dendrocytes were first described by Headington
(1986) as a population of bone marrow cells distinct from LC. They lack the
morphological and phenotypical characteristics of LC, but share some characteristics
with cells common to the mononuclear phagocyte system. Sontheimer (1989) and
Cerio et al., (1989) described a population of MHC class IT" dendritic cells in human
skin that resembled macrophages more than LC and were located within the papillary
dermis and around dermal vessels. These cells expressed a surface marker factor XIEla
and the authors concluded that these factor XIIIa+ dermal dendritic cells represented a
population of cells separate from LC, that resemble macrophages and may have the
potential for presenting antigen. Much more recent studies (from 1991 onwards) have
implicated dermal dendritic cells as having a crucial role in the development of
cutaneous immunity and these will be discussed in later chapters.
vii). The origin ofLC!dendritic cells
Dendritic cells originate in the bone marrow from as yet uncharacterised haemopoietic
precursor cells and their development is poorly understood. There is some
controversy surrounding the relationship of the dendritic cell with the monocyte-
macrophage lineage, with the suggestion that both sets of cells arise from a common
precursor. Peters et ai, (1991) have produced evidence supporting the concept that
monocytes/macrophages represent a reservoir of pluripotent cells that differentiate
into dendritic cells in situ. However Sternman (1983) supports the view that there is a
distinct precursor cell within the bone marrow that is pre-committed to development
into a dendritic cell rather than a monocyte or macrophage. Thus a common precursor
in the bone marrow differentiates into neutrophils, eosinophils, basophils or
monocytes. Once these cells emerge into the blood no further interconversion occurs.
These separate pathways of development can be recreated in bone marrow culture
using specific cytokines such as granulocyte-colony stimulating factor for neutrophils
and macrophage colony-stimulating factor for macrophages (Sieff, 1987; Clark and
Kamen, 1987; Metcalf, 1985). This would support the case for a separate lineage for
the development of dendritic cells. It is proposed that precursor cells migrate to the
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peripheral tissues such as the epidermis and reside there in an immature state as LC
and it is this stage of development that is poorly understood (Breathnach, 1991).
These immature cells, probably on antigenic stimulus, resume their migratory function
and accumulate in the draining lymph node where they arrive as mature dendritic cells.
It is believed that dendritic cells do not recirculate as they are not observed in the
efferent lymph, and the lymphoid organs are the terminal stage for dendritic cells
(Romani and Schuler, 1992).
Currently there is little information concerning the regulation of the maturation
process or the relationship of the LC with the dermal dendritic cells. The maturational
changes which occur during the culture of LC are mediated by granulocyte
macrophage-colony stimulating factor (GM-CSF) and may be augmented further by
interleukin-1 (IL-I) (Heufler et ai, 1987). In addition, GM-CSF and also tumour
necrosis factor-a (TNFa) (Koch et ai, 1990) sustain LC viability in vitro. GM-CSF,
IL-1 and TNFa are all products of keratinocytes. Keratinocytes represent the bulk of
the epidermis and are in close contact with LC, it is therefore possible that these
cytokines induce functional and phenotypical maturation of LC comparable to that
observed in culture, as they migrate to the lymph node.
1.2.2. Keratinocytes
i). Cytokine production
The keratinocyte, which constitutes the growing component of the skin, has generated
considerable interest over the last ten years due to its ability to influence
immunological reactions in the skin. In vivo, keratinocytes have been demonstrated to
produce a broad range of cytokines that can modulate LC function and induce
inflammation (Luger et al., 1988). Cytokines represent a heterogeneous group of
polypeptides that mediate intercellular communications both within and between
immune and non-immune cells. The cytokines produced by human and murine
keratinocytes are listed in Table 1.2.
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Platelet derived growth factor + (+)
Fibroblast growth factor + (+)
Interleukin-10 ? +
Note: + = known to be produced; (+) = presumably produced, ? = unknown.
Adapted from Luger and Schwarz (1991).
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As keratinocytes represent the major cell type within the epidermis and because
microenvironments play a major role in dictating cellular functions, keratinocytes are
now considered to be the major determinant of the intraepidermal space.
Keratinocytes thus set the tone for the activities of LC and other cells within the skin
that come under their influence. Under normal physiological conditions (in resting
skin) cytokine production by keratinocytes is at a baseline level maintaining the
immune homeostasis of the local environment The pattern and character of cytokine
production by keratinocytes is altered when the epidermis is perturbed either by
physical/chemical damage or by pathogens. This alteration activates LC thereby
initiating immune responses. There is evidence to suggest that keratinocytes may be
responsible for the stimulus of LC migration. TNF-a injected intradermally results in a
rapid reduction in the density of LC and a rapid and concentration dependent
accumulation of dendritic cells in the local lymph node (Cumbertatch and Kimber,
1992). Kock et al., (1990) have demonstrated the ability of keratinocytes to produce
TNF-a. Exposure of keratinocytes in vitro to UVB induces keratinocyte production
of TNF-a and causes a reduction in LC density (Koch et al., 1990) thereby
supporting the role of the keratinocyte in LC migration.
ii). T cell interaction with keratinocytes
In addition to the production of cytokines, keratinocytes may function as antigen
presenting cells in the skin resulting in a more efficient initiation of the immune
response. Keratinocytes can be induced in the presence of IFNy to express ICAM-1
and MHC class II molecules (Dustin et al., 1988, Volc-platzer, 1985). In vivo, MHC
class II and ICAM-1 expressing keratinocytes have been found in skin diseases
characterised by T cell infiltration (Volc-Platzer et ai, 1988, Wantzin et al., 1988). As
MHC class II and ICAM-1 are involved in antigen presentation with T cells,
keratinocytes in the presence of cytokines may play an essential role in cutaneous
immune reponses (Londei et al., 1984, Dustin et al., 1988).
The expression of MHC class II by keratinocytes following cytokine stimulation in
vivo in the presence of costimulatory signals could enable these cells to initiate
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immune responses in the absence of professional antigen presenting cells. Nickoloff
(1993a, 1993b) showed that keratinocytes could provide costimulatory signals to T
cells stimulated with bacteria derived antigens (known as superantigens) resulting in T
cell proliferation and cytokine production. This costimulatory signal did not appear to
occur through the B7/CD28 interaction that was described previously for professional
antigen presenting cells. Keratinocytes do express a member of the B7 family BB-1
(or B7-3), but it is unclear if CD28-BB-1 provides T cell costimulation and it is
thought that the keratinocytes deliver their costimulatory signals through unknown
cell surface or soluble proteins (Nickoloff, 1993b).
Recent studies have also shown that the nature of the antigen presenting cell,
professional or non-professional, may determine whether T cells become Thl or Th2
cells (reviewed by Nickoloff and Turka, 1994). Resting T cells (ThO) have the
potential to produce a variety of cytokines including IFNy, IL-4, IL-5 and IL-10
(reviewed by Howard, 1993). The cytokine profile and/or the type of costimulatory
signal provided by the two types of antigen presenting cells determines the
development of the ThO cell into Thl or Th2 cells. The production of the cytokines
IL-12 and IFNy by the professional antigen presenting cells such as macrophages and
activated B cells (Hsieh, 1993) is essential for the development of Thl effector cells
whereas the non-professional antigen presenting cells (the keratinocytes) do not
produce IFNy. Instead they synthesise IL-10 that appears to block IFNy (Enk and
Katz, 1992) and this results in the generation of Th2 cells.
Thus the cells of the epidermis have the ability to regulate the nature of the immune
response to local antigens and the disruption of this cytokine balance may be
important in the development of autoimmune states such as psoriasis.
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1.2.3. Epidermotropic lymphocytes
A large number of experiments support the existence of skin-seeking lymphocytes.
These cells represent a subset of recirculating T cells that preferentially migrate into
the skin and reside there for an undefined period of time (homing T cells - Streilein et
al, 1978). T lymphocytes are absolutely critical to cutaneous immunity, acting in
conjunction with antigen presenting cells to produce a specific immune response that
acts both locally and systemically. Dermal vessels promote T cell immigration by the
methods described below and the T cells themselves are postulated to possess specific
markers that enable this process to occur. Picker et al., (1990) recently identified a cell
surface marker (HECA-452) that is expressed on a subset of T cells in the blood and
on the majority of T cells in the skin but is rarely found on T cells in non-cutaneous
sites of the body, implicating this marker as a candidate marker for skin-seeking T
cells.
Ninety percent of the T cells present within the skin were found to be located in the
dermis, and in contrast to their circulating counterparts, the majority of these dermal
T cells were found to be activated (Bos et al., 1987). There was an approximately
even distribution of CD4+ (helper/memory) T cells and CD8+ (suppressor/cytotoxic)
T cells. The majority of the T cells within the skin appeared to be of the memory cell
type with naive T cells being relatively rare (< 5%) (Bos et al., 1987, 1989).
Epidermotropism of T cells is prominent in many dermatological diseases ranging
from rare cutaneous lymphomas (Stynavsui et al., 1985, Ruiter et al., 1982, Poppema
et al., 1983) to common benign inflammatory diseases such as eczema and psoriasis
(Bjerke, 1982; Bos et al., 1982; Baker et al., 1984). In diseased skin it is probable
that a proportion of the infiltrating T lymphocytes are antigen specific and have
become activated within the skin's microenvironment.
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1.2.4. Skin vasculature and lymphatic drainage
The S.I.S is connected to the remainder of the body's immune system by the blood
and lymphatic vasculature. It was proposed early on that there is a specialisation of
dermal microvessels that promote the immigration of skin-seeking lymphocytes from
the blood. It has now been firmly established that the post-capillary venules are
responsible for directing the migration of lymphocytes and other blood borne cells
into the extravascular space (Chin et al, 1988). Other studies have identified cell
adhesion molecules such as endothelial lymphocyte adhesion molecule -1 (ELAM-1)
that are expressed by stimulated and not resting endothelial cells (Albelda and Buck,
1990). These molecules are thought to act as receptors for coreceptors expressed by
leukocytes, including lymphocytes that promote migration of T cells and other cell
types into the skin. In vivo studies demonstrate that these cell adhesion molecules are
found primarily in pathological conditions and it is not known whether they are
involved in promoting T cell immigration in 'resting' skin.
The skin lymphatics are essential in the generation of cutaneous immune responses.
Very early studies of skin transplantation (Barker and Billingham, 1968) and contact
sensitisation (Frey and Wenk, 1957) showed that the afferent lymphatics had to be
intact in order to obtain immunity. The induction of a primary immune response to an
antigen is dependent upon the transport of antigen to the local lymph node where the
antigen can be presented to a naive T cell. The strategic location of the lymph nodes
ensures that a protected site exists where naive T cells can interact productively with
antigen bearing LC that have arrived via the lymph.
1.2.5. Other cellular components of S.I.S.
i). y8-type T cells
Another constituent of the S.I.S was identified in the murine epidermis as a bone
marrow derived population of dendritic cells distinct from LC that express the Thy-1
alloantigen. They are now called dendritic epidermal T cells (DETC) (Steiner, 1988).
These cells express unusually homogenous CD-2-associated TCR of y/5 type and are
26
preferentially located within the epidermis. They are thought to provide a more
primitive immunological defence system designed to recognise antigens in the context
of non polymorphic restricting elements resembling, but distinct from, the classical
class I or II molecules such as CD1 (Bucy et al., 1989).
The failure to demonstrate a dense network of CD3+ y/5+ cells in human epidermis led
to the conclusion that a human analogue for murine DETC does not exist (Bucy et al,
1989; Cooper et al, 1985). However recent studies have defined a minor subset of
y/5+ T cells within normal skin (Bos et al., 1990). These y/5+ T cells exhibit a greater
tendency to localise in the epidermis compared to the cc/f3 CD4 and CD8+ T cells.
They have functional properties similar to conventional T cells (Raulet, 1989) and it is
not known if they represent a human equivalent of murine DETC.
ii). Macrophages, mast cells and neutrophils
Macrophages, mast cells and neutrophils are all found in low numbers within normal
skin. However they can be found in large numbers in the inflammatory infiltrates
observed in several cutaneous immune reactions. Macrophages serve functions related
to both non-specific or natural immune reactions and specific defence systems, and
have a role in the resistance to viral infections (reviewed by Unanue and Allen, 1987).
The mast cells of the skin play an important role in immediate hypersensitivity
reactions and non immune inflammation (Metcalf et al., 1981; Lee, 1985) by
regulating vasculature and T cell traffic.
1.2.6. The role of cytokines in viral infections
Both IFNy and TNFa exhibit potent and-viral activities in vitro. IFN induces an anti¬
viral state in uninfected cells (Staeheli, 1990) and prevents viral replication and the
subsequent spread to neighbouring cells. TNFa also acts by inhibiting viral replication
(Feduchi and Carrasco, 1991) inducing an anti-viral state in the cells (Wong and
Goeddel, 1986), the process of which is enhanced by the synergistic actions of EFNa
and IFN|3 (Feduchi and Carrasco, 1991; Wong and Goeddel, 1986, Mestan et
al, 1988; Reis, 1989).
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In order to determine the anti-viral role for these cytokines in vivo, Ramsay and
colleagues (1993) carried out a series of experiments using recombinant vaccinia
viruses (rw) constructed to encode different murine cytokine genes, and injected
them into athymic, nude mice. These mice lack mature functional T cells and die from
disseminated infections with the wild type vaccinia virus. However it was found that
the local expression of specific cytokines at the site of infection could control vaccinia
virus replication. Infection of the mice with rw encoding IFNy (Kohonen-Corish et
al., 1990) or TNFa (Sambhi et al., 1991) led to the direct clearance of the virus in
vivo, without any evidence of enhanced host reactivity. It was demonstrated that
CD8+ T cells are the major producers of IFNy (Ruby et al. 1994) in a vaccinia virus
infection. Thus it has been been proposed that the major function of CD8+ T cells
following class I restricted recognition of virus infected targets is to focus anti-viral
cytokines EFNy and TNFa at the sites of viral replication (Ramsay et al., 1993).
Other cytokines may have a role in the induction of local inflammatory responses to
viral infections and these will be discussed in a later chapter.
1.3. THE CUTANEOUS RESPONSE TO ORF VIRUS
INFECTION
From early on orf virus was recognised to be highly epitheliotropic, thereby inducing
"tissue" immunity (Aynaud, 1923; Glover, 1928; Boughton and Hardy, 1935;
Darbyshire, 1961). Some of these early studies described an influx of inflammatory
cells consisting of mononuclear and polymorphonuclear cells into the dermis at the
site of infection (Glover, 1928; Aynaud, 1923; Wheeler and Cawley, 1956;
Abdussalam, 1957). Most of the subsequent studies were however concerned with the
humoral response described previously. Failure to detect protective humoral and
systemic cellular responses has led to a number of recent studies of the cutaneous
responses to orf virus infection.
Techniques exist for the chronic collection of both afferent and efferent lymph in
sheep (Lascelles and Morris, 1961). These techniques were employed together with a
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detailed immunohistological analysis of the orf lesion to study the local immune
response to orf virus. Most of the studies so far, have described the response of
previously exposed sheep to a secondary infection with orf virus and the results are
summarised below.
1.3.1. The polymorphonuclear neutrophil response
Following scarification and infection with orf virus there is a biphasic influx of
polymorphonuclear cells, predominantly neutrophils into the infected skin (Jenkinson
et al., 1990a). The initial inflammatory response occurs within the first 24 h, well
before the detection of viral antigen (the eclipse phase, Osman, 1976) and is the result
of tissue damage caused by scarification. The application of the viral inoculum
appears to enhance the initial inflammation in comparison with uninfected scarified
skin. It is not known if this is as a result of a generalised increase in the antigenic load,
or the presence of specific viral proteins. This initial influx of neutrophils into the
dermis is reflected by a transient increase in the number of neutrophils detectable in
the afferent lymph (Yirrell et ai, 1991a). Neutrophils do not appear in significant
numbers in the efferent lymph and the general flow of cellular traffic in the efferent
lymph is reduced transiently in the early hours following infection due to the
entrapment of cells within the lymph node, a phenomenon known as "lymph node shut
down".
The second phase of inflammation is observed 3-4 days post-infection and results
from a reaction to the viral replication within the epidermis. At this stage viral antigen
is detectable within the regenerating epidermal keratinocytes. The viral cytopathic
effect is characterised by ballooning and degeneration of the infected cells. An
extensive influx of neutrophils into the underlying dermis and infiltrating the
degenerated ballooning cells of the epidermis is observed. Subsequently the whole
degenerated mass and accumulated neutrophils are shed in the developing scab. In
contrast to the first wave of neutrophil infiltration, the second wave is not reflected by
the appearance of neutrophils in the afferent lymph (YiiTell et al., 1991a). It is
proposed therefore that there is either a stronger chemotactic signal holding the
neutrophils within the lesion or they are physically entrapped within the dense mass of
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cells. In efferent lymph there is a rapid recruitment phase of blood lymphocytes at this
time resulting in an increased number of lymphocytes in the lymph node. This is an
established response to antigen challenge.
The function of the neutrophil in the cutaneous response to orf virus is not clear.
Neutrophils are typically associated with tissue damage and the clearance of bacterial
infections. However neutrophils have been implicated in the clearance of some viral
infections (Rouse, 1981) possibly due to the production of an interferon-like anti-viral
protein termed polyferon (Rouse et al., 1980; Ohmann et al., 1989).
1.3.2. The dendritic cell response
The importance of LC/dendritic cells in the induction of cutaneous immunity was
discussed in detail above. The epidermotropism of orf virus and the generation of a
cutaneous inflammatory response might indicate a crucial role for LC/dendritic cells in
the control of orf virus infections. Jenkinson et al., (1991) carried out a study of the
ovine dendritic cell response to orf virus infection. Within 'normal' ovine skin, two
populations of MHC class II+ dendritic cells were described, neither of which were
reported to stain with the classical LC marker ATPase. The MHC class n+ dendritic
cells of the epidermis were found to contain Birbeck granules and stain with the
enzyme marker acetylcholine-esterase (AchE) (Pearse, 1980). These cells were thus
classified as ovine LC. A second population of MHC class II+ dendritic cells within
the dermis were negative for AchE. Following scarification and infection with orf
virus a network of MHC class II+ dendritic cells formed in the dermis. These cells
appeared to accumulate initially as a response to scarification directly beneath the
damaged epidermis. As the infection progressed this network increased, a
phenomenon that was not observed in the scarified, non-infected skin. The dense
accumulation of MHC class II+ dendritic cells did not appear to be of LC origin as
they were AchE". AchE+ dendritic cells were however observed 3-4 days post¬
infection in the afferent lymph but only at a very low frequency compared to AchE"
dendritic cells. Their appearance in the lymph correlated with the detection of viral
antigen, an increased output of AchE" dendritic cells and the ability of cells isolated
from the local lymph node to respond in vitro to orf viral antigens. Yirrell et
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al., (1994) have proposed that the AchE+ cells have a role in antigen carriage to the
local draining lymph node.
It is not known if AchE is expressed constitutively by ovine LC or whether it is a
marker of activation/differentiation, but the AchE" network of MHC Class II+
dendritic cells which gather at the orf lesion indicates that the cells share the
phenotype of the dermal dendritic cells of normal ovine skin. The origin and kinetics
of the MHC Class U' dendritic cell accumulation are not known. They are postulated
to provide a framework for epidermal repair and immune reactions. It is thought that
these dendritic cells are crucial to the control of orf virus infection, serving as a
physical barrier preventing the downward spread of the virus and possibly functioning
as antigen presenting cells interacting locally with T cells (Jenkinson et al, 1991).
1.3.3. T cell and B cell responses
T lymphocytes are critical to the generation of the cutaneous immune response and
also have a crucial role in the B cell production of antibodies. A study carried out by
Jenkinson et al., (1992) demonstrated the presence of B and T cells in the cutaneous
inflammatory response to orf virus. During the initial inflammatory response to
scarification and infection, T lymphocytes were observed to gather at the site of the
injury. The dermal T cell number remained high and continued to increase, peaking at
72 h post-infection. The CD4+ T cells, CD8+ T cells and yd T cells were all found to
be involved. The yd T cells appeared to have a prominent role within the epidermis
and pustules. The role of yd T cells remains undefined but their frequent association
with ruminant epithelial surfaces has implicated them in an immunosurveillance role
(Hein and McKay, 1991). In the lymph, the majority of the afferent lymphocytes were
demonstrated to have the memory phenotype in contrast to the efferent lymphocytes
which are almost exclusively naive (Yirrell et al., 1991b).
B cells were also shown to accumulate in response to orf virus infection, permeating
the dense accumulation of MHC Class IT dendritic cells and penetrating into the
infected epidermis. B cells were, however, most frequently observed in association
with dermal blood vessels. It is proposed that these B cells, presumably stimulated to
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produce anti-orf antibody, migrate directly into the blood, where increased levels of
antibody can be detected (Yirrell et al., 1989). This is supported by the absence of an
increase in antibody or antibody producing cells in the afferent lymph draining the
lesion (Yirrell et al., 1991a). Antibody producing cells are however detected within
the efferent lymph and it was determined that the major effort of the lymph node
draining the orf lesion may be the production of orf virus specific antibody (McKeever
etal, 1987).
1.3.4. Comparative aspects of orf virus infection with other viral
infections of the skin
The viruses vaccinia, herpes simplex virus (HSV) and human papilloma viruses (HPV)
are all, like orf virus, highly epitheliotropic replicating in the epidermal keratinocytes
of the skin. Cutaneous cellular immunity is proposed to be critical in the control of
each of these infections.
Vaccinia virus, like orf virus, is a member of the poxvirus family and was used to
vaccinate against smallpox virus infection in humans. The importance of cellular
immunity in the control of vaccinia virus infections is highlighted by the progressive
spread of infection in infants with defects in T cell immunity. The infection progresses
through stages of papule, vesicle and pustule similar to that of orf virus infections, but
when the scab that is formed is shed, it leaves a scar. The lesion is characterised by
epidermal degeneration and vacuolation plus cellular proliferation (Downie, 1939). An
influx of inflammatory cells including macrophages and lymphocytes is observed
separating the lesion from the dermis (Buller, 1991). Systemic cellular immunity is
detectable and the humoral response generated to vaccinia is thought to prevent the
dissemination of the infection and to protect the host from re-infection. Locally, cell-
mediated cytolytic killing of infected cells is thought to be one of the main responses
in experimental animals, although cytotoxic T cells are not detected in the peripheral
blood of vaccinated volunteers (Graham et al., 1991). Increased numbers of LC are
observed at the site of inoculation in mice (Sprecher and Becker, 1989) and in
vaccinated children the LC at the site of inoculation were found to contain non-
replicating viral particles with an associated increase in LC acidic organelles (Nagoa et
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al., 1976). Thus LC are involved in the control of infection. More recent murine
studies have implicated the Ly-1+DETC as the most important effector mechanisms in
early defence against vaccinia virus infection (Ikeda et al., 1991). These cells are
thought to act as natural killer cells within the epidermis (Koning et al., 1987).
HSV lesions differ considerably from vaccinia and orf virus lesions since they show no
epidermal proliferation. During a primary infection with HSV, the virus gains entry to
the local sensory nerves and establishes a latent infection within the neurones. The
local cutaneous immune system appears to maintain the virus in a latent mode, but
occasionally the virus reactivates causing a recrudescent lesion (reviewed by Stevens,
1989). The importance of LC in the control of HSV was demonstrated by a murine
experiment whereby the density of LC at the site of inoculation was found to affect
the severity of the infection (Sprecher and Becker, 1989). LC have also been shown
to take up HSV (Sprecher and Becker, 1986) and act as antigen presenting cells in
lymphoproliferation assays (Yasumoto et al., 1986). Other cells are involved in the
local inflammatory response to HSV; macrophages are thought to be important local
effector cells (Kohl, 1985) and both CD4+ and CD8+ T cells are present. Cytotoxic T
cells and T helper/delayed hypersensitivity have both been demonstrated to be
essential for effective clearance of HSV from skin lesions (Wildy and Gell, 1985).
HPV infections have proved more difficult to study due to the lack of an experimental
model. The importance of the immune response is however emphasised by the
extensive and persistent warts seen in individuals that are immunocompromised,
particularly those with depressed cell mediated immunity. Some types of HPV cause
highly proliferative lesions that can persist for several months/years and, although an
inflammatory infiltrate of T cells and mononulear phagocytes has been demonstrated
in regressing warts (Iwatsuki et al., 1986) it is not commonly observed. It is postulated
therefore, that HPV may cause an alteration in the local immune response which will
be described in more detail below.
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1.4. VIRAL MECHANISMS OF IMMUNE EVASION
The immunity induced by primary infections to all four viruses; orf, vaccinia, HSV and
HPV is incomplete despite high levels of circulating antibody. HSV, HPV and
vaccinia virus all have the ability to alter or evade the local cutaneous response and
this may be responsible for the incomplete immunity that is observed.
A direct method of immune evasion is employed by HSV. The virus establishes a
latent infection in the sensory nervous system and local cutaneous immunity maintains
latency. In a recrudescent infection, the inflammatory response initiated by the LC is
delayed until 2 days after virus can be detected in the skin, indicating that the virus
may also have other methods of evading the host response.
Studies of the lesions caused by HPV have demonstrated a reduction in LC numbers
(Tay et al., 1987), changes in MHC class II expression (Hughes et al., 1988) and a
decrease in T cell numbers with no detectable T cell activation (Tay et al., 1987),
suggesting that HPV may induce a local immunodefficiency by as yet unknown
mechanisms thereby resulting in the development of a persistent infection.
Vaccinia virus appears to be the most adept of the three viruses at interfering with the
host immune response. The extensive characterisation of the vaccina virus genome has
recently identified numerous genes that contribute to viral virulence. These genes
interfere with a number of different components of the host defence system and have
been extensively reviewed by Smith (1993). The mechanisms include interference with
the complement cascade and cytotoxic T cell responses-indicated as having an
important role in combatting vaccina virus infections, and general interference with
inflammatory processes though the production of serine proteinase inhibitors
(serpins). The importance of the cytokines, IFN and IL-1, in the control of vaccinia
virus is emphasised by the multiple mechanisms that the virus has acquired to evade
them. IFN produced by cells in response to viral infection acts by conferring an
antiviral state on the cell thereby limiting viral replication and the spread of the
infection (Samuel et al., 1991). It has been recognised for some time that vaccinia
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virus is resistant to IFN and can even rescue other sensitive viruses (Thacore and
Younger, 1973a and b). One of the ways the virus confers this resistance is by
preventing the IFN induction of the anti-viral state by expressing two gene products
K3L (Davies et al., 1992) and E3L (Chang et al., 1992) that interfere with the cellular
pathways of translational control. Vaccinia virus also expresses a serpin which inhibits
the interconversion of the IL-1(3 precursor form into the secreted and active form
(Ray et al., 1992). In addition to these mechanisms vaccinia has recently been
demonstrated to possess genes encoding soluble receptor homologues for IFNy and
IL-1(3 (Smith, 1993).
These soluble receptor homologues have added to the increasing family of immune
evasion proteins possessed by the poxviruses. The first to be identified was a receptor
homologue for TNF. Computer homology scores of the Shope fibroma virus genome
revealed a gene that encodes a protein with significant homology to the ligand binding
domain of the human type-1 TNF receptor (TNFR-1) (Smith et al., 1990). When the
recombinant protein was expressed it was found to be secreted as a soluble protein
that specifically binds TNFa and TNF|3 with high affinity (Smith et al., 1991).
Myxoma virus, another orthopoxvirus, has also been identified as possessing a TNFR
homologue. Vaccinia virus contains a sequence homologous to TNFR (Howard et
al., 1991) but the identified open reading frame is interrupted by a frame shift and a
termination codon that suggests that an intact receptor protein is unlikely.
Virally encoded proteins have been shown to help the virus evade the host immune
surveillance mechanisms, participate in the regulation of deleterious cytokine
production and interfere intracellularly with host derived anti-viral mechanisms. Upton
et al., (1991) predict the existence in the most pathogenic poxviruses of multiple
cytokine receptors, termed viroreceptors, each targeted for a different pathway
dependent upon lymphokine-receptor interaction.
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1.5. AIMS OF THESIS
The local cutaneous immune system is clearly important in the control of viral
infections of the skin but little is known about the interactions of the specific virus
with the cells involved in generating a protective immune response to the infection.
Orf virus infection of sheep provides an opportunity to study local in vivo immunity to
a skin tropic virus in its natural host where the skin lesion is localised and visible, and
and where there is no systemic disease.
The local cutaneous response to orf virus infection involves a number of different cell
types. Central to this response is a network of MHC class IT" dendritic cells that are
postulated to form a framework for epidermal repair and immunological reactions.
This thesis is designed to further knowledge of the local cellular response to orf virus
by characterising in detail the dendritic cell network of both the primary and
secondary orf lesions. The relationship of these MHC class IT dendritic cells with the
dendritic cells normally resident within the skin, the kinetics of the response and how,
or from where, the network of dendritic cells originates will be examined (see chapter
3). In addition, pure cultures of ovine keratinocytes will be infected with orf virus in
vitro to determine the kinetics of viral replication and CPE (see chapter 4) .This in
vitro model of infection will then be used to investigate cytokine production by ovine
keratinocytes infected with orf virus, to determine the ability of the virus to induce or
suppress a range of cytokines which may play an important role in the resolution of an





2.1. ORF VIRUS INFECTION OF SHEEP
2.1.1. Sheep
Female Suffolk cross sheep, reared at the Moredun Research Institute, were used in
all the experiments.
Group 1. Primary orf infection.
Four specific pathogen free (SPF) lambs were isolated from birth and kept in an
environment free from orf virus before and during the experiment When two months
old, all four animals were given a primary infection with orf virus following the
method described below.
Group 2. Secondary orf infection.
Four conventionally reared sheep, aged between 12 and 14 months old, were used.
Blood samples were taken from the animals prior to the start of the experiment and
analysis by ELISA (described below) revealed positive titres to orf virus antigen
which indicated previous exposure to orf virus in the field. The animals were
challenged experimentally with orf virus, as outlined below.
Group 3. Control scarification.
Four conventionally reared control sheep, aged between 12 and 14 months old, were
scarified experimentally but not challenged with orf virus to act as controls.
2.1.2. Viral inoculum and inoculation procedure
The virus used in the experiments was Scabby Mouth, a vaccine produced by the
Commonwealth Serum Laboratory of Australia consisting of live tissue culture
propagated orf virus which has retained virulence. All 12 animals were scarified on
the inner thigh with a single stroke using a 16 gauge needle. To groups 1 and 2, 0.1ml
of the vaccine (107 tissue culture infectious dose (TCID5o)/ml) was applied topically
to the treated skin. To the abrasions of group 3, 0.1ml of phosphate buffered saline
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(PBS) was applied. Skin samples (6mm in diameter) were taken by punch biopsy from
all 12 animals across the scar lines at Oh, 48h, 96h and 170h after treatment Extra
biopsies were collected from the primary infected animals at days 9,12,16, 22 and 30
for qualitative observations. The biopsies were immediately placed into formaldehyde
cacodylate fixative [20mls formaldehyde, 13.7g of sucrose, 3.424g of sodium
cacodylate (B.D.H, Poole, Dorset, UK) in distilled water].
2.1.3. ELISA for the detection of orf virus antibodies in ovine sera
Ovine sera were screened for antibodies to orf virus following the procedure of Yirrell
et al., (1989) and was carried out on my behalf by Janice Gilray. In brief, alternate
wells of a microtitre plate was coated with either control antigen (prepared from
monolayers of foetal lamb muscle cells (FLM)) or orf viral antigen (prepared from orf
virus infected monolayers of FLM) in coating buffer at 4°C overnight After washing,
doubling dilutions of the test sera, from 1:100, were added in duplicate to the plate
along with positive (ovine hyperimmune sera) and negative (sera from SPF lambs)
controls and incubated at room temperature for 2 hours. After further washing steps,
a secondary antibody, donkey anti-sheep IgG horse radish peroxidase conjugate
(Sigma), was allowed to react for a similar time. O-phenylenediamine (OPD, Sigma)
and 30% hydrogen peroxide were added for 3 min at room temperature before the
reaction was stopped by the addition of 2.5M H2S04. The end point titre was
calculated as the highest dilution greater or equal to the mean of eight wells (four
control and four orf antigen) of a 1/100 dilution of sera from SPF lambs.
2.1.4. Immunohistology
i). Tissue Processing
Each skin specimen was fixed for 2-3h at 4°C in the cacodylate/formaldehyde fixative
(described above) and then stored for up to 18h in 0.4M sucrose at 4°C (Jenkinson et
al., 1991). The specimens were halved; one half was frozen in liquid nitrogen and then
stored at -70°C. The other half was processed to paraffin wax by the St.Marie
method (Pearse, 1980). In brief, the tissue was placed into plastic cassettes and left
overnight in 70% ethanol at 4°C. The next day the tissue was processed through half-
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hour changes at 4°C of; absolute alcohol (three incubations), equal parts absolute
alcohol/xylene (two incubations) and then into xylene (at room temperature) before
being processed under vacuum into wax. For quantitation or semi-quantitation of
dendritic cells by immunohistology, 10pm thick serial sections of each of the biopsies
were cut and 5 sections of at least 50pm intervals apart, mounted on the same slide
pre-coated with Biobond (British Biocell, Cardiff). Extra non-serial 10pm paraffin
sections from primary lesions were cut for non-quantitative assessment. Sections of
fixed, frozen tissue were cut at 10pm thick in a cryostat for immunostaining with
some of the antibodies (see below).
ii). Avidin-biotin immunoperoxidase technique
Using an avidin/biotin immunoperoxidase technique (Vectastain Elite, Vector
Laboratories Ltd, Burlinghame, USA) a set of slides from each sheep was
immunostained with a panel of specific antibodies listed below.
The paraffin tissue sections were deparaffinized through xylenes and graded alcohol
series and rinsed in distilled water. Both frozen and paraffin sections were washed for
20 min in PBS buffer pH 7.5 (3.8g sodium phosphate, 9g sodium chloride dissolved in
1 litre of distilled water and adjusted to pH to 7.5 with hydrochloric acid, with the
addition of 0.5ml Tween 80) and blocked for 20 min with normal horse serum diluted
(1:4) in high salt PBS buffer (prepared by the addition of 2g of sodium chloride to
lOOmls of PBS wash buffer with no Tween 80). The excess serum was blotted from
the sections (without letting them dry) and the sections incubated with primary
antibodies overnight at 4°C in a moist box. The slides were washed in PBS buffer for
10 min and incubated with the Vectastain Elite secondary antibody solution,
biotinylated horse IgG anti-mouse immunoglobulin (2.5pl biotin conjugate and 17.5ul
normal horse serum diluted in 1ml of high salt PBS buffer) for 30 min at room
temperature. For the rabbit antiserum against factor XIHa, biotinylated goat anti-
rabbit immunoglobulin (Vector Laboratories) was used as the second stage reagent
After another wash any endogenous peroxidase activity in the tissue was quenched by
incubation in 1% hydrogen peroxide in methanol for 15 min. The sections were
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washed in PBS buffer for 10 min and subsequently incubated with Vectastain Elite
ABC reagent (20ul of reagent A and 20ul of reagent B in 1ml high salt PBS buffer)
for 30 min, again at room temperature. After a final wash in buffer the slides were
incubated in peroxidase substrate solution - diaminobenzidine (DAB) substrate kit
(Dako Ltd, High Wycombe) 1 drop of buffer, 2 drops of DAB and 1 drop of
hydrogen peroxide into 2.5mls of distilled water (mixing in between each addition)
until staining could be seen under the microscope (approximately 2-7 min) and the
DAB was washed off the sections under running tap water. All slides were
counterstained in haematoxylin and Scott's tap water (3.5g of sodium bicarbonate and
20g of magnesium sulphate dissolved in 1 litre of distilled water), dehydrated through
graded alcohols and histoclear (National Diagnostics, New Jersey) and mounted in
histomount (National Diagnostics).
iii). Double staining immunoperoxidase!alkaline phosphatase technique
For two colour analysis, a second monoclonal was applied after the first had been
coloured by DAB and was incubated for an hour at room temperature. The
incubations were repeated as described previously but the second stage reagent was
exchanged for an alkaline phosphatase labelled avidin-biotin complex (also supplied
by Vector laboratories). The enzyme was visualised using a different coloured
substrate; New Fuschin (Vector laboratories) that gave a red/violet colour. The slides
were counterstained and mounted as described before.
iv). Antibodies
Each antibody (in high salt PBS buffer) was titrated on ovine tissue and the optimal
working dilution determined.
MHC class II
Murine monoclonal IgG 2a antibody SBU II 49.1, an anti-MHC class II antibody that
recognises an epitope common to ovine DR and DQ (Puri et al., 1987) was used at a
dilution of 1:50. It was obtained from Dr Mai Brandon, University of Melbourne.
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SBUT 6
Murine monoclonal antibody SBU T6 20:27, an anti-ovine, pan CD-I specific
antibody that recognises an antigen expressed on the surface of cortical thymocytes,
epidermal/dermal dendritic cells and a subset of B lymphocytes (Mackay et al., 1985
and Howard et al., 1987). The optimal working dilution was 1:4. It was obtained
from DrMai Brandon, University of Melbourne.
Factor XJIIa
Rabbit IgG anti-human coagulation factor Xllla (Calbiochem-Novobiochem, La Jolla,
USA) has recently been used to identify a subgroup of dermal dendrititc cells which
coexpress MHC class II antigens in humans (Cerio et al., 1989). The optimal working
dilution was 1:750.
Anti-PCNA
The monoclonal antibody to proliferating cell nuclear antigen (PCNA), clone PC-10
(Dako Ltd, High Wycombe), recognises a phase specific nuclear antigen that
functions as a co-factor for DNA polymerase delta (Linden et al., 1992). PCNA levels
are increased through the mid G1 phase of the cell cycle, remain elevated through the
S phase, then rapidly decrease from G2/M to G1 (Bolton et al., 1992). The working
dilution of the antibody was 1:200.
And Orfvirus
Murine monoclonal antibody 5E2, specific for an unidentified orf virus protein, was
used at a dilution of 1:200. It was obtained from Dr H.W.Reid, Moredun Research
Institute, Edinburgh.
Monocyte!Macrophage markers
Five monoclonal antibodies that recognise antigens on the surface of
monocytes/macrophages were used. The OM monoclonals were used on sections of
frozen tissue as they gave unreliable results on paraffin sections.
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0M1, 2 and 3
The murine monoclonals OM1,2 and 3 were developed against ovine alveolar
macrophages and recognise both monocytes and tissue macrophages (Pepin et
al., 1992). OM1 has recently been identified as an anti-ovine CDllc (Gupta et
al., 1993). OM2 and OM3 recognise a subpopulation of alveolar macrophages and are
not specific for the monocyte-macrophage lineage. OM2 also labels vascular
endothelium. The working dilution of the antibodies was 1:5. They were obtained
from Dr M.Pepin, Institut National de la Recherche Agronomique, France.
IL-A15 and IL-A24
Antibodies IL-A15 and IL-A24 (ILRAD laboratories, Kenya) predominantly
recognise monocytes and granulocytes. IL-A15 is an anti-ovine/bovine CDllb
monoclonal (Splitter and Morrison, 1991). IL-A24 anti-ovine/bovine P110/75 antigen
recognises a subpopulation of dendritic cells as well as neutrophils, eosinophils,
macrophages and some lymphocytes (McKeever et al., 1991). The optimal working
dilution of both antibodies was 1:1000.
v). Controls
Negative controls included isotype matched murine monoclonal antibodies specific for
border disease viral epitopes (obtained from Dr G. Entrican, Moredun Research
Institute, Edinburgh) and rabbit serum IgG as a control for the factor Xllla specific
antibody. Monocyte-macrophage markers were tested for their activity on
formaldehyde/cacodylate fixed cytospins of ovine bone marrow cells and cultured
ovine alveolar macrophages (obtained from Dr G. Entrican, Moredun Research
Institue, Edinburgh).
vi). Quantification ofdendritic cells
Dendritic cells were defined by reported criteria (Steinman, 1991). In particular they
were mononuclear (with round or indented nuclei) cells with prominent dendritic
processes. Dendritic cells positive for MHC class II, Factor Xllla and CD1, were
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individually quantified within a total area of 1mm2 of dermis on five semi-serial
sections of each biopsy from normal skin and at the time-points 48h, 96h and 170h
after treatment (Jenkinson et al., 1991). The counts were performed on four
microscope fields across the length of the section of skin. Dual staining of dendritic
cells with 2 of the 3 antibodies was determined by comparison of serial sections or by
the two colour technique described. Counts were not performed for cells other than
dendritic cells or for the additional sections of primary orf lesions collected at
timepoints beyond 170h. Comparisons between consecutive times, between
treatments at the same time and for the different dendritic cell markers were made.
2.2. ORF VIRUS INFECTION OF KERATINOCYTES
2.2.1. Keratinocyte culture
i). Primary culture
The method of Weterings et al., (1981) was followed in outline. Hair follicles were
plucked from the muzzle of young lambs (up to 6 months old) that were restrained
but not anaethetised. Prior to plucking, the muzzle area was wiped with cotton wool
soaked in microgen to reduce the risk of contamination. The longer hairs were
plucked using eyebrow tweezers and placed directly into culture medium. The culture
medium was composed of Dulbeccos Minimum Essential Medium (MEM, ICN Flow,
High Wycombe, UK) buffered with 8% sodium bicarbonate containing 0.4% phenol
red, with 2% Ultroser G (Gibco BRL, Uxbridge, Middlesex, UK), 6% foetal calf
serum (heat- inactivated, Gibco), 1% glutamine, (L-glutamine, Sigma) 1% non¬
essential amino acids, gentamicin (25pg/ml, Roussell) and fungizone (0.5 units/ml,
Squibb) and for primary cultures only, the growth factors epidermal growth factor
(lOng/ml, Boehringer Mannheim, Lewes East Sussex, U.K) and hydrocortisone
(0.4ug/ml, Sigma) were included. The hairs were poured into petri dishes and the bulk
of the hair shafts cut off using a sterile scalpel. Each bulb was then placed on the side
of 25 cm2 flasks (Corning Inc, Corning, New York) and left to attach for about 5
min. Primary culture medium was then pipetted down the side of the flask free of
bulbs and then the flask was gently tilted into a horizontal position so that the bulbs
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were covered in medium without being disturbed. The cultures were incubated at
37°C in a humified atmosphere of 5 % C02 in air and left undisturbed for 10 days,
afterwhich the medium was routinely replaced twice a week. When the keratinocyte
colony surrounding the hair bulb had reached >lcm (2-3 weeks incubation) the cells
were ready for subculture.
ii). Subculture
Monolayers of keratinocytes were rinsed twice with PBS and detached from the flasks
by incubating with lml/flask of 0.25% trypsin/EDTA at 37°C for 10-15 min. Once
the cells were detached, 2mls of culture medium (no growth factors included) were
added to the flask to neutralise any remaining trypsin. The detached cells were
resuspended by pipetting vigorously and then centrifuged at 300g for 5 min to pellet
the cells. The pellet was resuspended in 1ml of culture medium and the single cell
suspension put back into the original flask and 8mls of culture medium (no growth
factors) added. A monolayer formed in the flasks after about 3-5 days, at which point
the cells could be subcultured into flasks by the method already described.
Hi). Cryopreservation
Cells were stored in liquid nitrogen at pass 2. The cells were detached from the
culture flasks as described above and after 1 wash the cells were resuspended in
lml/flask in medium containing 10% dimethylsulphoxide (DMSO, B.D.H) and 50%
foetal calf serum and transferred into a cryotube (Nunc Inc, Naperville, Illinois). The
tubes were then wrapped in cotton wool and stored at -80°C and 24 hours later, the
tubes were transferred to a liquid nitrogen tank, where they were stored until
required. In recovery from frozen storage, the cells were thawed rapidly in a 37°C
water bath and the suspension diluted in culture medium. The cells were washed and
inoculated into 25 cm2 flasks (lvial per flask).
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iv). Growth ofkeratinocytes onplastic coverslips.
A suspension of keratinocytes diluted 1:10 in trypan blue (0.2% in PBS, Gurr) was
counted in a modified Fucli's Rosenthal counting chamber (Weber) and the cells
diluted in medium to give a final concentration of lxl 05 cells/ml. This suspension was
seeded at lxl05 cell/ml into 24 well tissue cluster plates containing 13mm diameter
Lux Thermanox coverslips (Nunc). Foetal lamb skin cells provided by the tissue
culture department at the Moredun Research Institute were also cultured on the
coverslips. After 2-3 days incubation at 37°C, the cells formed a monolayer and were
ready for further experimentation.
Coverslips of keratinocytes and foetal lamb skin cells were fixed with
formaldehyde/cacodylate and stained for morphological observation with the
Leishman's stain (eosin-methylene blue, Gurr) by immersing the slides in the neat
solution for 2 min and then for 10 min with a solution of Leishman's diluted 1:2 in
distilled water before rinsing with tap water and air drying. The dried cells were then
mounted with DPX (B.D.H).
v). Immunohistochemical study
Keratinocyte cultures were incubated with a number of monclonal antibodies that will
distinguish keratinocytes from other contaminating cells such as fibroblasts, in order
to give a rough estimate of the purity of the established cultures. Foetal lamb skin
cells were included as controls as they constitute a mixed population of cells, the
majority of which are fibroblastic in nature.
Fixation
Monolayers of keratinocytes and foetal lamb skin cells grown on plastic coverslips as
described above were used. The medium was aspirated off using a vacuum suction
pump and the cells rinsed twice with PBS. The cells were then fixed with 0.5 mis/well
of ice cold acetone for 10 min. The acetone was aspirated off and the coverslips
rinsed with distilled water. Using forceps, the coverslips were lifted out of the wells
and laid on blotting paper to air dry. The coverslips were attached to glass slides on
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the non-cell side using the mountant DPX (B.D.H), and after the mountant had
solidified, the slides could be immmunostained.
Monoclonal antibodies
Monolayers of cells were immunostained using the enhanced avidin-biotin
immunoperoxidase kit (Vectastain Elite) method described above.Three antibodies
were used;
Anti- Keratin, an antibody that specifically stains networks of tonofilaments within
epithelial cells. The antibody was used at a dilution of 1:40 (guinea pig anti-keratin,
Sigma K-4252)
Anti-Pan cytokeratin, a monclonal antibody that detects three cytokeratin proteins
expressed in simple, cornifying and non-cornifying squamous and pseudostratified
epithelia. The antibody was used at a dilution of 1:50 (mouse anti-cytokeratin, Sigma
C-1801)
Anti-Vimentin, is immunospecific for vimentin, a cytoskeletal protein localised within
fibroblasts. The antibody was used at a dilution of 1:100 (mouse anti-vimentin, Sigma
V-5255).
2.2.2. Orf virus
i). Preparation oforf11 and Scabby Mouth.
Two tissue culture adapted strains of orf virus, orf 11 and Scabby Mouth were used in
the in vitro work. The viral stocks were prepared on my behalf by Irene Pow and
Janice Gilray. In brief, orf 11 was prepared from a scab virus isolate (McKeever,
1986) and adapted to tissue culture by passaging in different types of sheep cell; 22
passages in thyroid cells, 4 passages in foetal lamb muscle cells and 2 passages in
foetal lamb skin cells. The stock virus was prepared from foetal lamb skin cells
infected with the tissue culture adapted virus . Ninety-six hours post-infection, when
the cytopathic effect was at a maximum, the cells were subjected to 3 cycles of
freezing and thawing to release cell bound or cell-associated virions into the
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supernatant. Any cells still attached to the flask were scraped into the medium with a
rubber policeman. The virus-cell mixtures from the flasks were pooled and clarified at
1200g for 30 min at 4°C. The resulting supernatant was then titrated and stored as
stock virus at -80°C.
The Scabby Mouth vaccine orf virus strain has been adapted previously to tissue
culture and was passaged in foetal lamb skin cells twice before production of a
"master" stock of virus on the third passage in foetal lamb skin cells . This master
stock was then used to produce working stocks of virus by inoculating flasks of foetal
lamb skin cells and collecting the virus as described above.
ii). Titration ofthe stock viruses in keratinocytes.
Twenty-four well plates containing monolayers of keratinocytes grown on plastic
coverslips as described in section 2.2.1 (iv), page 46 were used for each of the two
viral preparations. The supernatant from the cultures was aspirated off and the
monolayers washed twice with PBS. Ten-fold viral dilutions from 10'1 to lO7 were
prepared in keratinocyte medium from the stocks of virus and 0.1ml of each dilution
added to 6 wells. The plates were incubated at 37°C for 1 hour following which the
inoculum was aspirated off, the monolayers washed twice with PBS, 0.5mls of
medium added and the incubation at 37°C continued. The monolayers were examined
at 12h, 24h and then daily for 4 days for cytopathic effects (CPE), indicated by cell
rounding, clumping or detachment of cells from the coverslip. At the end of 4 days
the total proportion of positive wells (i.e the wells that showed CPE) at each dilution
was summed and used to calculate the 50% tissue culture infectious dose (TCID_0) of
the stock virus. At each time point, coverslips from the 10_1 wells were fixed in
acetone or formaldehyde/ cacodylate for Leishman's staining and
immunohistochemistry.
iii). Viralgrowth curves
A one step growth curve was carried out to determine the various stages of viral
replication for Scabby Mouth and orf 11 in keratinocyte cultures.
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Fourteen 25cm2 flasks of keratinocyte monolayers were used for each of the two
virus preparations. The medium from the flasks was aspirated off and the monolayers
washed with PBS. The cells were infected with 1ml of inoculum/flask (a multiplicity
of infection of approximately 0.5) and adsorption carried out at 4°C for 1 hour. At the
end of the adsorption period the monolayers were washed with PBS to remove any
unadsorbed virus. Seven mis of growth medium was added to each flask which were
incubated at 37°C. Two flasks for each viral inoculum were removed from the
incubator at Oh, 4h, 8h, 12h, 24h, 48h, and 72h post-infection. On removal, the
growth medium was collected into universal containers which were stored
immediately at -70°C. The monolayers were washed with fresh growth medium and
also stored immediately at -70°C with a covering of about 3mls of medium/flask. At
the end of the incubation, all flasks and universals were removed from -70°C and
subjected to three cycles of rapid freeze-thawing. This procedure disrupts the cells
and releases any intracellular virus particles. After the final freeze-thawing step the
samples were centrifuged at lOOOg for 10 min to pellet any cellular debris. The virus
particles obtained from the disrupted cells and supernatants were diluted in ten fold
steps to 10-9 and titrated on to monlayers of keratinocytes grown in 96 well plates. At
96h the plates were read for cytopathic effect and the infectious virus titre (TCID5o)
of the supernatant and the cells for both viral preparations at each time point was
determined as previously described.
iv). Detection oforfviral antigen in infected keratinocytes.
Two methods were used for detecting expression of orf viral antigens in monolayers
of infected keratinocytes at various time points post-infection.
Immunofluorescence.
Keratinocytes did not monolayer well on glass substrates, the best monolayers being
achieved on plastic coverslips. However plastic coverslips autofluoresce under UV
light and so, for immunofluorescent studies, keratinocytes were grown to as near a
monolayer as possible on glass coverslips.
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A suspension of keratinocytes at lxl05 cells/ml was seeded into test-tubes (Greiner)
containing glass coverslips. The test-tubes were held at an angle and the cells
incubated at 37°C for 2-3 days until they had monolayered. The medium was
aspirated off, the coverslips rinsed twice with PBS and 1.5 mis of dilutions of virus
102 ,10"3 and 1CH (prepared in medium) added to the tubes which were incubated at
37°C for 1 hour to allow viral adsorption. The inoculum was then aspirated off, the
cells rinsed with PBS and 1.5mls of fresh medium added to each tube and the
incubation continued at 37°C. Coverslips from each dilution and the uninfected
controls were fixed by the addition of ice cold acetone (as previously described) at Oh,
6h, 12h, 18h, 24h and 48h post-infection. The coverslips were then laid to dry on
blotting paper and then attached to glass slides, cell-side up using the mountant DPX.
An indirect staining method was used for immunofluorescence. The coverslips were
first incubated with horse serum (Gibco) diluted 1:20 in PBS at 37°C for 30 min in a
humidity chamber to reduce any non-specific binding. The coverslips were then rinsed
with PBS (2 x lOmin). Any excess PBS was carefully dabbed off with tissue paper
and the coverslips incubated for 30 min at 37°C with a 1:50 dilution of whole serum
from a hyperimmune lamb D573. This lamb had been experimentally infected with orf
virus, the scab collected, and at 16 and 18 weeks post-infection it was inoculated
intramuscularly with autogenous scab suspended in Freund's complete adjuvant
(Difco, East Molesey, Surrey, U.K). It was bled 10 days after the second inoculation
and the serum stored at -20°C. After the primary antibody stage, the coverslips were
rinsed with PBS (2 x 10 min), and donkey anti-sheep FTTC conjugate (Scottish
Antibody Production Unit, SAPU) diluted 1:40 in PBS applied for 30 min at 37°C .
After a final rinse in PBS (2x10 min) the coverslips were mounted in glycerol and
viewed under the UV microscope (Ortholux-Leitz).
Immunoperoxidase
Acetone-fixed monolayers of orf-infected keratinocytes grown on plastic coverslips
(at the time-points described above) were incubated overnight at 4°C with the
monoclonal anti-orf antibody 5E2 (ascites 1:200, Dr H.W.Reid, Moredun Research
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Institute, Edinburgh) and the immunoperoxidase stain carried out with the Vectastain
elite kit as described in section 2.1.4 (i), page 40.
v). Incorporation of35S amino acids by keratinocytes.
Orf virus infection ofKeratinocytes
6 x 25 cm2 flasks of keratinocytes were grown to 80 % confluence in keratinocyte
growth medium. Twenty-four hours prior to infection, the flasks were rinsed twice
with PBS and the medium replaced with methionine and cysteine-free DMEM
medium containing 2% FCS and 1 % glutamine. The medium from the flasks was then
removed and the flasks rinsed with PBS. Four of the flasks were inoculated with 1 ml
of orf virus (orf 11, multiplicity of infection (MOI) 0.5 to l)and 2 control flasks
received 1 ml of the methionine and cysteine-free medium containing 2% FCS. All 6
flasks were incubated at 37°C for 1 hour. After the incubation, the virus was aspirated
off, the flasks rinsed with warm PBS and pulsed with 35S amino acids as described
below.
Incorporation of35S
The 35S work was carried out on my behalf by David Deane.
The flasks were divided into 2 sets of 3 flasks, containing 1 control flask and 2
infected flasks. Five ml of methionine and cysteine free DMEM (ICN, Flow, without
FCS) was added to the uninfected flask and one of the infected flasks of each set. The
other infected flask of both sets received 5 ml methionine and cysteine free medium
DMEM (without FCS) containing lug/mi of actinomycin D. One set of flasks (Early
set) was immediately pulsed for 2 hours with lOOuCi of 35S-methionine (Amersham
International, Little Chalfont, England). After pulsing the flasks were washed and
chased for 5 hours with DMEM (without FCS) containing methionine and cysteine.
The cells were scraped off into the culture medium and harvested by centrifugation at
2000rpm for 5 min. The supematants were carefully aspirated and both the cell pellet
and supernatant for each sample stored at -20°C. After 6-7 hours incubation at 37°C,
the second set of flasks (Late set) were pulsed with 35S-methionine for 2 hours,
washed and chased in DMEM containing methionine but no FCS and harvested as for
the Eariy set.
Trichloroacetic acid (TCA) precipitation-spotting
The frozen cell pellets were lysed in 1% Nonidet P40 in PBS and lOul of cell lysates
and supernatants were spotted onto dry, glass fibre filter disks (20mm diameter,
Whatman) and left to air dry. Once dry, the filter disks were immersed in a beaker
containing a 10 % solution of trichloroacetic acid (TCA) in water, and incubated on
ice for 30 min. The disks were then rinsed (x 2) with fresh 10 % TCA and washed
extensively (2 to 3 times) with 95 % ethanol in water. The filters were placed on
aluminium foil in a hood and left to dry. Once dry, the filters were placed into
scintillation vials with 10 ml of scintillant (Picofluor 15, United Technologies,
Packard) and counted in a scintillation counter.
Autoradiography
10 pi of each sample was loaded onto a 5 %, 12 % discontinuous sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS PAGE) and run under reducing
conditions at 200V for 1 hour. The gel was then stained with approximately 10ml of
0.02 % Coomassay brilliant blue (in 30% methanol 10% acetic acid) for 15 min. The
gel was then de-stained for 1-2 hours and impregnated with 10ml of Amplify
scintillant (Amersham) to enhance the signal. The gel was placed onto 3mm paper
(Whatman) and dried in a flat bed heater under vacuum for 1 hour. The dried gel was
then autoradiographed with hyperfilm MP (Amersham) in an X-ray cassette overnight
at -70°C. The gel was then developed under the appropriate light conditions, using
D19 developer and Kodafix (Kodak Ltd), diluted as per the manufacturer's
instructions.
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2.3. ANALYSIS OF CYTOKINE PRODUCTION BY
KERATINOCYTES
2.3.1. Experimental procedure
Keratinocytes were analysed for their ability to produce cytokines under normal
resting conditions, in response to infection with orf virus, after UV irradiation and
after stimulation with phorbol 12-myristate 13-acetate (TPA)/Calcium ionophore.
i). Orf virus infection ofkeratinocytes
25cm2 flasks of keratinocytes were washed twice with PBS and 1ml of either orf 11
or Scabby Mouth virus was added to each flask at an M.O.I of approximately 0.5;
keratinocyte medium was added to an equal number of control flasks. The flasks were
incubated at 4°C for 1 hour on a rocker to allow adsorption of the virus. At the end of
adsorption (time Oh), the flasks were rinsed with PBS, 8mls of keratinocyte medium
(containing 1%, 2% or 6% FCS) added to each flask and the flasks incubated at 37°C.
Control and infected flasks were removed at 2 hourly intervals from 0 hours up to 12
hours and then at 24 hours post-infection. On removal from the incubator the cell-free
supernatants were collected into universal containers and stored at -20°C. The
monolayers were rinsed twice with PBS and the cells lysed by the addition of
lml/flask of guanidine isothiocyanate (G.I.T.) extraction buffer (6M guanidium
isothiocyanate, 250mM sodium citrate pH 7, 0.5% sarcosyl and lOOmM 2-
mercaptoethanol). The cell lysate was collected and stored at -20°C for the
subsequent isolation of RNA.
ii). UV irradiation ofKeratinocytes
Monolayers of keratinocytes were grown in 18 small petri dishes (5cm in diameter,
Cell Cult). Immediately prior to exposure to UV light, the medium was removed and
the cells covered with the minimum volume of PBS to keep them wet Three sources
of UV light were used; UVB broad band TL12 (270-320nm, peaking at 310nm)
which emits 4.8mJ/cm2 in lmin, TL01 UVB narrow band (312 nm) emits 13mJ/cm2 in
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lmin and UVA (310-400nm, peaking at 310nm) emits 60mJ/cm2 in 1 min. Six
experimental groups were set up as follows and during exposure to UV, the lids of the
petri dishes were removed.
Two groups were exposed to a UVB broad band Phillips TL12 lamp; group 1 was
given a high dose exposure of 4 min 12 seconds (20mJ/cm2) and Group 2 was
exposed to a low dosage 2 min 6 seconds (10mJ/cm2). Groups 3 and 4 were exposed
to a UVB narrow band Phillips TL01 lamp at high and low exposures (50mJ/cm2, 4
min 12 seconds and 20mJ/cm2-1 min 42 seconds respectively). Group 5 was exposed
to 1 minute 42 seconds of UVA light (100mJ/cm2) and a control group 6 that was
unexposed was included.
After irradiation the PBS was removed from the dishes and replaced with 1ml of
medium. The dishes were then incubated at 37°C for 24 hours after which the
morphology of the cells was noted, the supernatants collected and the cells lysed into
extraction buffer as described above for subsequent cytokine analysis.
iii). Phorbol 12-myristate 13-acetate (TPA)/calcium iotiophore (Ca) stimulation
ofKeratinocytes
Monolayers of keratinocytes in 25cm2 flasks (Corning) were rinsed twice with PBS.
lOmls of growth medium containing 5ng/mi of TPA (Sigma) and 500ng/ml of calcium
ionophore (Ca) (Sigma) was added to each flask. An equal number of control flasks
received lOmls of growth medium and the flasks incubated at 37°C. Control and
stimulated flasks were removed at 4 hour intervals from 0 hours after stimulation up
to 12 hours. The culture supernatants and cells were collected and stored for
subsequent cytokine analysis as described above.
2.3.2. Cytokine mRNA detection:
Keratinocyte cytokine mRNA was measured using a reverse transcriptase polymerase
chain reaction (RT-PCR) technique.
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i). Extraction of total cellular RNA
The solutions containing the lysed cells were thawed and homogenised using a 201/2
gauge needle and the pH lowered by the addition of a 1/1Oth volume of 2M sodium
acetate (pH 4.5). An equal volume of water saturated phenol followed by l/5th
volume of chloroform/isoamyl alcohol 49:1 (water saturated) were added, mixing in
between each addition.The aqueous and solvent phases were then separated by
centrifugation in a microfuge at 13,000 rpm for 10 min. The upper aqueous layer was
transferred into a fresh tube and an equal volume of isopropanol added. The solution
was left at -20°C for 1 hour and RNA pelleted by centrifuging at 13,000 rpm for 10
min. The supernatant was removed and the pellet dissolved in lOOp.1 of the G.I.T.
extraction buffer, lOOul of isopropanol added, mixed and stored at -20°C for 1 hour.
The RNA was re-pelleted by centrifuging at 13,000 rpm for 10 min, the supernatant
removed and the pellet washed in 70% ethanol. Finally the RNA pellet was lyophilised
in a dessicator and then dissolved in 50ul of diethylpyrocarbonate (depc) treated
water (sterile, RNase-free water, produced by adding a solution of 1ml depc (Sigma)
and 5 mis ethanol to 1 litre of distilled water, incubating overnight and then
autoclaved to destroy the depc).
ii). Estimation ofRNA concentration
The concentration of RNA in each of the samples was measured
spectrophotometrically at 260/280nm (Beckman DV650) and the results confirmed by
checking the intensity of the bands after running equal concentrations of the RNA on
a denaturing 1% formaldehyde/agarose gel.
The gels were prepared by dissolving 0.4g of agarose (Gibco BRL) in 34mls of
distilled water in a microwave oven. Once the agarose had cooled below 65°C, 4mls
of lOx MOPS buffer [0.2M MOPS 3-(N-Morpholino) propanesulphonic acid
(Sigma), 50mM sodium acetate and lOmM EDTA pH7] and 2mls of formaldehyde
(39 %, Sigma) were added. Gels were then poured onto a horizontal gel apparatus
(Pharmacia, Milton Keynes, U.K). After removal of the comb, the gel tank was filled
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with lx MOPS buffer until the gel was just covered and the RNA samples were
loaded into the wells. 2pi of each of the RNA samples were prepared for
electrophoresis by the addition of 5ul/sample of electrophoresis sample buffer [0.75ml
deionised formamide, 0.15ml lOx MOPS, 0.24ml of formaldehyde, 0.1ml autoclaved
water and 0.1ml of 10% W/V bromophenol blue (Sigma) and lOul of a lmg/ml
solution of ethidium bromide]. This was then heated at 65°C for 15 min and then
cooled on ice prior to loading on the gel. Electrophoretic separation was typically
carried out at a voltage of 100V for 40 min and a UV transilluminator used to view
the RNA bands.
The intensity of the RNA bands for some of the samples did not appear to correlate
with the spectrophotometer readings obtained for them. This can happen as a result of
undissolved RNA and so these samples were re-mixed and the process repeated until
each sample gave bands of intensity which correlated well with the spectrophotometer
readings. Figure 2.1 shows an example of electrophoresed RNA samples from control
and orf virus infected keratinocytes, where the intensity of the bands correlate well
with the spectrophotometer readings contained within the Table (2.1) below.
Table 2.1 RNA spectrophotometer readings
SamDle 1/20 abs 260nm abs 280nm 260/280nm 280/260nm RNA up/ml
blank 0.0001 0.0002 0.836 1.1954 0.011
1. 0.5552 0.2520 2.2520 0.4535 22.190
2. 0.4863 0.2189 2.2162 0.4512 19.4897
3. 0.7431 0.3375 2.1990 0.4547 29.7569
4. 0.5861 0.2648 2.2130 0.4519 23.4437
5. 0.5792 0.2616 2.2101 0.4525 23.2065
6. 0.6747 0.3101 2.1993 0.4547 26.7414
7. 0.5864 0.2668 2.2107 0.4523 23.3381
8. 0.7121 0.3265 2.1974 0.4556 28.3369
9. 0.7268 0.3366 2.1945 0.4557 28.6704
10. 0.6801 0.3166 2.1975 0.4551 26.6841
11. 0.7333 0.3486 2.1840 0.4579 28.3882
12. 1.0871 0.5201 2.1649 0.4619 43.4878
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Figure 2.1 Whole RNA samples extractedfrom control and orf virus infected
keratinocytes were electrophoresed under denaturing conditions on a 1%
formaldehydelagarose gel. Tracks 1 to 12 contain the RNA samples.




cDNA synthesis was primed using a mixture of primers (see Table 2.2) specific for
each of the cytokines under study.
The cDNA synthesis reaction was carried out in a total volume of 40ul/sample in
individual, sterile eppendorf tubes containing 2ug of each RNA sample in a reaction
mixture of reverse transcriptase buffer (50mM TrisHCl, 6mM MgCl,, 10mM
dithiothreitol, lOOmM NaCl, pH8.2, supplied by Boehringer), 200uM
deoxynucleoside triphosphates (dNTPs, Pharmacia), luM of each of the 3' primers of
ovine specific GM-CSF, TNFa, IL-1(3, IL-3 and (3 actin (Oswel DNA Ltd,
Edinburgh, U.K) and 3 units/sample of avian myeloblastosis virus reverse
transcriptase enzyme (AMV, Boehringer). The synthesis involved two stages; firstly
before the addition of reverse transcriptase, the RNA samples and reaction mixture
were incubated at 65 °C for 15 min to denature the RNA. After cooling on ice, 3
units/sample of reverse transcriptase enzyme was added and cDNA synthesis allowed
to proceed at 37°C for 90 min. The cDNA was then made up to a total volume of
lOOp.1 with sterile distilled water and stored until use at -20°C.
iv). Polymerase Chain Reactions (PCR)
The cDNA samples were all amplified individually for GM-CSF, TNFa, IL-1(3, IL-3,
and (3-actin. PCR reactions were carried out in a total volume of 20ul with lOul of
each cDNA sample in sterile eppendorfs. Individual cytokine-specific reaction
mixtures were prepared by the addition of the appropriate primers (3' and 5', see
Table 2.2) for the above cytokines to give final concentrations of; 20mmol/l Tris-HCl,
15mmoI/l MgCl,, 500mmol/l KC1; pH8.3 (lOx PCR buffer Boehringer) and 200uM
ultrapure dNTP (Pharmacia) in an appropriate volume of sterile distilled water.
Immediately before addition to the samples lunit/sample of Taq polymerase
(Boehringer) was added to the mixture, which was gendy mixed and then centrifuged
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mineral oil was added to the top of each tube to reduce evaporation.The DNA was
denatured at 95°C for 5 min, then amplified through a total of 35 cycles of denaturing,
annealing and polymerisation in a Hybaid Omni Gene PCR machine (Hybaid,
Teddington, Middlesex, UK) as follows; 95°C for 1 minute, 50°C for 1 minute and
72°C for 1 minute followed by 1 cycle of 95°C for 1 minute, 50°C for 1 minute and




Approximately lpg of total RNA prepared from stable Chinese hamster ovary cell
(CHO) lines which over-produce the ovine cytokines GM-CSF (Mclnnes and Haig,
1991) and IL-3 (Mclnnes and Logan, 1993) were used as positive controls for the
reverse transcriptase polymerase chain reactions. Transfectants for the other cytokines
were not available.
Polymerase chain reaction
For each reaction carried out, both negative and positive controls were used. The
negative controls consisted of the sterile distilled water used to dilute the samples and
reaction mixture. cDNA prepared from the CHO cell lines for GM-CSF and IL-3 was
used as the positive controls in the respective reactions. In the absence of a reliable
source of ovine IL-1|3 and TNFa mRNA, positive controls for the PCR stage only
were used. These corresponded to 2ng of the cloned ovine cDNA for IL-1|3 (Seow et
al, 1990) and TNFa (Nash et aL, 1991).
vi). Agarose gel electrophoresis ofcDNA Samples
The PCR cDNA samples were electrophoresed on a 1% agarose gel prepared by
dissolving 0.4g agarose in 36mls of lxTBE (lOOmM Tris, lOOmM boric acid, ImM
EDTA and 0.5 mg/1 ethidium bromide) in a microwave oven. Once cool the gel was
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poured into a horizontal gel apparatus (Pharmacia) as before. After removal of the
comb, the gel tank was filled with lxTBE until the gel was just covered and the DNA
samples loaded into the wells.Four pi of each DNA sample was added to the well with
1.5pl of sample buffer (40% W/V sucrose, 0.25% bromophenol blue in distilled
water). On each gel the last well was loaded with 5pi of known molecularweight
standards generated from lOOpl of lambda phage DNA (500pg/ml, Gibco) digested
with 100 units of Hind IE. The DNA samples were electrophoresed at a constant
voltage of 100V for approximately 40 min. DNA fragments were visualised by a UV
light transilluminator and photographed.
The PCR reactions were considered to have worked, when there were no visible
bands in the negative controls and the positive controls contained bands of the
expected molecular weight for each of the specific cytokines (defined by the primers
shown in Table 2.2). Figure 2.2 shows an example of the electrophoresed RT-PCR
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Figure 2.2 GM-CSFRT-PCRproductsfrom control and orf virus infected
keratinocytes electrophoresed on a 1% agarose gel. Tracks 1 and 12
contain the negative control. Tracks 10 and 21 contain the GM-CSF
positive control with a single band of495bp and track 11 contains /,
DNA molecular weight markers. The amplified samples are in tracks 3 to
8 and 14 to 19 where some can be seen to contain bands at the expected
size for GM-CSF.
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The specificity of detection was increased by blotting the gels onto nylon membranes
and probing with cytokine specific labelled probes. The probes hybridise with an
internal sequence of DNA contained within the amplified region of each cytokine (see
Table 2.2).
vii). Immunoblot transfer ofcDNA to nylon membranes
The cDNA was denatured by soaking the gel for 30 min in two changes of a solution
of 0.5M sodium hydroxide and 1.5M sodium chloride and neutralised for 1 hour at
room temperature in several changes of 1M ammonium acetate and 0.02M sodium
hydroxide, both stages with constant agitation. The gel was then placed well-side
down on an area of bench covered with saranwrap. A square of nylon membrane
(Hybond N, Amersham) cut to the size of the gel was soaked in the ammonium
acetate solution and then placed on top of the gel, care being taken at this point to
ensure that there were no bubbles breaking the contact of the membrane with the gel.
Eight pieces of blotting paper cut to slightly larger than the gel were stacked on top of
the membrane, the first four pieces soaked in ammonium acetate, and on top of this a
stack of paper towels. The stack was compressed with a heavy book and the transfer
allowed to proceed for 16 hours overnight.The stack of towels and filterpapers were
then removed and the position of the sample wells on the resulting blot marked in
biro and the gel peeled away and discarded. After air drying, the DNA was
crosslinked to the nylon membrane in a UV crosslinker (Hybaid) and stored in
saranwrap.
viii). Digoxygenin Hybridisation
The membrane bound DNA for each of the PCR reactions was incubated with a
specific digoxygenin (Dig) labelled probe. The probes were prepared from
oligonucleotides labelled at the 3' end using the enzyme terminal transferase
(Boehringer) and the reaction conditions were such that only short tail residues were
added to each oligonucleotide. The resulting labelled hybrids were detected by
enzyme-linked immunoassay using an antibody-conjugate (antidigoxygenin alkaline
phospatase conjugate, <Dig> AP) using the Dig DNA labelling and detection kit
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(Boehringer) as follows. The membranes were prehybridised in hybridising solution
consisting of; 5x Standard saline citrate (SSC, a 20x stock was prepared by dissolving
175.3g of sodium chloride and 88.2g of sodium citrate in 800mls of distilled water,
the pH adjusted to 7.0 with sodium hydroxide and the volume made up to 1 litre),
0.5% W/V Boehringer blocking reagent; 0.1% W/V N-laurylsarcosine, Na salt and
0.02% W/V sodium dodecyl sulphate (SDS) for 30 min at 55°C in a Hybaid oven.
The hybridising solution was then replaced with about 2.5ml per 100cm2 of membrane
with hybridisation solution containing approximately 10-50 ng of freshly denatured
Dig-labelled DNA probe per ml of hybridisation solution and left to hybridise
overnight at 55°C . The probe solutions were then poured off and collected for re-use,
any unbound probe was washed off in two washes of 2 x SSC; 0.1% W/V SDS each
for 15 min followed by two washes in O.lx SSC ; 0.1% W/V SDS again for 15 min,
all carried out at 55°C. The membranes were transferred into containers on a shaker
at room temperature and washed briefly with buffer 1 (100 mM/I Tris-HCl;150mM/l
NaCl pH 7.5) and incubated for 30 min in buffer 2 [0.5% W/V blocking reagent
(Boehringer) dissolved in buffer 1], This stage is included to block any non-specific
binding of the antibody-conjugate to the membrane. After another 1 minute wash in
buffer 1, the membranes were incubated with a 1:5000 dilution (150 mU/ml) of the
antibody- conjugate (sheep, polyclonal anti-digoxygenin Fab fragments, conjugated to
alkaline phosphatase, Boehringer) prepared in buffer 1. Any unbound conjugate was
subsequently removed by washing the membranes twice in buffer 1 (15 min each).
The membranes were equilibrated for 2 min in buffer 3 (lOOmM/1 Tris-HCl; lOOmM/1
NaCl; 50mM/l MgCl2, pH 9.5) and incubated with 10ml of the colour solution (45ul
of 75mg/ml solution of nitroblue tetrazolium salt and 35ul of a 75mg/ml solution of
dimethylformamide prepared in buffer 3) in a container kept unshaken in the dark.
When the bands appeared (4-6 hours) the reaction was stopped by washing the
membrane for 5 min in buffer 4 (10mM/l Tris-HCl; ImM/l EDTA, pH 8). The
membranes were then air-dried and stored wrapped in saranwrap.
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2.3.3. GM-CSF cytokine protein detection assays
i). GM-CSFAntibody capture quantitative ELISA
A sandwich ELISA developed at the Moredun Research Institute (Entrican et
aL, 1994) was used for the detection of ovine GM-CSF. The ELISA uses two affinity-
purified, neutralising antibodies, 8D8 and 3C2, that recognise mutually exclusive
epitopes of GM-CSF. The antibody 8D8 is used to coat the plate and capture any
GM-CSF present in the samples and the second antibody 3C2 conjugated to horse
radish peroxidase (HRPO) then recognises the second epitope on the captured GM-
CSF. The GM-CSF present in the samples is standardised using recombinant ovine
GM-CSF (Mclnnnes and Haig, 1991; Mclnnes et al., 1993).
Flat-bottomed ELISA plates (Dynatec 129B) were coated with 50ui/well of the anti-
GM-CSF affinity purified monoclonal antibody at lug/ml in 0.1M carbonate buffer
(0.1M sodium carbonate, pH adjusted to 9.6 with 0.1M sodium bicarbonate). The
plate was gently tapped to ensure that the whole well was covered and the plates
wrapped in clingfilm and left at 4°C overnight. The plates were washed 6 times with
wash buffer (PBS/0.05% Tween 20) using a wash bottle and blocked for a minimum
of 30 min at room temperature with 50ul/well with 3% bovine serum albumin (BSA,
Sigma) in PBS/Tween 20 wash buffer. At this stage the GM-CSF standards were
prepared; a stock of recombinant ovine GM-CSF (Mclnnes and Haig 1991; Mclnnes
et al., 1993) at a concentration of 400ug/ml was diluted to 4000, 2000, 500, 400, 200,
100 and 50pg/ml in 3% BSA/PBS/Tween 20. After the incubation period the plates
were washed 6 times with wash buffer and 50u.l/well of the standards, samples, or
buffer alone were loaded in duplicate to the plates. The plate was left for 90 min at
room temperature and then washed 6 times in wash buffer. A 1:800 dilution (of a
0.5mg/ml stock) of the affinity-purified peroxidase-conjugated monoclonal 3C2, was
made in wash buffer and 50ul loaded in each well and the plate left at room
temperature for 1 hour. After the washing steps the plates were loaded with 50ul/weil
of O-Phenylenediamine (OPD) substrate (12.85mls 0.2M Na2HP04,12.15mls 0.1M
citric acid, 25mis distilled water, 40mg OPD and 40pi hydrogen peroxide) and the
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colour reaction allowed to develop. OPD must be stored in the dark and the substrate
mixture was prepared immediately before addition to the plate. The reaction was
stopped by the addition of 25ul/well of 2.5M H, S04 when a gradation of colours
could be seen in the standards and the blank wells were still clear (approximately 10
min). The plates were then read at 492nm by a Titretek Multiskan MC.
ii). Inhibition ofGM-CSF detection by ELISA
An experiment was designed to determine whether there were any factors released by
otf-virus infected keratinocytes that interfered with the detection of GM-CSF in the
ELISA. The ELISA was carried out as described previously but before the samples
were added to the plate, exogenous GM-CSF at the concentration of 4pg/ml was
added to culture supernatants from both uninfected and infected cells. After
incubation for 1 hour at 37°C, the samples were diluted serially and added to the plate
in duplicate. The ELISA was developed and the adsorption read at 492nm.
Further experiments were carried out to identify the nature of the factor/factors
produced by orf virus infected keratinocytes. Before the addition of the exogenous
GM-CSF (4ug/ml), the culture supernatants were treated either by heating or by the
addition of various protease inhibitors and then the ELISA was carried out as
described above. Untreated control and infected samples were included in each
ELISA
Heating
Oh, 12h and 24h orf virus infected and control supernatants were heated in a
waterbath at 56°C for 1 hour.
Protease inhibitors
Four types of protease inhibitors; Phenylmethyl sulphonyl fluoride (PMSF), L- trans-
epoxysuccinic acid (E64), Pepstatin A and phenanthroline were added individually to
both uninfected and orf virus infected 24h supernatants. The targets for the inhibitors
and the optimal working concentrations that they were used at, are listed in table 2.3
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The supernatants were incubated with the inhibitors for 30 min at 37°C and then the
ELISA carried out as described above.
2.3.4. Antibody capture quantitative ELISAs for the Interleukins IL-
1(3 and IL-8
Two ELISAs for the detection of IL-1(3 and IL-8 were used. The method of detection
was based on the same principle as the GM-CSF ELISA, i.e. the plate is coated with a
monoclonal antibody to the specific cytokine which then captures the cytokine but the
second stage antibody is a rabbit polyclonal antibody to either EL-1(3 or IL-8 which
requires a third step, a goat anti-rabbit HRPO labelled antibody to visualise the
reaction.
i). Antibodies
Antibodies for both the IL-1(3 ELISA and the IL-8 ELISA were gifts from Jim
Rothel, CSERO, Australia.
The antibodies used in the EL-1(3 ELISA were M IL-1(3 (monoclonal IgGl at a 1:200
dilution in 0.05M carbonate buffer) and a second stage polyclonal rabbit anti IL-1(3 (at
a dilution 1:500 in 3% BSA/PBS/Tween 20).
The antibodies used in the IL-8 ELISA were 8M6 (at a 1:200 dilution in 0.05M
carbonate buffer) and a second stage polyclonal rabbit anti IL- 8 (at a dilution of
1:2000 in 1.5% BSAPBS/Tween 20).
ii). Procedure
The ELISA plates were coated overnight at 4°C with the first stage antibody, M IL-































and lOOpl of the blocking buffer (3% BSA/PBS/tween 20, described in section 2.3.3
(i)) was added to each well and the plates incubated for 1 hour at room temperature.
The plates were then washed four times with PBS/tween 20 (0.05%). 50pl of each
supernatant samples and recombinant ovine IL-1(3 or IL-8 standards were added to
the wells in duplicate and incubated at room temperature for 75 min. After washing
with PBS/tween 20 (x 4), lOOpl of polyclonal rabbit anti- IL-1|3 or IL-8 sera diluted
at the dilutions described above was loaded into each well and the plate incubated at
room temperature for 75 min. After a further four washes with PBS/tween 20, lOOul
of goat anti-rabbit HRPO diluted 1:1000 in 1% non-specific mouse ascitic fluid (in
PBS), to block any non-specific binding, was added to each well and the plate
incubated at room temperature for 1 hour. The plates were washed 5 times with
PBS/Tween 20 and 50pl/well of the OPD substrate added to the plates and the
reaction developed as described for section 2.2.3 (i).
2.3.5. Interferon Bioassay
The method used for the detection of interferons (IFNs) was a bioassay developed at
the Institute (Entrican, Haig and Norval,1989). The assay measures IFNs by their
ability to inhibit virus replication in ovine fibroblasts. The target cells were ovine ST-6
cells, originally cultured from an adenocarcinoma of the small intestine (Norval et
al., 1981). The virus used was Semliki Forest virus (SFV) which infects ST-6 cells and
induces a CPE after 48h. This procedure was carried out with the assistance of Mary
McLean.
Procedure
lOOul of a suspension of ST6 cells at 5 x 103 cells/ml in growth medium (IMDM
supplemented with 5% FBS) was seeded into each well of a flat bottomed, 96 well
microtitre plate (Costar, High Wycombe, UK). The plates were incubated for 3 days
at 37°C in 5% CO2 humid atmosphere until confluent monolayers had formed. The
supematants to be tested, were filtered through 0.1pm filters (Supor Acrodisc filters,
Gelman) to remove any virus present, as orf virus has been shown to infect ST6 cells
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(unpublished data) and would therefore affect the assay. Samples were added to
duplicate wells in lOOpl volumes and allowed to incubate for 24 hours. After
incubation, the medium was discarded from the plates and 200pl of 100 TCID50 of
SFV (supplied by Dr. A.G. Morris, University ofWarwick) was added to each well
and the plates incubated for a further 48 hours. The plate were read visually and the
titres expressed as the highest sample dilution which inhibited the cytopathic effect of
SFV by greater than 50%.
2.3.6. TNFa detection
i). Bioassayfor TNFa
TNFa was monitored using a semi-automated L929 fibroblast cell lytic assay as
described by Flick and Gifford (1984). The assay is based on the sensitivity of the
transformed murine cell line L929 to TNFa and was carried out with the assistance of
Mary McLean.
In brief, L929 TNFa sensitive or TNFa resistant cells were set up in 96 well
microtitre plates (Costar) at a density of 1 xlO5 cell/ml (lOOpl/well, in serumless
IMDM medium) and incubated overnight at 37°C in 5 % CO2 humid atmosphere until
the cells reached sub-confluence. 50pl of each sample was added to duplicate wells,
followed by 50ul/well of actinomycin D (in medium, final concentration of lug/ml)
and the plates incubated overnight The viability of the cells was checked, the m dium
discarded and cell lysis measured by staining the monolayers with crystal violet
(0.5%) methanol/water (1:4, V/V). Dye uptake was calculated using an automated
micro ELISA autoreader (Titertek, Flow) equipped with a 540nm filter. One unit of
TNFa activity was defined as the amount required to lyse 50% of the target cells. An
internal standard of positive ovine TNFa from COS-1 transient transfectant
supernatant (ovine TNFa cDNA, Egan et al., 1994) was included in each assay.
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ii). Radioimmunoassayfor TNFa
A radioimmunoassay for the detection of bovine TNFa that has also been shown to
detect ovine TNFa was developed at the Moredun Research Institute, following a
method based on that reported by Kenison et al., (1990). The method used
recombinant bovine TNFa (rbo TNFa) cloned and expressed in Escherichia coli
(provided by Gary Entrican, MRI, obtained from CIBA-GEIGY Ltd, Switzerland),
and anti-bovine polyclonal antiserum also produced at MRI. The procedure was
carried out on my behalf by Gordon Moon. In brief, the assay was performed in 75 x
11mm polystyrene tubes (Sarstedt). 50pl of standards (rbo TNFa), controls or test
samples were mixed with 50pl polyclonal antiserum (1:4000) and 50ul of assay buffer
(0.15M PBS pH 7.4, containing 1%BSA) and incubated for 24 hour at 4°C. At the
end of this period 50ul of radiolabeled TNFa (prepared by the iodogen method, Peel
et al., 1990) was added to all the tubes which were vortexed and incubated for a
further 18h at 4°C. 200ul of the second antibody: donkey anti-rabbit IgG (SAPU),
was then added to all the tubes except total count (TC) tubes (contain radiolabelled
TNFa only) and incubated for 2h at 4°C. To enhance pellet formation, 50pl of 1%
rabbit serum (SAPU) was added to the tubes and the incubation continued for a
further 30 min. All tubes, except Tc, were then centrifuged (383g) for 15 min and the
supernatant decanted. The radioactivity in the pellet was measuerd in a gamma
counter (Packard Auto-Gamma 5650). Results were analysed using an in-house RIA
programme.
2.3.7. Analysis of the proteolytic activity of keratinocytes
The supernatants and cell lysates collected for the analysis of 35S methionine
incorporation (previously described) were also analysed for proteolytic ativity. The
cell-free supernatants were concentrated 10-fold in a Centricon 10 micro-concentrator
cell (Amicon, Stonehouse, U.K) at 6000 x g for 3 hours. Supernatant and cell lysate
samples were loaded onto 5 %, 12 % discontinuous SDS page gel containing 0.2 %
(W/V) azocasein (Sigma) in the separating gel component and the gels run as above
but under non-reducing conditions (in sample buffer without 2-mercaptoethanol and
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without boiling). Once run, the substrate gel was washed in 2 volumes of 2.5% Triton
X100 in water for 2 hours, then briefly in water and finally in PBS before an overnight
incubation at 37°C. Digestion of the substrate was detected by staining the gel with
Coomassie brilliant blue and identifying clear areas.
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CHAPTER 3
PHENOTYPIC CHARACTERISATION OF THE
DENDRITIC CELLS ACCUMULATING IN THE OVINE




Dendritic cells form a system of highly specialised antigen presenting cells (APC) that
are widely distributed in the body (Steinman, 1991). In the skin, two populations of
dendritic cells exist; the epidermal Langerhans cell (LC) and the dermal dendritic cell.
Epidermal LC represent the best characterised APC. They function as sentinels in the
skin and are important in inducing immunity to the foreign antigens encountered there
(Romani and Schuler, 1992). LC have been shown to be involved in the pathogenesis
of a number of infections of viral origin (Sprecher and Becker, 1988). Dermal
dendritic cells, recently identified by Headington (1986), are a poorly defined
population of cells of bone marrow origin. They lack the LC associated antigens such
as CD1 and the distinctive organelle, the Birbeck granule and thus represent a
population of cells distinct from LC. Dermal dendritic cells have recently been
characterised as being positive for the antigen factor Xllla and are increasingly being
recognised as having a role in the induction of cutaneous immune responses (Cerio et
al., 1989).
Orf virus enters through abrasions in the skin where it replicates in the regenerating
epidermal keratinocytes (Jenkinson et al., 1990a). Orf is an acute, localised infection
that has no systemic phase. The localised nature of the infection and the ability of the
virus to reinfect despite the presence of specific anti-viral antibodies, highlights the
importance of the local, cellullar immune response in controlling the infection. The
host cutaneous response to orf virus infection involves the accumulation of a large
number of neutrophils and lymphocytes adjacent to and underlying the infected
epidermis (Jenkrnson et al., 1990a). A secondary infection is characterised by an
accelerated response resulting in a much milder infection which resolves faster
(Jenkinson et al., 1990b). As LCs play a role in the control of infections of the skin
with viruses such as herpes simplex virus-type 1 and vaccinia virus (Sprecher and
Becker 1986,1988 and 1991), they were postulated to have an important role in the
immune response to orf virus infection. Jenkinson et al., (1991) showed that a dense
accumulation ofMHC class II+ dendritic cells formed at the site of the orf lesion.
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These dendritic cells were hypothesised to form a barrier to viral invasion and a
template for subsequent epidermal repair. However they lacked the ovine LC marker
acetylcholinesterase (AchE), thereby sharing the phenotype of the AchE' dendritic
cells found in the dermis of normal ovine skin. It was proposed that these AchE"
dermal dendritic cells were likely to represent a heterogeneous population of cells that
may be differentially involved in the MHC class II+ dendritic cell response to orf virus
infection (Jenkinson et al, 1991).
In this chapter, sheep were infected with orf virus following scarification and skin
biopsies were collected at various times thereafter. These were examined by
immunocytochemistry using a range of specific antibodies. Comparisons were made
between the dendritic cell populations in primary and secondary orf virus infection,
control scarification and normal ovine skin.
The aims of the study were three-fold;
1. Using the dendritic cell markers CD1 and factor XHIa, we wished to
further characterise more fully the AchE" dendritic cells and in particular,
to determine whether the dendritic cells, accumulating adjacent to or
below the orf lesion, differ phenotypically from those normally present in
uninfected ovine skin.
2. To establish whether there is any relationship between the accumulating
dendritic cells and cells of the monocyte-macrophage lineage.
3. To determine whether the dendritic cells proliferate locally.
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3.2. RESULTS
3.2.1. Clinical observations and serology
i). Control scarification
The lines of scarification in the control, uninfected group developed scabs by 24h,
with a mild associated erythema. By 48h the scabs were beginning to detatch, and at
72h only a fine, non-inflamed scar was visible. No swelling or vesicles, indicating any
secondary infection of the animals, was evident
ii). Primary orf virus infection
Each of the four SPF lambs developed all the typical phases of an experimental orf
virus infection; macule, papule, vesicle, pustule and the formation of a scab which was
shed on resolution of infection. The initial erythematous response observed in the first
24 to 48 hours could not be distinguished from the scarification controls and was due
to the trauma of scarifiying the skin. Vesicles and pustules, approximately 2mm in
diameter, developed along the scarification lines at day 3 (72h) and day 6 (148h)
respectively and by day 9 scab formation was observed on all four sheep. In 3 of the 4
sheep detachment of the scab was observed after 22 days, however the fourth animal
still had profound lesions after 30 days.
Hi). Secondary orfvirus infection
The stages of papule, pustule, scab formation and resolution of infection were
observed in 3 of the 4 sheep. The lesions developed earlier (pustules appeared at 48-
72h) and resolved faster than the primary challenge; scabs forming by 96h and
beginning to be shed by day 7 (170h). The fourth animal did not develop any visible
evidence of an orf infection, but subsequent studies, described below, showed that
the animal was successfully infected with orf virus, although it was a milder infection.
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iv). Serology
The four animals used in the secondary challenge had been conventionally raised and
as they were over the age of 1 year were expected to have been exposed to natural orf
infection in the field. Previous exposure to orf virus was confirmed by screening
serum taken from the animals prior to the start of the experiment using an ELISA
specific for orf virus. The sera of all four animals showed high titres of antibodies to
orf virus indicating recent exposure. The fourth animal that did not develop an
obvious lesion (mentioned above), did not have an antibody titre that differed
significantly from the other three animals.
3.2.2. Immunohistochemistry
The results for each of the markers are described individually and subdivided into four




Four populations of MHC class II+ dendritic cells were observed in normal skin. Their
phenotypes are summarised in Table 3.1.
Table 3.1 The dendritic cellpopulations ofnormal skin
markers/cells MHC class II AchE CD1 factor
XHIa
%*
Epidermal LC + + + -
Dermal DC (1) + - + - 45
Dermal DC (2) + - - + 15
Dermal DC (3) + - - - 40
* Each population as a percentage of the total MHC class II + dendritic cells present
within normal skin.
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CD1+dendritic cells were seen within the epidermis generally at, or immediately
above, the stratum basale and within the dermis clustered at the dermal/epidermal
junction or closely associated with dermal structures such as sweat glands, hair
follicles and blood vessels. A comparison between dendritic cells expressing MHC
class II and CD1 antigens in serial sections (Figure 3.1A and B) showed that all CD1+
dendritic cells coexpressed class II antigens. Within the epidermis all dendritic cells
were CD1+ and MHC class II+, but only 50% of the MHC class II+ dendritic cells in
the dermis were positive for CD1. A small population of factor XIIIa+ dendritic cells
were observed within the dermis, typically at the dermal/epidermal junction (Figure
3.1C) and surrounding blood vessels, particularly in thepapillary dermis. Analysis of
serial sections showed that factor XIIIa+ dendritic cells were CD1" and coexpressed
MHC class H. However, they represented only a small proportion (approximately
15%, Table 3.1) of the MHC class II+ dendritic cells present within normal ovine
skin.
Scarified skin
A significant increase of MHC class II+ dendritic cells and factor XIIIa+ dendritic cells
from the number found in normal skin was observed at 48h, following scarification
(p < 0.05 and p < 0.01 respectively, Figure 3.2). The populations accumulated
transiently at the dermal/epidermal junction on either side of the abrasion at 48h
(Figure 3.3A and B). Some diffuse staining, that did not appear to be cell-associated,
was observed with factor XIHa at the very edges of the lesion and also within the
scab. CD1+ dendritic cells were absent from the dendritic cell accumulation and were
found only in the undisturbed dermis/epidermis adjacent to the abrasion. At 96h CD1+
dendritic cells had appeared along the boundary of the new epidermis and by 170h
their distribution in the epidermis and dermis had returned to that seen in normal,
uninfected skin.
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Figure 3.1 Serial sections ofnormalovine skin showing the distribution ofA) MHC




























Figure 3.2 Changes in the MHC class II+, CD1+ andfactorXllla* dendritic cell
populations of the skin in response to scarification.
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Figure 3.3 Serial sections ofovine skin, 48showing the
accumulation ofA) MHC class cells and B) factor
XIIhfdendritic cells beneath the damaged epidermis. Note the diffuse
staining offactor XHIa atthe edges ofthe abrasion. Immunoperoxidas
X 560
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Primary Orf virus infection
The dendritic cell response at 48h post-infection was similar to the response observed
for scarification, with an increase in MHC class II+ and factor XIIIa+ dendritic cells.
From 48h onwards the MHC class n+ dendritic cells continued to accumulate
forming a dense network beneath the infected, degenerating epidermis (Figure 3.4 and
Figure 3.5A) and clustered between epidermal down growths. The dendritic cell
accumulation reached a maximum between days 9 to 12 and then decreased returning
to a pre-infection distribution by day 30 (not shown). Factor XIIIa+ dendritic cells
accumulated in high numbers at the lesion (Figure 3.4 and Figure 3.5B), forming a
significantly high proportion of the dendritic cell network at 170h when compared
with the equivalent time point in the scarified only skin (53%, p < 0.0001). The
accumulation of factor XIIIa+ dendritic cells was restricted to the dermis (Figure
3.5C), unlike the MHC class II+ dendritic cells which could be seen infiltrating the
infected epidermis (Figure 3.5D). Although 170h post-infection was the last timepoint
for cell enumeration, qualitative analysis thereafter showed that factor XHIa+ dendritic
cells persisted until day 12, clustered between the epidermal downgrowths, and then
declined in parallel with the MHC class II+ dendritic cells. The dense accumulation of
dendritic cells was negative for CD1 at all the timepoints studied. With the onset and
spread of infection (from 48h post-infection), CD1+dendritic cell numbers decreased
(Figure 3.4), and by 170h these cells were virtually absent from the skin when
compared with the same timepoint of the control scarified skin (p < 0.015). On
resolution of infection (day 16, as shown by disappearance of viral antigen) CD1+
dendritic cells reappeared at the epidermal/dermal junction and subsequently within
the thickened epidermis on day 22.
Secondary orfvirus infection
The MHC class II+ dendritic cell response that occurred within the first 96h after a
secondary challenge with orf virus was similar to the response observed during this time
following primary infection (Figure 3.6). The dendritic cell network was densest at 96h
after which cell numbers declined as the infection resolved (170h, not shown). Which is






























Figure 3.4 Changes in the MHC class IF, CDF andfactorXIIIa" dendritic cell
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Figure 3.5 Serial sections ofovine skin 170hpost-primary infection with
showing the extensive nature of the lesion, with the balloooning
degeneration of the epidermis and the accumulation ofA) MHC class II+






Figure 3.5 Highpower view ofthe dendritic cell nature o/'C) the factor XIIIa+
dendritic cells gathered at the site ofaprimary orf lesion, where they
restricted to the dermis and D) the class II+ dendritic cells which
infiltrate into the infected epidermis. X 560
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dendritic cells peaked transiently at 48h, as observed for control scarification group,
and were not present in the dense network of MHC class IT dendritic cells at 96h,
representing only 1% of the total MHC class ET dendritic cells present in the section-
However their numbers had increased by 170h (reaching 10% of the total MHC
class n+ dendritic cells present) as the infection started to regress. CD1+ dendritic cells
were absent from the lesion and their numbers decreased as the lesion extended into
previously unaffected dermis/epidermis. At 170h the occasional CD 1"" dendritic cell was
present at the dermal/epidermal junction of the healing lesion.
ii). Anti-proliferating cell nuclear antigen (PCNA)
Normal skin
PCNA*- cells were present in low numbers in the normal skin of all the animals
studied. Typically the positive cells were observed in the basal layer of the epidermis
and surrounding sweat glands and at the base of hair follicles (Figure 3.7A). These
cells did not have a dendritic cell morphology.
Scarified skin
Intense PCNA staining was observed at 48h post scarification in the epidermal cells
flanking the edges of the newly regenerating epidermis (Figure 3.7B). The cells
infiltrating the dermis beneath the lesion were negative for PCNA. The newly formed
epidermis also contained some positive cells at 96h and by 170h the skin resembled
the uninfected state, with only faintly staining PCNA+ cells detectable.
Primary orfvirus infection
At 48h post infection, PCNA staining was similar to that seen at the same time
following scarification only, being focused at the edges of the lesion and in the newly
formed epidermis. The proliferative activity within the epidermis decreased after 96h
when the epidermal cells at the edges of the expanding lesion became vacuolated due
to viral replication and only faint staining with PCNA was detectable. By 170h PCNA
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Figure 3.6 Changes in the MHC class II*, CD1* andfactorXllla* dendritic cell
populations ofthe skin in response to a secondary infection with orf
virus.
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staining began to increase and intense nuclear staining was observed within the
developing epidermal downgrowths (Figure 3.8A), which increased in size over the
next few days (days 9 to 12, not shown). Positive cells were also present within the
dermal cellular influx (48h onwards). Dual staining of these cells with MHC class II
revealed that a few of the proliferating cells were class II+ dendritic cells (Figure
3.8B). By days 22 to 30 PCNA+ cell numbers decreased and the skin returned to a
normal level of pre-infection PCNA staining.
Secondary orfvirus infection
The pattern of cellular proliferation was similar to the scarification already described,
with positive cells flanking the edges of the lesion at 48h. Proliferation was not
observed at any time within the dermal influx of dendritic cells; and the dense
accumulation of cells at 96h was completely negative for PCNA staining. Epidermal
downgrowths were not observed and the only proliferating cells that were present
were within the healing epidermis (at 170h).
Hi). Monocyte-macrophage markers
As the monoclonals which recognise monocytes/macrophages had not been fully
characterised on ovine cells, they were first used on alveolar macrophages and bone
marrow cells from sheep. The monoclonals used were OM1, OM2, OM3 and IL-A15
and IL-A24.
Alveolar cytospins
The three OM monoclonals gave strong staining of the alveolar macrophages with the
most intense staining observed for OM3 (Figure 3.9A). The IL-A antibodies, giving
fainter and more variable staining, did not recognise all of the macrophages.
Bone Marrow cytospins
The three OM monoclonals reacted with only a few of the cells in the bone marrow
cytospins. These cells had macrophage-like morphology. The EL-A antibodies
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Figure 3.7 Theproliferative response ofovineskin A) under normal 'resting'
conditions, where some epidermal arepositive for PCNA,
ImmunoperoxidaseX 560 and B) at where PCNA
positive cells can be seen to line the edges ofabraded skin and represent
the epidermal keratinocytes involved in the healing process.
Immunoperoxidase X 112
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Figure 3.8 Theproliferative reponse ofovine skin infection
orf virus .A) A large number ofintensely PCNA positive cells are seen in
the developing epidermal downgrowths and surrounding infected hair
follicles and within the dermal influx. XI12
B) Double staining with MHCclass II (pink) and PCNA (brown) shows a
proliferatingMHC class II+ dendritic cell within the inflammatory influx
ofcells. Immunoperoxidase and alkaline phosphatase X 560
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stained a larger proportion of the cells. IL-A15 stained neutrophils strongly and a
population of pro-monocytes. IL-A24 stained monocytes and the more mature
neutrophils and reacted slightly with a population of macrophages (Figure 3.9B).
Normal skin
Few cells within normal skin stained with the OM monoclonals. The occasional
positive cell that had macrophage-like morphology could be detected within the
dermis, typically associated with dermal structures such as sweat glands. The OM2
monoclonal also recognised endothelial cells lining blood vessels in the skin. EL-A15
gave very similar results, with only a few positive macrophage-like cells detectable
within the dermis. IL-A24 stained cells with dendritic processes in the epidermis and
surrounding the tops of hair follicles.
Scarified skin
Scarification of the skin generated a small influx of neutrophils along with the MHC
class II+ cells. The OM monoclonals did not recognise either the neutrophils or the
MHC-class IT dendritic cells. Both IL-A15 and IL-A24 monoclonals did show some
staining but this was of neutrophils and not class II+ cells. No macrophage-like cells
were observed to react with any of the markers used.
Primary Orf virus infection
The primary lesions formed quite extensive pustules beneath the scab and the high
neutrophil content within them stained intensely with IL-A15 and IL-A24 (Figure
3.9C). The OM monoclonals gave no staining with any of the cell types at any of the
timepoints observed. No macrophages or dendritic cells were observed staining with
any of the markers.
Secondary orfvirus infection
The IL-A antibodies did not stain any dendritic cells present at any of the timepoints
following infection and the positive cells that were present in high numbers were the
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Figure 3.9 Antibodies specific formonocyte-macrophages. A) showing the intense
staining ofovinealveolarmacrophages with the antibody OM3 and B)
IL-A24positive cells within a preparation ofovine bone marrow
shows IL-A24positivepolymorphonuclear neutrophils within the
inflammatory influx at 96h post-primary infection with orf virus. No
positive dendritic cells are visible. Immunoperoxidase X 560
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neutrophils. The OM monoclonals did not stain any of the cells in the dermis at any
time post-infection.
iv). Orf virus antigen
Normal skin! Scarified skin
Viral antigen was not detected in the sections of normal, uninfected skin or in the
control scarified group.
Primary orf virus infection
The regenerating epidermal keratinocytes, positive for PCNA at 48h post-scarification
and infection were negative for orf viral antigen. From 72h onwards these epidermal
cells became vacuolated and positive for orf viral antigen. As the infection progressed
(170h onwards), viral antigen spread laterally and intense staining of the damaged,
vacuolated cells of the epidermis was seen (Figure 3.10A). The cells containing viral
antigen were negative for PCNA, but the epidermal keratinocytes directly beneath
them were intensely PCNA+ (Figure 3.10B). It was directly below these two layers of
viral antigen and PCNA+ cells that the factor XIIIa+dendritic cells were gathered
(Figure 3.10C). By day 12, orf viral antigen was no longer restricted to the outer
edges of the lesion and had spread to encompass hair follicles and was observed in
areas of degenerating epidermis in between PCNA+ epidermal downgrowths. On day
16 viral antigen was detectable within the epidermal downgrowths, which had lost
their intense PCNA staining, but were surrounded by high proliferative activity. By
day 22 only one sheep still had detectable viral antigen between the epidermal
downgrowths and by day 30 no viral antigen was visible in any of the sheep.
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Figure 3.10 Serial sections ofovine skin 17infection with
showing A) the distribution oforf viral antigen 2E5)
at the very outer layers of the degenerating epidermis that lie directly
above B) the areas ofepidermalproliferation (PCNA positive) and C)




Like the primary response, viral antigen was not seen at 48h. At 96h viral antigen was
detected within the ballooning degenerated cells of the infected epidermis underlying
the scab. Little proliferative activity in the underlying epidermal cells was observed.
By 170h post-infection no viral antigen was found.
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3.3. DISCUSSION
Our studies show that within normal ovine skin the MHC class II+ dendritic cells
comprise at least four sub-populations of dendritic cells; one is found exclusively
within the epidermis- the LC and is Ache+ and CDlri The Ache" dermal dendritic cells
described by Jenkinson et al., (1991) constitute three sub-populations of dendritic
cells, CD1+ dendritic cells (that represent about 45% of all dermal dendritic cells) and
CD1" dendritic cells of which a proportion (approximately 30%) are positive for the
marker factor Xllla.
The MHC class II+ dendritic cells that gather in response to scarification and orf vinos
infection (primary and secondary) were found to be a population of CDT cells. In all
three of the groups the dendritic cell accumulation was similar at 48h, confirming the
work by Jenkinson et al., (1991) which showed that the initial dendritic cell response
in experimentally infected animals is due to the procedure of scarifying the skin. From
48h onwards the increase in dendritic cells is in response to viral replication and the
subsequent degeneration of infected epidermis, shown to contain viral antigen.
Meanwhile the numbers of dendritic cells in scarified skin return to normal. A larger
and more prolonged accumulation of dendritic cells is observed in a primary orf virus
infection compared with a secondary challenge infection. This correlates with the
persistence of the virus in a primary infection, where viral antigen is still detectable 16
days post-infection. In contrast, the secondary infection resolves much faster, with the
clearance of viral antigen from the lesion by 170h post-infection. It would have been
interesting to study the response to inactivated orf virus to confirm the importance of
the replicating virus in cellular recruitment
Factor XIIIa+ dendritic cells appear to form part of the dendritic cell response to
epidermal injury; they are observed 48h after scarification alone and may have a role
in the initial healing process of the skin. Evidence to support this putative role of
factor XIIIa+ dendritic cells comes from recent studies in humans which show that
factor XHIa is found regularly in the early stages of repairing lesions, most clearly in
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evolving scars (Penneys et al., 1990). Factor Xllla is a transglutaminase involved in
the final stages of clot formation (Mosher et al., 1980) and one theory suggests that
XHIa is stored in the cells for extracellular release after local injury, crosslinking the
fibrin clot to structural protein and helping to seal the wound (Penneys et al., 1990).
This theory of factor Xllla deposition at the scar could explain the diffuse non cell-
associated staining often observed within the scab and at the edges of the lesion and
may also be the reason for the transient expression by the cells. Factor XIIIa+
dendritic cells were present in much higher numbers and persisted for much longer in
the primary orf lesion than in the scarified skin and secondary orf lesion. Factor Xllla^
dendritic cells formed a considerable part of the dendritic cell network in the primary
orf lesion, persisting until the viral antigen was cleared. This may have been due to the
more extensive nature of the lesion, or these cells may have a role other than in
wound healing.
Recently, human factor XHIa* dendritic cells have been identified as coexpressing
intracellular adhesion molecule-1 (ICAM-1) and lymphocyte function-associated
antigen (LFA-1). The presence of these immunological markers and the distinctive
distribution of these cells, with the highest concentration being in the skin and
mucosal tissues, has led to the suggestion that they play a central role in skin immune
responses (Derrick et al., 1993). Other studies have reported possible phagocytic and
antigen processing functions of factor XUIa+ dendritic cells (Foucar and Foucar
1990). Factor Xllla* dendritic cells have been demonstrated in psoriatic skin lesions
as being potent producers of tumour necrosis factor -a (TNFa) (Nickoloff et
al., 1991), which is implicated in the increased growth rate of the keratrnocytes in the
lesions. It was hypothesised that the ability of the dermal dendritic cells to produce
TNFa could increase lymphocyte trafficking through the skin by inducing IL-8 and
ICAM-1 production by keratinocytes (Nickoloff et al., 1991). Thus a possible function
of the cells could be the attraction of neutrophils and T lymphocytes into the skin in
response to epidermal damage or viral replication. High numbers of factor XIIIa+
dendritic cells are seen in the verrucous skin lesions of HIV-1+ patients caused by
secondary infections with DNA viruses, such as varicella zoster virus, herpes simplex
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virus and molluscum contagiosum (Smith et al., 1992). The ability of factor XIIIa+
dendritic cells to influence keratinocyte growth via TNFa production could contribute
to the process of healing damaged skin. Interestingly, factor XTa" dendritic cells
were most numerous adjacent to the epidermal downgrowths which are characteristic
of primary but not secondary orf lesions. A similar association of factor XIHa+
dendritic cells with epidermal cell proliferation is observed in psoriasis. As the
secondary orf lesion heals well without the presence of these cells, the high numbers
of factor Xllla4" dendritic cells that accumulate in a primary orf lesion may have an
immunological role, possibly reflecting fundamental differences in the primary and
secondary immune response to orf virus infection and contribute to the epidermal
proliferation observed.
CD1+ dendritic cells do not form part of the dendritic cell network in the responses to
scarification, primary or secondary orf virus infections. The number of CD1+ dendritic
cells in the dermis decreased with the onset and spread of virus infection, the
depletion being most marked at the peak of a primary infection. The function of the
family of CD1 molecules is poorly defined, but they share a resemblance to MHC
class I molecules (Terhorst et al., 1981 and Knowles et al., 1982) and have been
implicated as playing a role in cell mediated endocytosis and antigen presentation
(Hanau et al., 1987 and Kapsenberg et al., 1990). CD1+ dendritic cells have been
characterised in ovine afferent lymph (Budjoso et al., 1989) and are postulated to act
as accessory cells for T lymphocytes. It could be hypothesised that the disappearance
of CDT dendritic cells from the skin reflects their migration to the draining lymph
node via the afferent lymphatics following orf virus infection, to present viral antigen
to the T lymphocytes. It is unknown, however, whether the antigens CD1 and factor
Xffla can be influenced by the focal effects of inductive cytokines. The differences in
the level of expression of factor Xllla between primary and secondary responses
could be explained by differences in the local cytokine profiles. The depletion of CD1
from the surrounding dermis may occur as a direct result of orf virus replication and
the induction or suppression of local cytokines which may down regulate CD1
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expression. The levels of CD1 return to normal only when the infection is well into
regression.
Cerio et al., (1989) studied dermal dendritic cells that expressed factor Xffla and
concluded that they were bone marrow derived, distinct from LCs and shared some
common epitopes with mononuclear phagocytes. The relationship of the dendritic cell
with the monocyte-macrophage lineage is still under debate. The lack of staining of
the MHC class IT dendritic cells with a panel of monoclonal antibodies which
recognise markers on macrophages, confirms that these cells are not activated
macrophages expressing MHC class II, but still leaves their origin unknown. Factor
XlUa is also expressed by monocytes and is retained during their differentiation into
macrophages. It is possible that the factor XIIIa* dendritic cells observed in a primary
orf virus infection represent an immature population of dendritic cells, the subsequent
maturation and differentiation of which is dependant upon an array of cytokines
produced locally. The differences in the level of expression of factor XHIa between
the two populations of CDT dendritic cells below the primary and secondary lesions
may reflect differences in the cytokine profiles present.
As the accumulation of cells in response to scarification and secondary orf virus
infection occurs in the absence of any proliferative activity, it is unlikely that the small
population of MHC class II+, CDT dendritic cells present in normal ovine skin
proliferate locally to form the dense network of dendritic cells. High proliferative
activity is observed within the dermal influx in primary orf virus infections. A large
proportion of this may be due to the local proliferation of B/T cells that is not
observed in the secondary response where memory cells come into play. Dual staining
revealed that a few of these proliferating cells are MHC class II+ dendritic cells. It
seems more likely that the large accumulation within the dermis arises from an influx
of cells from the blood in response to changes in surface markers of the endothelial
cells lining the blood vessels of the skin. This may represent a positive selection of
circulating dendritic cells or a population of precursor cells that go on to develop their
dendritic characteristics after infiltrating the tissues. This could be investigated by the
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application of antibodies to adhesion molecules such as ICAM-1 to sections of orf
infected skin.
The proliferation of epidermal keratinocytes appears to be a pre-requisite for orf virus
infection. The initial procedure of scarifying the skin permits the access of orf virus
into the skin, where it replicates in the regenerating keratinocytes involved in the
healing of the abrasion. The absence of orf viral antigen within the first 48h post¬
infection is known as the eclipse phase and it is hypothesised that the virus resides
within the replicating cells but requires them to reach a certain stage in their cell cycle
before it itself, can replicate. This pattern of proliferation followed by the appearance
of viral antigen is much more prolonged in a primary infection. In the primary orf
lesion the extensive epidermal proliferation that occurs results in the formation of
epidermal downgrowths, which initially are PCNA positive but lack orf viral antigen.
A few days later, however, the reverse is true, they lose their PCNA reactivity and are
shown to contain viral antigen. The less proliferative nature of the secondary orf
lesion may restrict the spread of the virus and result in a much milder lesion.
In summary, the dendritic cells accumulating in orf virus infected skin share the
phenotype of the population of CDT dermal dendritic cells found in normal ovine
skin. A proportion of these cells express the marker factor Xllla, the number varying
considerably between primary and secondary responses. Detailed functional studies
will be required to determine whether factor XHIa and CD1 are inducible on these
cells and if the expression of the different markers reflects functional differences, such
as antigen presentation or cytokine production, between the different subpopulations
of dendritic cells. The information gained from these studies should then provide an




ESTABLISHMENT OF KERATINOCYTE CULTURES FOR
IN VITRO STUDIES OF ORE VIRUS REPLICATION
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4.1. INTRODUCTION
Detailed in vivo studies of the orf lesion located orf viral antigen within the newly-
regenerating epidermal keratinocytes, identifying the keratinocyte as the site of orf
virus replication (Jenkinson et al., 1990a,c). Whilst orf virus will replicate in vitro in a
variety of different cell types (Robinson and Balassu 1981), there have been no
reports of orf virus growth in keratinocytes. It became apparent from the many in
vitro studies of orf virus, that the onset of cytopathic effect (CPE) was variable
ranging from 2h-48h post-infection. The factors involved in this variation were
considered to include the titre of infectivity, the age of the cultures, with orf virus
reportedly replicating to higher titre in young rapidly dividing cells, and the type and
batch of cells used (Nagington et al., 1968). These studies highlight the need to
investigate, in vitro, the kinetics of orf virus replication in the target cell of the
natural infection - the keratinocyte.
Epidermal keratinocytes can grow in culture to form a stratified squamous epithelium
(Holbrook and Hennings, 1983). These cultures contain a dividing as well as a
terminally differentiating population and undergo surface desquamation. The
establishment of such keratinocyte cultures is, however difficult due to the problem of
fibroblast contamination which occurs as a direct result of using skin samples obtained
from circumcision, surgical waste or by biopsy as a source of cells. This problem was
initially overcome by Rheinwald and Green (1975) through the use of a feeder layer of
lethally irradiated 3T3 fibroblasts which support the growth of keratinocytes and
prevent fibroblastic overgrowth.
A variety of different methods for growing keratinocytes in culture have since been
developed, most of which are based on the technique of Rheinwald and Green (1975).
The cultivation of keratinocytes, although now routine, is nevertheless complex. The
desire to produce a more normal epidermis in vitro for experimental purposes has led
to the development of substrates of collagenous gels, including extracellular matrix
components, or constructs of dermal equivalents (Bell et al., 1983, Hansborough et
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al., 1989, Yarrnas et al., 1989). Other studies have favoured the use of conditional
media containing added growth factors such as epidermal growth factor (Rheinwald
and Green, 1977) and cholera toxin (Green et al., 1978), which encourage
keratinocyte growth in the absence of a feeder layer.
A unique method for cultuning keratinocytes was established by Weterings et
al., (1981) where the follicular epithelium of plucked hair follicles was used as a
source of cells. The plucked hairs were explanted and colonies of keratinocytes
formed from the follicular epthelium surrounding the hair. A number of workers went
on to develop this technique using a variety of substrates, such as bovine lens capsules
with varied success (Wells, 1982; Weterings et al., 1981; Limat and Noser, 1986;
Wells and Sieber, 1985; Sieber and Wells, 1986; Stark et al., 1986; Imke et al., 1989;
Sieber and Hopewell, 1990), the major drawback being the limited cell numbers that
could be obtained. The absence of dermal components from the plucked hair follicle
reduces the risk of fibroblast contamination, therefore providing a relatively pure
source of keratinocytes. This system has been described for plucked sheep hairs (V.K.
Sieber, personal communication) and would appear to be a simple technique to obtain
ovine keratinocytes that is less invasive and more selective than the alternative method
of biopsying skin as a source of cells.
The aim of this study was to establish pure cultures of ovine keratinocytes from
plucked sheep hairs, infect them with orf virus and determine the kinetics of viral
replication and development of CPE. This preliminary study provides the necessary
information about the time course of infection for the subsequent studies of cytokine
production by orf virus infected keratinocytes described in chapter 5.
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4.2. RESULTS
The details of the materials and methods used in this chapter are described in chapter
2.
4.2.1. Establishment of ovine keratinocyte cultures
i). Primary cultures
Several attempts to grow keratinocytes from plucked hairs in some of the
commercially available keratinocyte media were unsuccessful. The first successful
primary cultures from plucked hairs were achieved in the keratinocyte medium
described by Wells and Sieber (1985) with additional growth factors; hydrocortisone
(0.4pg/ml) and epidermal growth factor (EGF, lOng/ml). These were used at the
optimal concentrations established for human keratinocyte cultures (Limat et
al., 1986, Lin et al., 1988).
After approximately 3-5 days of culture, the first signs of keratinocyte growth were
visible. Small outgrowths of balloon-like cells could be observed, originating from the
outer root sheath of the plucked hair. Cells then appeared to radiate outwards from
the attached hair follicle to form a small colony of cells with polygonal morphology
(Figure 4.1A). Only a small percentage of the attached hair follicles of each flask gave
rise to a colony of growing keratinocytes (<30%). The successfully established
colonies increased slowly in size reaching approximately 1cm in diameter after 14-20
days incubation. Figure 4.1B shows a 14 day old keratinocyte colony. Variations in
the cell morphology were observed across the radius of the outgrowth. The cells at
the boundary of the colony were a single cell thick and had a flat shape with some
cellular processes reaching out into the surrounding area (similar to the cells of the
early outgrowth observed in Figure 4.1A). Towards the centre of the colony, closest
to the follicular epithelium, the cells were densely packed, stratified and several layers
in thickness. Occasionally the layers of keratinocytes became so thick that they




Figure 4.1 Outgrowth ofkeratinocytes from the follicular epithelium ofa plucked
sheep hairfollowing A) 5days incubation and B) 14 days incubation.
Phase contrast X 112
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centre of the outgrowth. After 14 to 20 days in culture the cells were trypsinised for
the first time. At this stage the cell outgrowths did not cover the entire surface of the
culture flask, if they were left longer however, the colonies increased in thickness, but
not in diameter. The multilayered colonies of cells were often difficult to detach from
the culture flasks. Detachment was aided by a longer incubation in trypsin combined
with gently tapping the sides of the flasks. After the first trypsinisation the cells were
returned to the original flasks to encourage cell attachment. They were then grown in
medium containing no supplementary growth factors. Usually within 3-4 days of their
first passage the cells formed a uniform monolayer (Figure 4.2).
Figure 4.2 Monolayer ofkeratinocytesatfirstpassage. X 112
ii). Subculture
The keratinocytes grew well in the medium described and a single flask (25cm2) of
keratinocytes obtained after the first passage could be split 1 to 2, for repeated
passages, 5 or more times to give 32 flasks (25cm2) of cells in approximately 4 to 5
weeks. Attempts to culture the cells beyond a sixth passage were unsuccessful.
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Keratinocytes collected and stored after the second trypsinisation were successfully
recovered from liquid nitrogen and could be passaged as described.
4.2.2. Immunohistochemical characterisation of keratinocytes
Due to the virtual absence of dermal components in the plucked hair follicle,
overgrowth of the cultures by fibroblasts was rarely encountered. The characteristic
morphology and slow growth rate of the keratinocytes was a good indication of the
purity of the cultures. Any fibroblast contamination was clearly apparent due to their
fast growth rate and fibroblastic morphology. The purity of the cultures were,
however, evaluated by immunoperoxidase with antibodies against keratin
polypeptides which are synthesised in the epidermis and cultured keratinocytes. The
anti-keratin antibody was shown to stain the keratinocytes surrounding a hair follicle
in a section of normal ovine skin (Figure 4.3).
Figure 4.3 Paraffin section (10[xmthick) ofnormal skin showing anti-keratin postive
keratinocytes lining a hairfollicle. Immunoperoxidase X 112
\
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An antibody was also included that reacts with vimentin; a marker for mesenchymal
cells (including fibroblastic cells). Monolayers of foetal lamb (FL) skin cells which
should contain both populations of keratinocytes and fibroblasts were also stained
with the two antibodies.
i). Anti-keratin
Approximately 99% of the keratinocyte monolayers were positive for keratin (Figure
4.4A). The antibody could be seen to stain intensely tonofilaments of keratin that
were present within the cytoplasm of the cells (Figure 4.4B). The population of cells
within the FL skin cultures was observed to be largely fibroblastic and these cells did
not stain with anti-keratin. However, small islands of smaller, fatter cells could be
observed in the cultures that did appear to stain with anti-keratin and these cells were
assumed to be keratinocytes (Figure 4.5A).
ii). Anti-Vimentin
The keratinocyte cultures were negative for vimentin (not shown). The majority of the
cells in the FL skin cultures were, however, intensely positive for vimentin (Figure 4.5
B). The smaller islands of cells that were observed to stain with anti-keratin did not
stain with anti-vimentin, again indicating their keratinocyte nature.
4.2.3. Orf virus infection of keratinocytes
Initial studies of orf virus that were carried out at the Moredun Institute used a virus
isolate derived from natural cases to experimentally infect sheep for in vivo studies.
This scab virus isolate was adapted to tissue culture for in vitro studies and
designated orf 11 (Mckeever, 1986). Orf 11 does not. however, produce experimental
orf lesions in vivo (Dr H.W.Reid, personal communication). More recently,
experimental work has favoured the use of a commercially available tissue culture
adapted strain of orf virus, Scabby Mouth (see chapters 2 and 3). This strain of orf
virus represents a purer inoculum than the undefined components of the scab virus
and can be used in both the in vivo work, as it will produce lesions experimentally,
and in the in vitro studies. In this study both strains of tissue culture adapted orf
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A)
Figure 4.4 Monolayer ofanti-keratin positive keratinocytes A) low magnification




Figure 4.5 Monolayers o/FL skin cells stained A) anti-keratin, showing a
singlepositive cell and B) antwherethe majority ofcells
positive, lmmunoperoxidase X 560
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(orf 11) and Scabby Mouth were included and their ability to replicate within ovine
keratinocytes determined.
i). Titration oforf virus in keratinocytes
Keratinocyte monolayers grown on plastic coverslips in 48 well plates were infected
with tenfold dilutions of Scabby Mouth or orf 11 and the plates examined for viral
cytopathic effect (CPE) at 12h, 24h and then daily until day 4. The final titre was
calculated on day 4 following the method described by Karber (1931). Fixed
monolayers of infected cells at 12h, 24h and 48h were stained with Leishman's and
photographed.
Cytopathic effect (CPE)
The coverslips infected with the 10~l dilutions of virus were fixed and stained with
Leishman's at 12h, 24h, and 48h to observe the CPE of both Scabby Mouth and orf
11. The Scabby Mouth virus preparation that was used gave a rapid CPE that caused
cell death and marked disruption to the monolayer by 12h post-infection (Figure
4.6A). This CPE was not observed for the orf 11 infected cells, as at 12h the
monolayer was intact and the only indication of infection was the presence of some
small pyknotic cells (Figure 4.6B) that were not observed in the uninfected control
cells (Figure 4.6C). At 24h post-infection virtually 99% of the cell monolayer was
disrupted by Scabby Mouth; all the cells that were still attached were rounded (Figure
4.7A). A visible CPE was now detected for orf 11 infected cells, with some cell
rounding and the appearance of patches in the monolayer was observed (Figure 4.7B).
By 48h post-infection with Scabby Mouth very few cells were left attached to the
coverslip. At this timepoint a dramatic CPE was observed for the orf 11 infected cells
(Figure 4.8A and B), which was only now comparable to the CPE observed for
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Figure 4.6 Monolayers ofkeratinocytesat p st-infection A) Scabby Mouth










Figure 4.7 Monolayers ofkeratinocytes at 2A) Scabby Mou h
virus and B) orf 11 virus. Leishman'sstain X 112
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A)
Figure 4.8 Monolayers ofkeratinocytesat virus A)




The total proportion of positive wells (i.e wells that showed CPE) of each dilution
was summed (see Table 4.1) and used to calculate the 50% tissue culture infectious
dose (TCID50) of the stock virus (Karber, 1931).
Table 4.1 Orf virus titration readings showing theproportion ofpositive wellsfor
each dilution.
Viral dilutions Proportion of positive wells
Scabbv Mouth Orf 11
lcr1 6/6= 1 6/6=1
10'2 6/6=1 6/6= 1
10"3 6/6= 1 6/6=1
KT4 6/6= 1 6/6= 1
10"5 3/6= 0.5 3/6= 0.5
10"6 0/6=0 0/6=0
The TCID50 calculated from the above readings was found to be 106/ml for both
Scabby Mouth and orf 11. Therefore, despite the accelerated CPE of Scabby Mouth,
both virus preparations contained the same infectivity.
ii). Detection ofviral antigen in infected keratinocytes
Monolayers of keratinocytes infected with Scabby Mouth or orf 11 preparations were
examined for the presence of viral antigen at 12h, 24h and 48h post-infection by
immunofluorescence and immunoperoxidase.
Immunofluoresence
Using orf hyperimmune serum as a first step antibody (see chapter 2 section 2.2.2
(iv)) orf viral antigen was detected at 12h post-infection in the cytoplasm of single or
small groups of infected cells dotted across the monolayer for both strains of viruses
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(Figure 4.9A). No difference was observed between the two strains of viruses despite
the accelerated CPE of Scabby Mouth. By 24h, groups of fluorescing cells could be
observed, which for orf 11 were beginning to round up and detach from the culture
vessel (Figure 4.9B). The distribution of viral antigen in the monolayer was similar for
Scabby Mouth, although the CPE was well advanced. At 48h post-infection clumps of
brightly fluorescing rounded cells were observed for orf 11 (Figure 4.9C) and the cells
infected with Scabby Mouth, that were still attached, were also brightly positive.
Immunoperoxidase
The anti-orf antibody 5E2, that was used to detect orf viral antigen in the in vivo orf
lesions described in chapter 3, also recognised viral antigen in the infected cultures of
cells. No difference between the appearance of viral antigen was observed for the two
strains of virus. At 12h post-infection, single cells in the monolayer could be seen to
be faintly positive for orf virus antigen (Figure 4.1OA). By 24h, a larger number of
cells in the monolayer were positive and the viral antigen was located in large
inclusion bodies within the cytoplasm of the cell. By 48h the cells were rounded and
densely packed with viral antigen (Figure 4.1OB).
Hi). Viralgrowth curves
One step growth curves for Scabby Mouth and orf 11 were carried out to determine
tire kinetics of orf virus replication in keratinocytes. A series of keratinocyte
monolayers were infected with either Scabby Mouth or orf 11 and incubated at 37°C.
At various stages during the growth cycle, flasks were removed from incubation at
37°C and viral replication arrested by freezing the cells and supernatants separately at
-70°C. Infectivity in both the cells and supernatants for each time point was then
determined by titrating the samples on pre-formed monolayers as described above for
the stock virus.
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Figure 4.9 Immunofluorescent stainingofor/ virus infected keratinocytes at A) 12h




Figure 4.10 Immunoperoxidasestaining oforf virus infected keratinocytes with the
antibody 5E2at A) 12hpost-infection and B) 48h post-infection X 560.
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The TCID50 of the cell and supernatant samples for Scabby Mouth and orf 11 at each
timepoint post-infection were calculated as described before and the results plotted
(Figures 4.11A and 4.1 IB).
Overall, the kinetics of viral replication for both strains of virus were similar. Initially,
in the first 8h post-infection an eclipse phase was observed, where the number of
infectious virus particles detected decreased for both cells and supematants. This
reflects the penetration and uncoating of the virus in the cytoplasm of the cell
(Onwuka, 1989). From 8h onwards, orf virus replication occurred with an increase in
the number of infectious progeny detected in both the cells and supernatants. Early in
infection orf virus appears to remain cell-associated; infectious virus in the cells and
supernatants increased in parallel until about 48h post-infection when the amount of
virus released into the supematants was higher than the cell-associated vims. By 72h
the cell-associated vims decreased as the dead cells can no longer support viral
replication and the highest number of infectious vims particles were detected in the
supematants.
There was however, a slight difference between the growth curves of the two strains
of orf vims. Between 12h and 24h, the number of infectious particles released by
Scabby Mouth increased dramatically before levelling off between 24h and 48h. In
contrast, orf 11 was slow to release infectious vims, with an increase first detected
between 24h and 48h. This difference may be associated with the accelerated CPE
observed for Scabby Mouth. At 72h orf 11-infected cultures had higher titres in the
supematants than detected with Scabby Mouth indicating that although orf 11 is
slower to initiate the release of infectious vims and to cause a visible CPE it may be
the more efficient of the two strains of vims at replicating.
iv). Incorporation of 'sS methionine by keratinocytes.
This study was carried out to determine the effect of orf vims infection on
keratinocyte protein synthesis. Monolayers of keratinocytes grown to 80% confluence













24 Time (h) 48
—■— cell-associated virus
— •— cell-free virus
Figure 4.11A Orf virus replication (Scabby Mouth) in ovine keratinocytes. 25cm2
monolayer cultures were infected with a MOI of0.5 and the TCIDso of
cell-free and cell-associated virus determined at timepoints post¬
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Figure 4.11B Orf virus replication (orfll) in ovine keratinocytes. Monolayer
cultures were infected with a MOI of0.5 and the TCIDso ofcell-free and
cell-associated virus determined at timepoints post-infection. The TCID50
for each timepoint is expressed as total infectivity present.
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= 9h) protein synthesis was measured by the incorporation of35 S labelled amino
acids. Initial studies analysed both the cell lysates and supematants from the
infected/uninfected cells. However, analysis by SDS page revealed a large number of
protein bands from the cells with no obvious qualitative difference of cellular/viral
protein expression between infected and uninfected cultures. Thus subsequently only
the incorporation of 33S into proteins that were secreted into the culture supernatants
of the infected/uninfected cells was measured. Actinomycin D was included in two of
the infected flasks (for early and late collections) in an attempt to inhibit viral protein
synthesis and thus to measure the incorporation of j5S that was entirely due the
cellular protein synthesis. Shatkin et al., (1963) had shown that 2ug/ml of actinomycin
D could prevent vaccinia virus protein synthesis. However in the present study
actinomycin D was used at a concentration of lug/ml since at higher concentrations
it was found to be toxic to the keratinocytes. The results for the experiment are
shown below in Table 4.2 and in Figure 4.12.
Table 4.2 35S amino acid incorporation into protein secreted into the culture
supernatants of infected and uninfected control keratinocytes
Cells TPC* (cpm) % Incorporation*
Early Late Early Late
Control 8346 10190 4.17 5.09
Infected 18426 15666 9.21 7.83
Infected + Act 13557 12334 6.78 6.16
* TPC represents the trichloracetic acid (TCA) precipitable counts per minute (cpm)
of 10pl of a 5ml aliquot of culture medium measured in a scintillation counter with an
assumed efficiency of 50% (see chapter 2 for experimental details).
# % Incorporation is the percentage of total 3oS added that was incorporated into
secreted protein in each sample.
+ Act = + lpg/ml of actinomycin D.
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Orf virus infection did not result in the shutdown of protein synthesis by
keratinoc^les. An increase in protein synthesis after orf virus infection was observed
at both the early and late timepoints. The protein synthesis measured also includes
that of viral proteins as well as cellular proteins. The exact effect of actinomycin D on
orf virus protein synthesis or on host cell protein synthesis was not established in this
study but it did appear to reduce the overall amino acid incorporation of the infected
cells. If actinomycin was indeed inhibiting viral but not host cell protein synthesis,
then a comparison with the control would indicate that orf virus infection stimulates
cellular protein synthesis. Analysis of the radiolabelled proteins by SDS page revealed
that whilst actinomycin D reduced the level of incorporation of the labelled amino
acids by the infected cells, a comparison with the untreated, infected cells did not
reveal any protein bands that were directly attributable to the virus (Figure 4.12).
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CES= control early sample
VES= virus early sample
VEAS= virus early + actinomycin D
CLS= control late sample
VL= virus late sample
VLAS= virus late sample + actinomycin D
Figure 4.12 Autoradiograph ofearly and late protein synthesis ofcontrol and orf
virus infected keratinocytes. 35S methionine incorporation by cultures of
control and orfvirus infected keratinocytes + or - actinomycin D was
analysed by SDSgel electrophoresis.
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4.3. DISCUSSION
Using a modification of the technique described by Wells (1985), cultures of ovine
keratinocytes from the follicular epithelium of plucked sheep hairs were successfully
established. This was a simple technique where the plucked sheep hairs were attached
directly to the bottom of plastic culture flasks and keratinocyte colonies formed
without the aid of substrates or feeder layers. Initially, however, some difficulty was
experienced in obtaining successful outgrowths from the plucked hairs. The
outgrowth of keratinocytes is dependent upon the stage of growth that the hair follicle
is in. The anagen phase of hair growth, where the hair has an almost intact epithelial
outer root sheath acting as the source of the keratinocytes, is the most successful at
producing keratinocytes colonies (Weterings et al., 1981). In some studies the anagen
phase hairs were selected microscopically and explanted for culture (Weterings et
al., 1981, Imcke et al., 1987; Limat and Noser, 1986). In the present study however,
all the plucked hairs, regardless of their stage of growth were explanted for culture as
microscopic selection of anagen phase bulbs could not be readily accomplished
aseptically. In order to increase the chance of obtaining primary cultures from follicles
at unknown stages of growth, the number of hair follicles that were explanted into
each culture flask was increased and the growth factors, hydrocortisone and epidermal
growth factor (EGF) were included in the culture medium. Successful cultures of
keratinocytes were subsequently obtained, the technique was reproducible and
fibroblastic overgrowth was rarely observed. The concentrations of hydrocortisone
and EGF added to the medium, were the concentrations typically used in human
keratinocyte culture (Ogawa et al., 1990, Grief et al., 1988) and both have been
reported to promote keratinocyte growth without fibroblastic overgrowth (Rheinwald
and Green, 1975; Dover and Watt, 1987; Boyce and Ham, 1983; Pittlekow and Scott,
1986; Shipley and Pittlekow, 1987; Barnes and Sato, 1980). Typically EGF and
hydrocortisone are included along with other growth factors such as cholera toxin
(Dover and Watt, 1987) and insulin (O' Keefe and Chiu, 1988) as necessary
constituents in serum-free medium used to grow keratinocytes. As EGF and
hydrocortisone were not titrated in this study, their exact effect on ovine keratinocyte
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growth was not determined. Human recombinant EGF was used which may not cross
react with ovine EGF receptors. However it is possible that the addition of these
growth factors to the culture medium reduced the risk of fibroblastic overgrowth. The
direct explant of plucked hairs onto plastic cultures was reported not to be selective
for keratinocytes (Wells et al., 1985). The presence of serum within the medium will
also promote keratinocyte growth as well as fibroblast growth. Both of these factors
could have resulted in fibroblast contamination and yet fibroblastic overgrowth within
the cultures was uncommon. The absence of fibroblasts from the primary cultures
could be due to the lack of dermal components on the plucked hair and the promotion
of keratinocyte growth by EGF and hydrocortisone.
Once established, the ovine keratinocyte cultures grew well and could be subcultured
in the absence of EGF and hydrocortisone. Whilst the purity of the cultures could be
judged by the slow growth rate and distinct morphology of the keratinocytes
compared with fibroblasts, staining with anti-keratin and anti-vimentin confirmed
these observations. The keratinocytes unlike the fibroblasts synthesised keratins that
were detected as tonofilaments within the cytoplasm of approximately 99% of the
cells in the cultures. Vimentin did not recognise keratinocytes and was observed to
stain fibroblasts that formed the majority of the cells in the FL skin cultures. This
technique of explanting plucked sheep hair follicles directly onto the bottom of plastic
culture flasks without a feeder layer or substrate in the presence of EGF and
hydrocortisone therefore appeared to be selective for keratinocytes, the only
disadvantage being the limited numbers of cells that were obtained. As the cultured
ovine keratinocytes were obtained from plucked hair follicles from the muzzle region
of the sheep, the area typically infected by orf virus, they represent a good source of
cells for in vitro studies of orf virus infection.
The initial in vitro studies of orf virus used a tissue culture adapted strain of virus, orf
11. This strain infects cells in vitro, but will not produce lesions in vivo (personal
communication Dr. H.W. Reid). A second strain, Scabby Mouth was introduced into
the in vivo work (see chapter 3) which does produce a lesion in vivo. As there is little
known about differences in virulence between strains of orf virus, it was decided to
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include Scabby Mouth in the in vitro work to determine any major differences
between the two strains of virus. It became apparent that there were major differences
in the induction of CPE by the two strains of orf virus. Scabby Mouth had an
accelerated CPE that gave quite dramatic cell death by 12h post-infection. Orf 11
however, induced very limited CPE at 12h, the infected cultures differing from the
control cultures by a slightly higher number of pyknotic cells. Orf 11 showed a
disruption to the monolayer equivalent to that of 12h Scabby Mouth by 48h post¬
infection. Whilst there was a significant difference in the rate of appearance of CPE,
there was no difference in the appearance of viral antigen for either strain. Viral
antigen was detected in single cells at 12h post-infection, which for orf 11, occurred
before the onset of CPE. The number of positive cells in the monolayer increased
with time and by 48h virtually all the cells still attached to the culture vessel were
positive for orf virus antigen. Both methods of viral antigen detection,
immunofluorescence and immunoperoxidase, located the infected cells equally well,
although immunofluorescence was more effective at highlighting the single infected
ceils at 12h post-infection. The monoclonal used in the immunoperoxidase method
(5E2), which detected viral antigen in the cell in vivo (chapter 3) recognises an
uncharacterised orf virus antigen. The hyperimmune serum used for
immunofluorescent studies recognises 13 orf virus structural proteins (McKeever,
1987).
The production of infectivity by Scabby Mouth and orf 11 was not observed until 12h
post-infection, which coincided with the detection of viral antigen. Both strains of orf
produced infectivity that remained predominantly cell-associated until 72h post¬
infection when the viral 'burst' occurred, when most infectivity was released into the
culture supernatants by lysis of the infected cells. Differences between the growth
curves of Scabby Mouth and orf 11 were observed. Scabby Mouth replicated more
rapidly than orf 11, with more infectivity being produced between 12h and 24h. Orf
11 however, appeared to be slower but more efficient at replicating in keratinocytes
and produced greater infectivity than Scabby Mouth at 72h post-infection. It is
possible that the slower CPE of orf 11 leaves a larger number of cell still viable and
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capable of supporting viral replication, whilst Scabby Mouth infection results in rapid
cell death leaving very few cells still attached to the flask at 48h post-infection.
Despite the accelerated viral replication of Scabby Mouth, the CPE was observed
before virus release and there was no difference in the expression of viral antigen
between the two strains of orf virus. This indicates that there may be a toxic
component in the Scabby Mouth inoculum that is affecting the cells, however the
greater rate of replication of Scabby Mouth would suggest that this may not be the
case emphasising the need to repeat this study using different batches of Scabby
Mouth to confirm whether there is a significant difference in the cytopathogenicity of
the two strains of orf virus; Scabby Mouth and orf 11.
The study of 35S labelled amino acid incorporation by resting and orf virus infected
keratinocytes was carried out to determine whether orf virus shuts down host cell
protein synthesis. Vaccinia virus has the ability to switch off host cell protein synthesis
within 30 minutes of infecting HeLa cells (Moss et al„ 1968). The present study
measured protein that was synthesised and secreted into the culture supernatants
within the first 12h post-infection with orf 11, where viral antigen, but not CPE was
detected. Initial studies of cell lysates revealed a large number of protein bands
making analysis difficult and so only the labelled proteins secreted into the
supernatants were measured. Within the first 12h post-infection with orf virus,
keratinocyte protein synthesis was not shutdown and instead appeared to be
increased. Inhibition of viral protein synthesis was attempted by including actinomycin
D (Shatkin 1963) in order to measure host cell protein synthesis alone. However
actinomycin D was found to be quite toxic to keratinocytes at the concentrations used
to inhibit vaccinia virus protein synthesis (Shatkin, 1963; Moss, 1968) and so it was
included in the medium of two of the infected flasks at a low concentration of lpg/ml.
Whilst the ability of actinomycin D to inhibit viral protein synthesis or its affects on
host cell protein synthesis was not determined, it did appear to reduce the level of
protein synthesis by the infected cells. This reduction of protein synthesis could not be
directly related to the inhibition of viral protein synthesis as it did not result in the
disappearance of specific protein bands from the gel. The effect of actinomycin D on
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orf virus and host cell protein synthesis needs to be determined and the experiment
repeated using optimised conditions to identify viral protein bands. It was however
concluded from this study that during the first 12h post-infection, orf virus appears to
increase rather than decrease host cell protein synthesis.
In conclusion, this study established that pure cultures of ovine keratinocytes obtained
from the follicular epithelium of plucked sheep hairs support orf virus replication. It
was also observed that the two strains of virus orf 11 and Scabby Mouth, used in the
studies differed in their ability to replicate and induce CPE. The first 12h post-orf
virus infection represents an interesting area for subsequent study as during this
period of time, in orf 11 infection there is no disruption to the cell monolayer, but orf
viral antigen can be observed, coinciding with the detection of infectious virus
particles and an increase in host cell protein synthesis. From 12h onwards, the cells
are damaged by viral activity and become factories for the release of viral progeny.
The next chapter will use this information to study cytokine production by
keratinocytes over a time course following infection with orf virus.
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CHAPTER 5
ANALYSIS OF CYTOKINE PRODUCTION BY OVINE
KERATINOCYTES INFECTED WITH ORF VIRUS
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5.1. INTRODUCTION
The target cell for orf virus replication in vivo is believed to be the keratinocyte
(Jenkinson et al., 1990). Keratinocytes, which represent more than 95% of the
epidermal cell population, are a rich source of cytokines including IL-1, IL-3, IL-6,
IL-8, GM-CSF, TNFa, and transforming growth factors (Kupper, 1990; Damm et
al., 1989; Luger and Schwarz, 1990). Most studies on keratinocytes have been carried
out using human and murine transformed cell lines; such as human epidermoid
carcinoma cell lines and spontaneously transformed neonatal murine keratinocyte-
derived (Pam 212) cells. The constitutive production of cytokines by these cells is
typically very low but can be significantly increased by various injurious agents such
as endotoxin, tumour promoters (for example, phorbol mvristate acetate, TPA),
mitogens (for example, concanavalin A), ultraviolet irradiation (UV) or viral infection
(Kupper et al., 1990, Damm et al., 1989 and Luger and Schwarz, 1990).
With regard to the immunological control of cutaneous viral infections, keratinocytes
and LC have previously been shown to play a critical role in the mechanisms of
defence against herpes simplex virus tvpe-1 (HSV-1). Both cell types have been
hypothesised to be able, not only to trigger a systemic immune response to HSV-1, by
presenting viral antigens to T cells, but also to oppose virus progression by local
secretion of cytokines with anti-viral activity (Sprecher and Becker, 1986, 1987,
1989). The cytokines, IL-1 and TNFa, display strong anti-viral activity and messenger
RNA (mRNA) for both has been shown to be induced in murine keratinocytes
infected with HSV-1 (Sprecher and Becker, 1992). Orf virus, like HSV-1, is
characterised by its epidermotropism. The ability of orf virus to re-infect the host,
despite the presence of specific anti-viral antibodies, has recently focused attention on
the importance of the local, cellular immune response at the site of the infection. It
might be envisaged, therefore, that ovine keratinocytes infected with orf virus produce
a number of cytokines in vivo that modulate Langerhans cell function, induce
inflammation and prevent the replication and spread of the virus in the host
Alternatively, or in addition, it may be posible that the infection induces an alteration
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in the normal cytokine profile of keratinocytes leading to the prolongation of the orf
lesion in vivo, ineffective clearance of the virus from the local site, and the chance of
developing lesions again on re-infection. Thus the overall aim of this study was to
characterise the cytokines produced by keratinocytes infected by orf virus in vitro
which may play an important role in the local immune response to orf virus in vivo.
Cytokine production by cultured ovine keratinocytes has not been previously
analysed. Thus, in order to characterise the cytokines produced by ovine keratinocytes
and the sensitivity of the detection systems used to measure their production, fresh
cultures of keratinocytes were analysed for their ability to produce cytokines under
normal, resting conditions and after stimulation with TPA or UV irradiation.
Keratinocytes were then infected in vitro with orf virus and cytokine production
measured at specific time points post-infection. Cytokine expression was assayed in
terms of both mRNA and protein, wherever possible.
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5.2. RESULTS
In this study, cultures of ovine keratinocytes were first analysed for their ability to
produce a number of cytokines under resting culture conditions and in response to
two stimuli known to induce cytokine production by human and murine keratinocytes,
namely incubation with TPA/calcium ionophore, and UV irradiation. The main part of
the study was then to determine the effect of orf virus infection on the profile of
cytokines produced by ovine keratinocytes in culture. Cytokine production by
keratinocytes was measured at two levels; at the level of transcription, using an RT-
PCR technique to detect cytokine mRNA, and at the level of protein, using ELISAs
and bioassays developed for the detection of ovine cytokines.
5.2.1. TPA/calcium ionophore stimulated keratinocytes
Confluent monolayers of keratinocytes were incubated with 5 ng/ml of TPA and
500ng/ml of calcium ionophore in keratinocyte culture medium containing 6% FCS.
The supernatants and cellular RNA were collected from control and stimulated cells at
Oh, 4h, 8h and 12h after stimulation, and were assayed for various cytokines as
outlined below.
i). IL-8
Production of IL-8 by keratinocytes was examined by measuring its concentration in
the culture supernatants by ELISA. Supernatant samples from the Oh control
(unstimulated) and Oh TPA stimulated cultures contained low levels of EL-8 which
could also be detected in the keratinocyte culture medium itself. IL-8 was found to be
constitutively produced by the control, unstimulated keratinocytes as the
concentration of IL-8 in the culture supernatants increased steadily over the 12 hour
incubation period (Figure 5.1). The stimulation of keratinocytes by TPA/calcium
ionophore resulted in a marked increase in the production of IL-8 by the cells (Figure
5.1). At each time point analysed post-stimulation, the stimulated cells had markedly
higher levels of IL-8 in their supernatants when compared with the unstimulated
controls.
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Neat supernatants gave high readings which were out of the ELISA range and so the
results shown are for 1:3 dilutions of supernatants and are representative of two
independent ELISA tests of the same samples carried out in duplicate.
As the primers and probes were not available for IL-8, the induction of mRNA by
TPA/calcium ionophore could not be correlated with the induction of IL-8 protein
measured above.
ii). GM-CSF
The concentration of GM-CSF in the supernatants of resting and stimulated
keratinocytes was measured by ELISA. The keratinocyte culture medium itself
contained a negligible amount of GM-CSF. Constitutive production of GM-CSF was
observed in the unstimulated cells with a steady accumulation of GM-CSF being
detected in the culture supernatants over the 12h collection period (Figure 5.2). TPA
stimulation did not appear to increase the production of GM-CSF by keratinocytes as
the concentration of GM-CSF in the supernatants was no higher than in the
unstimulated cells (Figure 5.2). The production of GM-CSF mRNA gave a good
correlation with GM-CSF released into the supematants. Initially at Oh, GM-CSF
mRNA was not detected (Figure 5.3) but by 4h mRNA was present in both the
control and stimulated cells and remained so in both cultures up to the last time-point
examined (12h).
iii). Cytokines TNFa, IFN, IL-l$andIL-3
The supernatants from resting and TPA/calcium ionophore stimulated keratinocytes
were tested for TNFa and IFN in bioassays and for IL-lfj in an ELISA. The results
for all three cytokines for both resting and TPA stimulated keratinocytes were
negative. Very faint bands on the blots for TNFa mRNA were observed for both


















Figure 5.1 The effect ofTPA/calcium ionophore treatment on keratinocyte
production ofIL-8. The supernatants from the control and treated
(TPA/Ca) cultures were assayedfor IL-8protein by ELISA at 4h
intervals until 12h post-treatment.
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re 5.2 The effect of TPAlcalcium ionophore treatment on keratinocyte
production ofGM-CSF. The supernatants from the control and treated
(TPAlCa) cultures were assayedfor GM-CSFprotein by ELISA at 4h
intervals until 12h post-treatment.
136




Figure 5.3 The effect of TPA/calcium ionophore treatment on A) GM-CSF and B)
TNFa. mRNAproduction. mRNA for control and treated (TPA/Ca)
cultures was analysed by RT-PCR at 4h intervals until 12hpost-
treatment. Positive controls were includedfor each cytokine.
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produced by the cells may be too low for the level of detection of the bioassay.
mRNA was not detected for either IL-1|3 or IFN- 7 or IL-3.
5.2.2. UV irradiated keratinocytes
Cytokine production by monolayers of keratinocytes irradiated with UV light was
analysed. The keratinocytes were exposed to three types of UV light; UVB broad
7
band (270nm-320nm) at doses of 20mJ/cm2 or 10mJ/cm", UVB narrow band
(312nm) at doses of 50mJ/cm2 or 20mJ/cm2 and UVA (310-400nm) at a single dose
7
of lOOmJ/cm", which was then followed by incubation for 24 hours in keratinocvte
culture medium.
i). IL-8
IL-8 production by UV-irradiated keratinocytes was not studied as the ELISA only
became available after the experiment was completed.
ii). GM-CSF
The number of cells used in the experiment was lower than in the TPA/calcium
ionophore experiment and so the levels of GM-CSF detected within the culture
supematants by ELISA can only be compared with the non-irradiated, control group.
The results for the experiment are shown in Figures 5.4 and 5.5. Constitutive
production of a small amount of GM-CSF was seen in the supernatants of the control
cells (Fig 5.4) which correlated with the low production of mRNA (Figure 5.5) and
was consistent with previous findings. UVB broad band irradiation resulted in a
marked increase in the production of GM-CSF mRNA for both the high and low
doses (Figure 5.5), with the strongest band detected in the high dose irradiated cells.
The increased mRNA correlated with a dramatic increase in the level of GM-CSF
detected in the culture supernatant of the cells receiving the low dose only, the
supernatants from the keratinocytes that received the high dose contained only low
levels of GM-CSF. The high dose of UVB light resulted in visible damage (cell
rounding) to the cell monolayers that was not observed at the low dose and it is
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possible that such a high dose inhibits translation of GM-CSF or that the cells are
killed before translation can occur. Neither the UVB narrow band, high or low doses,
or UVA had any effect on the production of GM-CSF, with the concentrations of
GM-CSF protein not differing from the controls. This result was reflected in the low
levels of mRNA observed for each treatment (Figure 5.5, lanes 3, 4 and 5).
iii). Cytokines TNFa, IFN, IL-lfi and IL-3
The bioassays for the detection of TNFa and IFNs and the ELISA for IL-1(3 gave
negative results for all irradiated groups. Similarly, no mRNA for the above cytokines
could be detected in any of the groups. A faint mRNA signal for the cytokine IL-3
could be detected in the cells irradiated with UVB broad band high and low doses
(not shown) but no bioassay or ELISA was available to confirm these results.
5.2.3. Orf virus infected keratinocytes
The previous experiments showed that, under normal culture conditions, ovine
keratinocytes constitutively produced the cytokines EL-8 and GM-CSF. The
production of these cytokines by control keratinocytes was found to correlate with the
concentration of foetal calf serum (FCS) in the culture medium. When the FCS was
reduced from 6% to 1%, the concentration of IL-8 produced by the cells after 24h
fell from approximately 18ng/ml to about 0.2ng/ml. Similarly the concentration of
GM-CSF produced by the cells after 24h was reduced from 200 pg/ml (6% FCS) to a
concentration that was below the limit of detection of the assay (1% FCS). In order to
study the effect of orf virus infection on keratinocyte cytokine production, it would
have been preferable to culture the keratinocytes in serumless medium. However
several attempts to maintain cells in different serumiess formulations of keratinocyte
culture medium from commercial companies were unsuccessful. Thus keratinocytes
were infected with orf virus (Scabby Mouth or orf 11) in culture medium containing
































Figure 5.4 The effect ofUV irradiation on keratinocyteproduction ofGM-CSF. The
supernatants from the control and UV irradiated cultures were assayed
for GM-CSFprotein by ELISA 24h post-treatment.
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brd = broad band
nrw = narrow band
h = high dose
1 = low dose
Figure 5.5 The effect ofUV irradiation on theproduction ofGM-CSFmRNA. mRNA




Constitutive production of IL-8 was observed, with low concentrations accumulating
within the control culture supernatants from 2h onwards (Figure 5.6). In response to
infection with orf virus (both Scabby Mouth and orf 11), IL-8 production was
stimulated, and increased amounts of IL-8 accumulated within the supematants
compared with the controls (Figure 5.6). Initially there was no difference between the
response of the cells to the two strains of orf viruses. Increased production of IL-8
occurred from 2h post-infection and by 10-12h post-infection with orf virus, a seven
fold increase in the concentration of IL-8 was observed in the infected supernatants
compared with the equivalent controls. However, between 12 and 24h post-infection,
the level of IL-8 in the supernatant from the keratinocytes infected with Scabby
Mouth decreased dramatically and was probably associated with the accelerated CPE
observed for Scabby Mouth. The CPE for orf 11 was not as advanced at 24h and the
supematants from these cells contained the highest concentration of IL-8 detected for
the infected samples.
ii). GM-CSF
The reduction of the serum in the culture medium to 1% abolished the constitutive
production of GM-CSF by the control, uninfected keratinocytes. No GM-CSF could
be detected in the culture supematants and only very low GM-CSF mRNA was
detectable (Figure 5.7). Similarly, there was no detectable GM-CSF in the orf infected
culture supematants at any of the timepoints studied. Despite this, however, mRNA
analysis showed increased production of GM-CSF mRNA in orf virus (orf 11 and
Scabby Mouth) infected keratinocytes at 2h and 4h post-infection (Figure 5.7).
In order to establish whether the absence of GM-CSF from the supematants of the
infected cells was purely due to the lack of stimulus from the FCS, cultures of
keratinocytes were infected with orf vims and incubated in medium containing 2%
FCS. As there was no detectable difference in the response to either of the strains of
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re 5.6 The effect oforf virus infection on keratinocyte production ofIL-8 in the
presence of 1% FCS. The supernatants from control cultures and
cultures infected with Scabby mouth or orf11 virus were assayedfor 1L-8
protein by ELISA at 2h intervals until 12h post-treatment, and





Scab = Scabby Mouth
orf = orf 11
Figure 5.7 The effect oforf virus infection on GM-CSFmRNAproduction in the
presence of1% FCS. GM-CSFmRNA was analysed by RT-PCRfor
control cultures and cultures infected with Scabby Mouth or Orf11 vims
at 2h intervals until 12h post-infection, and subsequently at 24h post¬
infection.
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The increase in the concentration of FCS stimulated the production of GM-CSF by
the control, uninfected cells (Figure 5.8), as was expected. The accumulation of GM-
CSF within the control, culture supernatants was reflected in the production of high
levels of GM-CSF mRNA at each timepoint (Figure 5.9). However, although some
GM-CSF was produced by the infected cells, the concentration was much lower than
the amount produced in the equivalent control cultures (Figure 5.8). Analysis of
mRNA from the infected cells showed little difference to the results observed for the
controls (Figure 5.9). Thus in the first 12h post-infection, the level of transcription of
GM-CSF by the infected cells was equivalent to that of the controls but did not seem
to correlate with the low amount of GM-CSF protein present within the infected
culture supernatants. It appeared, therefore, that during the first 12h post-infection,
orf virus inhibited the production of GM-CSF by keratinocvtes at a level beyond the
transcription of mRNA. A decrease in the level of GM-CSF mRNA production was
only detected at 24h post-infection.
Hi). fi-actin mRNA
(3-actin mRNA production by control and orf virus infected cells was analysed and
included as a positive control for gene transcription by the cells. The results showed
that during the first 12h post-orf virus infection, there was no effect on the ability of
the cells to transcribe the (3-actin gene into mRNA (Figure 5.10). Even at 24h post¬
infection when GM-CSF mRNA was decreased the (3-actin mRNA did not appear to
be affected by Scabby Mouth or orf 11 infection.
iv). Cytokines TNFa, IFN, IL-l$and IL-3
The bioassays for the detection of TNFa and IFNs were both negative for all samples
analysed. The samples were also tested for TNFa in a more sensitive
radioimmunoassay. A very low concentration of TNFa was detected in the
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Figure 5.8 The effect oforf virus infection on keratinocyte production ofGM-CSF,
in the presence of2% FCS. Orf 11 virus infected keratinocytes were
assayedfor GM-CSFprotein by ELISA at 2 hour intervals until 12h post¬









Figure 5.9 The effect oforf virus infection on GM-CSF niRNAproduction in the
presence of2% FCS. GM-CSFmRNA was analysed by RT-PCRfor
control cultures and cultures infected with orf11 virus at 2h intervals
until 12hpost-infection and subsequently at 24h post-infection.
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Figure 5.10 The effect oforf virus infection on \1-Actin mRNA production in the
presence ofl% FCS. fi-actin mRNA was analysed by RT-PCRfor control
cultures and cultures infected with Scabby Mouth or orf11 virus at 2h
intervals until 12h post-infection and subsequently at 24hpost-infection.
148
was detected between 6 and 12 hours in the infected supernatants but this was also
observed in the uninfected control supernatants. TNFa in both the control and
infected supernatants then declined between 12 and 24 hours to levels at the limit of
detection. mRNA for TNFa could be detected in some of the samples (infected and
uninfected), but, the results were very variable with no obvious pattern making it
difficult to come to any conclusions (see Figure 5.11). IL-1(3 could not be
reproducibly detected within the supernatants by ELISA which correlated with the
absence of IL-1(3 mRNA for control and infected cells at all timepoints studied. The
presence of mRNA for EL-3 was occasionally detected in the infected cell cultures.
However the results were not reproducible, and as there was no assay available to
measure the concentration of IL-3 protein in the culture supernatants, no conclusions
could be reached about the production of IL-3 by the infected keratinocytes
v). Clearance ofGM-CSFfrom supematants oforf infected keratinocytes
As it appeared from the data in Figure 5.8 that orf virus infection of keratinocytes
inhibited the production of GM-CSF, further experiments were carried out to
ascertain whether there were any inhibitory factors produced by the infected cells that
interfered with the detection of GM-CSF in culture supematants.
Exogenous, recombinant ovine GM-CSF at a concentration of 4000pg/ml was added
to cell-free culture supematants collected from control and infected cells and then,
after incubation, the samples were diluted (as for the ELISA standards) and the
ELISA carried out as before. The OD at 492nm for each of the control and infected
supematants was read and plotted against the amount of GM-CSF that was contained
within each dilution. The results are shown in Figure 5.12A, B and C, and the
standard curve for GM-CSF prepared in diluting buffer, included in each. GM-CSF
incubated with supematants collected from orf virus infected keratinocytes was found
to be reduced in concentration when measured in the ELISA. This effect was specific




orf = orf 11
Figure 5.11 The effect oforf virus infection on TNFamRNA production in the
presence of1% FCS. TNFa mRNA was analysed by RT-PCRfor control
cultures and cultures infected with Scabby Mouth or orf11 virus at 2h
intervals until 12h post-infection and subsequently at 24h post-infection.
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Figure 5.12A shows that there was no obvious difference in the concentration of GM-
CSF, as measured by the ELISA, between the Oh control and Oh infected
supernatants and the standard curve. Using supernatants collected from 2h post¬
infection, the concentration of the exogenous GM-CSF became gradually lower, with
the curves for each of the infected supernatants falling away from the standard curve.
Figure 5.12B shows that from 4h-10h post-infection the inhibition of GM-CSF
measurement does not increase dramatically but by 12h and 24h post-infection there is
a marked reduction from the levels of GM-CSF expected from the standard curve
(Figure 5.12C). The GM-CSF in the 12h and 24h control supernatants was unaffected
and produced results similar to the standard curve (Figure 5.12C). The results
described above were for supematants from orf 11 infected cells in the presence of
2% FCS. Supernatants from keratinocvtes infected with both Scabby Mouth and orf
11 cultured in the presence of low and high serum were found to exhibit the same
effect when tested in the inhibition ELISA, with the highest inhibition detected at 24h
post-infection (data not shown).
vi). The effect ofheating andprotease inhibitors on the clearance ofGM-CSF
from infected culture supernatants
Two further experiments were carried out to identify the possible nature of the
factors involved in the clearance of GM-CSF from orf infected supernatants. Control
and orf infected supernatants were heated or mixed with protease inhibitors before the
addition of a known quantity of exogenous GM-CSF (as described previously). The
ELISA was then carried out to determine whether the process of GM-CSF clearance
could be abolished by either of these steps.
Heating
Cell-free supematants from 12h and 24h control and orf virus infected cultures were
heated to 56°C for 1 hour before the addition of exogenous GM-CSF. The




















Figure 5.12A The standard curves produced after the incubation of dOOOpg!ml of
exogenous recombinant ovine GM-CSF in the supernatants collected
from oh control keratinocytes and keratinocytes infected with orf 11 virus
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—T—8h infected
— ♦— 10h infected
Figure 5.12B The standard curves produced after the incubation of4000pgimL of
exogenous recombinant ovine GM-CSF in the supernatants collected
from keratinocytes at 4h, 6h and Sh post-infection with orf 11 virus.
Standards prepared in buffer were also included.
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Figure 5.12C The standard curves produced after the incubation ofSOOOpg/ml of
exogenous recombinant ovine GM-CSF in the supernatants collected
froml2h and 24h control and orf11 virus infected keratinocytes.
Standards prepared in buffer were also included.
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as a bar chart and the results shown in Figure 5.13. The 12h and 24h control
supernatants did not inhibit the GM-CSF, the readings for both untreated and heated
supernatants varying slightly around the 3000-4000 pg/ml level (Figure 5.13). The
process of heating was found to affect the ability of the infected supernatants to clear
GM-CSF. The 12h unheated orf infected supernatant contained approximately 1600
pg/ml detectable by the ELISA, whereas after heating approximately 4000pg/ml could
be detected corresponding to the amount of GM-CSF added (Figure 5.13). Heating
the 24h infected supernatant only partially reversed the inhibitory effect - the unheated
sample gave a reading of less than 1000 pg/ml of GM-CSF whereas, after heating,
1500 pg/ml was detectable (Figure 5.13).
The effect ofprotease inhibitors on the clearance ofGM-CSF
Protease inhibitors that stop the action of the four main types of proteases; aspartate
proteases, cysteine proteases, metalloproteases and serine proteases (see table 2.3,
chapter 2) were incubated individually with the control and 24h orf virus infected
supernatants before the addition of exogenous GM-CSF to determine whether the
clearance of GM-CSF could be attributed to protease activity. The ELISA was
carried out as before and untreated control and infected samples were included. The
inhibition of protease activity within the infected supernatant for all four types of
proteases, had no effect on die ability to interfere with the detection of GM-CSF as
both treated and untreated 24h infected supernatants reduced the amount of GM-CSF
to the same extent (Figure 5.14).
5.2.4. Analysis of the proteolytic activity of keratinocvtes
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The supernatants and cell lysates collected for the S incorporation experiment
described in chapter 4 were also examined for their proteolytic activity. The
supematants were concentrated ten-fold and both supernatants and cell lysate
preparations analysed on aso-casein gels.
All of the cell lysate preparations collected from both control and orf virus infected
keratinocytes contained proteolytic activity detected by a band of degradation of the
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Figure 5.13 The effect ofheating on the clearance of recombinant ovine GM-CSF by
culture supernatants collectedfrom keratinocyte cultures at 12h and 24h




Figure 5.14 The effect ofprotease inhibitors on the clearance of recombinant ovine
GM-CSF by culture supernatants collectedfrom control and orf11 virus
infected keratinocytes (at 24h post-infection).
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asocasein gel at a molecular weight of approximately 100-130 KD (not shown).
Analysis of the supernatants showed that the early collection (2h post-infection) from
the virally infected cells contained proteolytic activity at a molecular weight of
approximately 28 KD in the asocasein gel (Figure 5.15). This proteolytic activity was
not observed in the supernatants from the control cells or the early collection of
infected cells which were incubated with actinomycin D. The late collection (9h post¬
infection) of infected supernatants also contained this band of proteolytic activity, at
28 KD which was also present in the infected supernatants containing actinomycin D.
No bands were present in the late, control supernatants.
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CES= control early sample
VES= virus early sample
VEAS= viais early + actinomycin D
CLS= control late sample
VLS= virus late sample
VLAS= virus late sample + actinomycin D
Figure 5.15 Asocasein gel analysis ofkeratinocyte proteolytic activity. Early and
late collections ofthe supernatants from control and orfll virus infected
keratinocytes with and without actinomycin D were analysedfor their
proteolytic activity which could be detected by a clear band (of
approximately 100-130 kD) within the gel.
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5.3. DISCUSSION
Ovine keratinocytes were screened for their ability to produce the cytokines IL-1(3,
IL-3, IL-8, TNFa, GM-CSF and interferons (a, (3 and 7). The production of cytokine
protein was measured in a number of ELISA and bioassays specifically developed for
the detection of ovine cytokines. As cytokines exert their effects at low
concentrations, sometimes below those detectable by bio- or ELISA assays. The RT-
PCR technique was utilized to measure the production of cytokine mRNA. The
strategy used in the present study provided only semi-quantitative results, which
enabled the assessment of relative changes in mRNA synthesis. Although the cDNA
for each of the cytokines was prepared from the same concentration of cellular RNA,
signal strength is dependent on the efficiency of the primers used in the RT-PCR and
of the probes used in hybridisation. Thus the signal strength of each cytokine mRNA
can only be compared to itself.
5.3.1. IL-1(3, TNFa, Interferons and IL-3
The anti-viral properties and the increased production by keratinocytes of the
cytokines IL-1(3, TNFa and interferons in response to HSV-1 (Sprecher and Becker,
1992; Torseth et al., 1987) would indicate a potential role for these cytokines in the
keratinocyte response to other viral infections. However this study failed to detect the
induction of any of these cytokines following orf virus infection. Similarly these
cytokines were not induced by stimuli such as TPA or UV irradiation. It is possible
that ovine keratinocytes, unlike their human and murine counterparts lack the ability
to produce these cytokines, although this seems unlikely. The bioassays were sensitive
only to 30,000 pg/ml for TNFa, and approximately 50 pg/ml for interferon and so it
may be that the methods of detection used lack the sensitivity required for low
cytokine production, or it is possible that the stimuli of TPA or UVB irradiation,
which were not optimised, may not have been adequate for the induction of these
cytokines.
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All that can be concluded is that if these cytokines are being produced, then it must be
at a level below the sensitivity of the detection methods used. Recently, the induction
of human keratinocyte TNFa by UVB irradiation, first described by Kock et
al., (1990) has proved difficult to reproduce (Dr Mary Norval, personal
communication) indicating that variations in experimental procedures may affect the
induction of cytokine production.
Keratinocytes of several species, as well as transformed keratinocytes and carcinoma
cell lines, have been shown to spontaneously release molecules with IL-1 activities,
whose production is significantly increased in response to mitogens and UVB
irradiation (Kupper et al., 1986). Recently, it has been demonstrated that although
cultured human and murine keratinocytes express mRNA encoding EL-la and IL-1 [3,
all IL-1 biological activity that is produced by keratinocytes in vitro and in the
epidermis is due to IL-la (Kupper et al., 1986, 1988). Keratinocytes in vitro also
express high affinity receptors for IL-1 (Kupper et al., 1988). Thus keratinocytes can
potentially respond in an autocrine fashion, the significance of this in vivo will be
discussed in more detail below. Ovine EL-la was not investigated in this study and it
may be the type of IL-1 preferentially produced by ovine keratinocytes, which would
explain the absence of IL-1 [3. The production of EL-la by ovine keratinocytes in
response to orf virus infection would be interesting to study and will require the
development of an ELISA or bioassay, as currently there is no method of measuring
ovine EL-la production.
The anti-viral activities of the interferons led to their discovery (Wheelock 1965).
Although EFNy production has not been demonstrated for keratinocytes, keratinocytes
upon infection with HSV-1 release cytokines with anti-viral activity (Schnipper et
al., 1984) which was demonstrated to belong to the IFNa group (Yaar et al., 1988).
However at present it has not been formally proven whether keratinocytes are capable
of producing IFNa or IFN|3. The interferon assay that was used should detect any
interferon activity (a, (3, or 7) present within the culture supernatants, but it may not
have been sensitive enough to detect low amounts of EFN activity. IFNy mRNA only
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was studied and so a more detailed analysis of keratinocyte IFN mRNA using primers
and probes for IFNa and IFN(3 is required to confirm the lack of IFN production by
orf virus infected keratinocytes. The selection of the primers from the wide range of
possible interferons produced will be the main problem for mRNA analysis.
The production of IL-3 by keratinocytes is less well defined, although IL-3 like
activity has been found in murine neonatal keratinocytes and the transformed cell line
Pam 212 (Luger et al., 1989). Production of IL-3 has not been demonstrated in human
keratinocytes. The study of ovine keratinocytes would indicate that, at the level of
mRNA, IL-3 may be produced in response to orf virus infection, but the inconsistent
mRNA patterns that were observed highlight the need of a bio- or ELISA assay to
identify EL-3 activity within culture supematants.
5.3.2. IL-8
Interleukin 8 (IL-8) is a newly identified potent chemotactic cytokine for neutrophils
(Matsushima et al., 1992) and T lymphocytes (Larsen et al., 1989). IL-8 has been
shown to be synthesised by a number of different cell types including
monocytes/macrophages, dermal fibroblasts and keratinocytes (Zachariae et al., 1992).
The production of IL-8 is generally not constitutive but can be induced by several
stimulants including mitogens and viruses (Matsushima et al., 1992). This study
confirmed that IL-8 could be produced by ovine keratinocytes. Initially it appeared
that IL-8 was constitutively produced by resting keratinocytes. However the
production of such a high level of IL-8 was found to be in response to unknown
stimuli within the FCS included in the culture medium. IL-8 was similarly induced by
the stimuli of TPA and in response to orf virus infection. IL-8 was induced early in
infection by both strains of orf virus (Scabby Mouth and orf 11) in a virtually identical
manner. It was only at 24h that a difference became apparent. A decrease in IL-8
production was observed for the Scabby Mouth infected cells whereas the level of IL-
8 in the orf 11 infected cells remained high. This is likely to be due to the more rapid
cytopathic effect caused by Scabby Mouth. The induction of IL-8 in vitro could be
tentatively related to the in vivo orf lesion, as IL-8 might induce the infiltration of T
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lymphocytes and neutrophils into the skin observed in response to orf virus infection.
This will be discussed in chapter 6.
5.3.3. GM-CSF
GM-CSF is a glycoprotein that was first identified by its ability to promote
differentiation of haematopoietic progenitor cells to mature granulocytes and
macrophages (Metcalf, 1985). A variety of cells types including mononuclear
phagocytes (Chevemick et al., 1972, Golde et al., 1972), T lymphocytes (Cline et
al., 1974, Ruscetti et al., 1975), fibroblasts (Guez et al., 1973) and keratinocytes
(Kupper et al., 1988) are known to produce GM-CSF. Synthesis of GM-CSF by
keratinocytes can be upregulated by tumour promoters, other cytokines and UV
irradiation (Nozaki et al., 1991).
The present study showed that ovine keratinocytes can be stimulated to produce GM-
CSF. In resting cultures, the constitutive production of GM-CSF was, like EL-8,
found to be as a result of the unknown stimuli contained within the FCS of the culture
medium. The presence of TPA did not appear to induce the production of GM-CSF.
UVB irradiation increased GM-CSF production by keratinocytes, but this induction
was found to be dependent on wavelength and dose. Broad band UVB light (270nm-
320nm) but not narrow band UVB (312nm) induced GM-CSF mRNA, confirming
recent studies (Dr Mary Norval, personal communication) where narrow band UVB
light was found to be ineffective at stimulating cytokine production. The high dose of
UVB increased GM-CSF mRNA but not the production of protein which may be due
to an inhibition of translation or the death of the cells before the message can be
translated. The low dose of UVB did not damage the cells, and the high level of
mRNA was reflected in a high level of GM-CSF protein detected in the supematants.
Nozaki et al., (1991) showed that the induction of GM-CSF was mediated by UV
induced IL-la. It is possible therefore that the induction of GM-CSF that was
observed in this study is mediated by a similar mechanism and highlights the need to
investigate IL-la production by ovine keratinocytes in future studies.
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In the present study, we have shown that ovine keratinocytes possess the ability to
produce GM-CSF, which can be enhanced by UVB. However on infection with orf
virus, GM-CSF production by keratinocytes was not induced and instead appeared to
be inhibited. The inhibition of GM-CSF production appeared to be a post-
transcriptional effect as GM-CSF mRNA in the presence of high serum was detected
in both the control and infected keratinocytes at equal levels. The amount of GM-CSF
protein that was subsequently released into the supernatants by the infected cells was
however dramatically reduced compared with the control cells. Even without the
stimulus of high serum, it appeared that orf virus may induce GM-CSF mRNA
production (2h-4h post-infection) and yet this was not reflected in the secretion of
GM-CSF into the supernatants. Thus orf virus inhibits the production of GM-CSF at
a point after transcription.
Theoretically orf virus could interfere with the production of GM-CSF in three main
ways;
1. The process of translation of GM-CSF mRNA into protein could be inhibited by
the virus.
2. Post-translational modifications (such as glycosvlation) required for the transport of
GM-CSF out of the cell could be prevented, thereby trapping GM-CSF
protein within the cell.
3. The virally infected cells may produce a counteractive protein that is released into
the supernatants that alters the GM-CSF protein produced by the cells,
preventing its detection by ELISA.
All three of these mechanisms could be employed by orf virus, but in this study the
last possibility was examined in more detail.
A simple experiment, whereby a known concentration of exogenous GM-CSF was
added to supernatants collected from orf virus infected cells revealed the presence of a
factor or factors that interfered with the detection of GM-CSF. This effect was
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specific for the supernatants from infected cells and, although GM-CSF inhibition
occurred within the first lOh post-infection, it was most marked at 12h and 24h post¬
infection. Whatever the nature of the inhibitory factor(s), it prevents the recognition
of one or both of the epitopes of GM-CSF by the antibodies in the ELISA. The two
antibodies used in the ELISA are neutralising antibodies (Entrican et al., 1994) and so
this suggests that the inhibitory factors also block the biological activity of GM-CSF
which would need to be confirmed in a bioassay.
Although control and orf virus infected keratinocytes were identified as containing
intracellular protease activity this activity was not released into either culture
supernatants. In addition however separate proteolytic activity, of a different size was
observed in orf infected supematants only, at both early and late timepoints post¬
infection. The production of this protease by the virallv infected cells was inhibited at
the early timepoint post-infection by the presence of actinomycin,which inhibits new
mRNA synthesis and hence viral protein synthesis, indicating the possible viral nature
of the protein. The effect of the actinomycin was overriden later in the infection as the
virally induced protease could be detected in the supematants of late collections
despite the presence of actinomycin. The nature and specificity of the protease was
not identified. Whilst the infected cells were shown to produce protease activity the
addition of proteolytic inhibitors to the supematants did not prevent the inhibition of
GM-CSF. Although, this proteolytic activity is not involved in the inhibition of GM-
CSF it would be interesting to characterise fully this virally induced proteolytic
activity and to identify its role in an orf virus infection.
The GM-CSF clearance was, however, affected by the process of heating. The ability
of the 12h infected supernatant to interfere with the added exogenous GM-CSF was
completely abolished by heating. Although the inhibitory effect of the 24h infected
supernatant was affected, it was only partially reduced when compared to the un-
heated supernatant. These results, along with the fact that the inhibition of GM-CSF
does not appear to be mediated by a protease, might indictate the production of a
protein released into the supematants of the virally infected cells that binds specifically
to GM-CSF. The process of heating may alter the confirmation of this protein which
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may prevent it from binding to GM-CSF and so preventing the inhibition. Heating did
not completely reverse the inhibition of GM-CSF for the 24h infected supernatant,
and it is possible that this is because of the large quantity of the inhibitory protein
present in the culture supernatant, whose activity may not be completely abolished by
heating.
The production of a soluble GM-CSF receptor analogue in orf virus infected
keratinocytes is an interesting possibility, as recently other members of the pox virus
family have been shown to produce a number of cytokine receptor analogues for IL-1,
TNF and interferon. These viral receptor analogues are postulated to interfere with
the host response to pox viruses by binding the cytokines in the exracellular space and
preventing them from reaching their target receptors on the surface of cells
Future studies will determine whether orf virus does have the ability to code for such
a receptor analogue for GM-CSF.
5.3.4. Conclusions
It emerged from this study that orf virus induces IL-8 production but inhibits the
production of GM-CSF in cultures of infected ovine keratinocytes. It would appear
that the inhibition of GM-CSF is a specific effect that occurs early in infection and
does not affect GM-CSF transcription. The inhibition of GM-CSF is mediated, at least
in part, by factor(s) released into the supernatant from the infected cells. The exact
nature of the inhibition was not identified but the results from this study might indicate
the possession by orf virus of a gene coding for a soluble GM-CSF receptor analogue,
which binds to secreted GM-CSF. The failure to detect IL-1, TNFa and EFNs,
cytokines that would be expected to be produced by keratinocytes in response to orf
virus infection, raises the possibility that orf virus also inhibits their production.
However, as these cytokines were not demonstrated for control or stimulated
keratinocytes, it is unclear if they are inhibited by orf virus. The ability of the virus to
interfere with specific cytokines emphasises the importance of these mediators in the
host response to virus infections. The significance of these in vitro results as applied
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The ability of orf virus to re-infect its host despite the generation of a specific humoral
response and the localised nature of the infection, led workers to the conclusion that
local, cellular immunity is probably the major factor in recovery and protection from
orf virus infection (Robinson and Balassu, 1981). The main aim of this thesis was to
characterise the ovine skin response to orf virus infection.
Studies carried out previously at the Moredun Research Institute examined the local
cellular immune response to orf virus and demonstrated an influx of inflammatory
cells, involving a large number of neutrophils and T lymphocytes, into the dermis
underlying the infected epidermis (Jenkinson et al., 1990a). The cutaneous defence
mechanisms after primary and secondary challenge with orf virus were concluded to
be essentially the same, even hough a secondary infection is generally milder and
resolves faster than a primary infection (Jenkinson et al., 1990b). Further studies of the
secondary orf lesion revealed the formation of a dense network of MHC class IT
dendritic cells directly beneath the lesion (Jenkinson et al., 1991). These cells were
postulated to have an important barrier function preventing the downward
progression of the virus into he underlying dermis.
The experiments described in this hesis were herefore designed to extend our
knowledge of the local, cellular response to orf virus by characterising in more detail
he dendritic cell network of both the primary and secondary orf virus lesions. These
experiments were aimed at determining the relationship of he accumulating dendritic
cells with the dendritic cells normally resident within the skin, he kinetics of the
response and how or from where the network of dendritic cells originates. Studies of
cytokine production by ovine keratinocytes infected in vitro wih orf virus were also
undertaken to determine the ability of the virus to induce or suppress a range of
cytokines, which may play an important role in the local immune response to orf virus
infection in vivo.
This final chapter will attempt to bring together he main findings of he hesis and
discuss hem in relation to what is known about orf virus and other viral infections of
he skin.
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Orf virus induction and inhibition of keratinocyte cytokine
production
Orf virus enters through abrasions in the skin where it replicates in the newly-
regenerating epidermal keratinocytes (Jenkinson et ai, 1990a). Keratinocytes, which
constitute the bulk of the epidermal cell population, have been implicated as playing
an important role in the immunological control of viral infections by their ability to
produce a wide range of cytokines that can act locally to modulate LC function and
induce inflammation (Sprecher and Becker, 1992). Thus it was proposed that the
infection of keratinocytes with orf virus may stimulate the release of cytokine signals
that initiate the influx of inflammatory and dendritic cells into the skin and prevent the
spread of the virus.
Normal ovine keratinocytes cultured from the follicular epithelium of plucked sheep
hairs (chapter 4) were shown to produce the neutrophil and T cell chemoattractant
IL-8. The in vitro production of IL-8 was increased when the keratinocytes were
stimulated with TPA or infected with orf virus (chapter 5). It could be envisaged
therefore, that, in vivo, BL-8 is produced initially in response to the epidermal damage
caused by scarification and subsequently in response to orf virus replication and
results in the biphasic influx of large numbers of neutrophils and lymphocytes that are
observed in both primary and secondary orf lesions. Increased numbers of neutrophils
are observed in the afferent lymph following scarification but not in response to viral
replication (Yirrell et ai., 1991).The increased production of IL-8 observed in
response to orf virus infection could be responsible for trapping the neutrophils at the
site of infection and preventing their migration into the lymph.
Other cytokines, demonstrated to be produced by human and murine keratinocytes
with anti-viral activities such as IL-1, TNF, and IFNs that would be expected to play
a role in opposing orf virus progression were not demonstrated to be produced by orf
virus infected keratinocytes in vitro. In addition to the absence of these cytokines, orf
virus was shown to specifically interfere with the production of GM-CSF by the
cultured ovine keratinocytes. The inhibition of GM-CSF production by orf virus
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infected keratinocytes appeared to be mediated at least in part by a soluble factor or
factors released into the culture supernatants. This inhibition was unaffected by the
addition of specific protease inhibitors, indicating that proteolytic degradation of GM-
CSF by the release of viral proteases is unlikely to be responsible for the effect. One
possiblity is that the orf virus infected keratinocytes release a soluble receptor
analogue protein into the supernatants that interferes with any GM-CSF present The
inhibition of GM-CSF by a soluble receptor produced by orf infected cells is a very
interesting possibility as recently a number of virally encoded receptor homologues of
cellular receptors have been identified for other members of the pox virus family.
Pox virus cytokine receptor analogues
The first cytokine receptor homologue to be identified was a TNFR in myxoma virus,
Shope fibroma virus and malignant rabbit virus (Smith et al., 1991, Upton et al., 1991,
see chapter 1). Since then receptor homologues for IFNy have been found in Myxoma
virus, Shope fibroma virus and vaccinia virus (Upton et al., 1992) and an IL-1(3
receptor analogue has also been discovered in vaccinia virus (Alcami and Smith,
1992). These receptor analogues were originally identified in the viral genomes by
computer homology scores with their cellular counterparts. Not all of the homologues
identified, however, result in the expression of active proteins. Vaccinia virus lacks a
functional TNFR as the gene sequence encoding it is fragmented by frame shifts and
stop codons. Complete receptors for TNF (myxoma virus and Shope fibroma virus),
IL-1(3 (vaccinia virus) and IFNy (myxoma virus) have been demonstrated to be
secreted either by virally infected cells or by cells transfected with the relevant viral
gene, and they have the ablity to bind the specific cytokine. TNF, IL-1(3 and IFNy are
all molecules with important and overlapping functions in the inflammatory immune
response to viral infections. The cytokine receptor analogues produced to counteract
them are secreted in a soluble form by infected cells with the trans-membrane anchor
sequence and cytoplasmic tails absent. These soluble receptors are then believed to
compete with the cellular receptors for the free cytokines, effectively intercepting and
short circuiting the anti-viral immune response pathways dependent on the cognate
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cytokine. The ability of the pox viruses to interfere with TNF, IL-1(3 and IFN
suggests a role for these cytokines in combating pox virus infections. The importance
of IL-1[3 in vaccinia virus infection is highlighted by the nature of the specificity of the
inhibition - the EL-1 receptor analogue will bind IL-1(3 but not IL-la (Alcami and
Smith, 1992). In addition vaccinia virus expresses a serine protease inhibitor (serpin)
which inhibits, in vitro, the conversion of the IL-1(3 precursor form into the secreted
and active form (Ray et al., 1992).Thus, if orf virus specifically inhibits GM-CSF, then
it is possible that GM-CSF is important in combating orf virus infections; this will be
discussed in more detail below.
A receptor homologue for GM-CSF has not yet been described for the pox virus
family of 'viroreceptors' (Upton et al., 1991). The present study indicates only that
there is inhibitory activity for GM-CSF in the culture supernatants of orf virus
infected cells. The specificity of this inhibition and the nature of the factors involved
need to be identified and a much more detailed study of the orf virus genome will be
required to determine whether there is a gene encoding a GM-CSFR homologue. The
orf virus genome is for the most part uncharacterised. Sequencing of selected regions
has shown that there is a significant degree of conservation of structure and
arrangement of genes between orf virus and vaccinia virus. The latter virus has been
completely sequenced (Fleming et al., 1993 and Goebbel et al., 1990). The similar
locations and orientations of homologous orf virus and vaccinia virus genes on their
respective genome maps has allowed the tentative alignment of the two genomes
(Lyttle et al., 1994). Despite the regions of conservation, significant differences
between the two viral genomes were discovered (Fraser et al., 1990, Fleming et al.,
1993). The genes closest to the termini of the pox virus genomes appear to be the
regions of interest as they encode a number of different virulence factors, including
the cytokine receptor homologues. The region of the vaccinia virus genome encoding
the identified cytokine receptor homologues, however, lies outwith the aligned orf
virus genome. As there are substantial areas of the orf virus genome between the
overlapping regions that have not been characterised, the possibility of the possession
of a number of uncharacterised virulence factors by orf virus cannot be ruled out
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The complete absence of IL-1|3, TNF and IFNs from control, stimulated and infected
keratinocyte cultures is puzzling. The possible reasons for this are discussed
individually in chapter 5. The results from chapter 4 showed that host cell protein
synthesis is increased during the first 12h after orf virus infection, therefore dispelling
the possibility that the absence of cytokine production by the infected cells is due to a
non-specific shutdown of all host cell metabolic activity. Although the cytokine
detection systems may have lacked the sensitivity required to detect these cytokines,
another consideration is that orf virus also interferes with the production of a number
of cytokines including EL-1[3, TNF and IFN. This could be through the production of
specific cytokine receptors or by other unknown mechanisms. The development of
assay systems with increased sensitivity for ovine cytokines and the complete
molecular analysis of the orf virus genome will clarify the ability of the virus to
interfere with the host immune response.
The possession of virulence factors that enable the evasion of specific immune
effector mechanisms would be beneficial to the virus, possibly leading to the
prolongation of the infection, ineffective clearance of the virus from the site or by
increasing the chances of developing lesions again on re-infection. Thus, if the
inhibition of GM-CSF by orf virus is a specific mechanism employed by the virus in
vivo, what is the significance of this for the host and can it be related to the
incomplete immunity to orf virus infections ?
The significance of GM-CSF inhibition in the host response to orf
virus infection
The cutaneous inflammatory response that is observed after a secondary orf infection
was believed to differ from a primary infection only by the timescale and severity of
the reaction (Jenkinson et ai, 1990b). Whilst a secondary infection results in an
accelerated and milder response, orf virus is still able to replicate successfully within
the epidermis and infectious virus is shed into the environment. Thus, the cellular
immunity generated locally in the skin is not fully protective.
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The MHC class IT dendritic cells that gather in response to orf virus infection
represent a population of dendritic cells separate from the epidermal LCs of normal
ovine skin (Jenkinson et al., 1991). Further characterisation of both primary and
secondary orf lesions identified these cells as a population of CD1" dendritic cells,
sharing the phenotype of a small subpopulation of dendritic cells found in the dermis
of normal ovine skin (chapter 3). A second marker, factor XlUa, expressed by a small
number of the resident CD1" dermal dendritic cells revealed significant differences in
the phenotype of the dendritic cells accumulating at a primary orf lesion compared
with a secondary orf lesion. Factor XIIIa+ dendritic cells were present in much higher
numbers and persisted for much longer in the primary orf lesion compared with the
small numbers of factor XH3a~ dendritic cells transiently observed in the secondary orf
lesion. Recent research has implicated factor XIIIa+ dendritic cells in playing a central
role in wound repair and the skin immune response (chapter 3). Factor Xllla is a
marker that is also found on the surface of monocytes and is retained during their
differentiation into macrophages (Adany et al., 1985). The relationship between
dendritic cells and the monocyte-macrophage lineage remains highly controversial.
One school of thought believes that the dendritic cells arise from a separate
haematopoietic cell lineage distinct from macrophages, but which share a common
progenitor cell (Steinman, 1983) whereas another proposes that monocytes can
differentiate into dendritic cells as oppposed to macrophages when appropriately
stimulated (Peters et al., 1991). Jenkinson et al., (1991) failed to detect a high number
of dendritic cells circulating in the blood that could account for the formation of such
a dense network of cells and proposed that these cells may circulate in a precursor
form which then differentiate at the site of infection. Thus it could be envisaged that
the factor XIIIa+ dendritic cells that accumulate in a primary infection represent an
immature population of cells that have retained the macrophage marker factor Xllla
and are dependent upon the local production of cytokines to fully differentiate into
mature dendritic cells.
Factor XIIIa+ dendritic cells have been associated with immunosuppression and are
involved in the secondary verrucous lesions that develop in HIV" individuals that are
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infected with herpes simplex virus or human papilloma virus. The presence of these
factor XIIIa+dendritic cells in the lesions of these patients could be related to
alterations in the local cytokine profile in the skin due to the HIV induced
immunosupression.
Recently, the cytokines GM-CSF and TNFa have been shown to support the in vitro
development of dendritic cells from haematopoietic progenitor cells present in blood
and bone marrow (Caux et al., 1992, Reid et al., 1992). These cytokines also support
the survival and or proliferation of isolated murine epidermal LCs and influence their
development into potent T-cell stimulatory accessory cells (Heufler et al., 1988, Koch
et al., 1990). Veiled dendritic cells, isolated from ovine afferent lymph, survive in vitro
in the presence of TNFa and increase in number if GM-CSF and TNFa are added in
combination to the cultures (Haig et al., 1994). It would appear therefore, that GM-
CSF and TNFa plav an important role in the maturation and survival of dendritic cells
in vitro.
In vivo, the maturation of precursor cells into mature dendritic cells may be dependent
therefore, upon the local production of the cytokines GM-CSF and TNFa. Thus, if
orf virus inhibits the release of GM-CSF and possibly TNFa by keratinocytes in vivo
then the dendritic cell precursors accumulating in response to a primary orf virus
infection may be prevented from differentiating, resulting in a network of
phenotypically and functionally immature dendritic cells. The factor Xllla* dendritic
cells of the primary orf lesion represent only half of the dendritic network. The factor
XHIa' cells comprising the other half may have been able to mature in the presence of
low amounts of GM-CSF and TNFa produced by other cells present. T cells, which
are potent producers of GM-CSF (Nozaki et al., 1991), and factor XHIa'1'dendritic
cells which also produce TNFa and may represent an alternative source of these
cytokines. The production of these cytokines in a secondary infection, where there is
an accelerated response may be sufficient to compensate for the lack of the
keratinocyte cytokine source and induce the maturation of the accumulating dendritic
cells as they enter the dermis, resulting in the transient expression of factor Xllla that
is observed. It is also possible that the factor XIIIa+ dendritic cells of the primary orf
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lesion return to the peripheral circulation after the resolution of infection, where they
lose the surface marker factor Xffla. On a secondary infection they may migrate
preferentially into the skin to give an accelerated response and a milder infection.
Recent studies at the Moredun Research Institute have shown that intradermal
injections of GM-CSF and TNFa into ovine skin induces an accumulation of MHC
class IT dendritic cells similar to that observed in response to an orf virus infection.
These dendritic cells lack detectable levels of both CD1 and factor Xllla (Haig et
al., 1994). It was concluded that GM-CSF in particular is involved in an in vivo
pathway that induces the accumulation of predominantly (but not only) MHC class
ir/CDl" dendritic cells. These results support the significance of GM-CSF in vivo, in
generating a network MHC class II" dendritic cells that lack the expression of factor
XHIa. In vitro however, neither fresh nor cultured ovine afferent lymph dendritic cells
in the presence of TNFa or GM-CSF, expressed the marker factor XHIa. Therefore
more detailed studies are required to determine whether the expression of the
dendritic cell markers can be regulated by specific cytokines and whether the
expression of the markers reflect functional differences.
The origins of the accumulating dendritic cells of primary and secondary infections
were not established. Although both CDF/factor Xllla" and CDl'/factor Xllla"
dendritic cells represent small subpopulations of dermal dendritic cells found in
normal skin the results showed that it is unlikely that these cells proliferate locally to
form the network of cells seen in response to infection. The general lack of cellular
proliferation in the dermis of primary and to a greater extent secondary orf lesions
would support the theory that the cells infiltrate into the skin from the blood. The
origin and relationship of these cells with the monocyte-macrophage lineage remains
to be determined. The network of MHC class 11" dendritic cells did not share surface
markers that were found on ovine macrophages, regardless of their expression of
factor XIHa. Thus, if the dendritic cells represent a population of macrophage-related
precursor cells, then they have lost the expression of a number of macrophage surface
markers and may represent an indeterminate stage of differentiation.
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The proliferative nature of the primary orf lesion
Studies of the reaction of abraded and scarified ovine skin to challenge by orf virus
have demonstrated that viral replication begins after initial repair of the epidermis and
dermis following the trauma. During this first 48h of repair, viral antigen cannot be
detected and this period is known as the eclipse phase (Osman, 1976). Orf virus
appears to require the proliferation of the epidermal cells before it can replicate, as the
viral growth cycle begins during the differentiation of the new epidermis at a stage
which has still to be identified (Jenkinson et al., 1990c). In vitro studies of orf virus
replication also indicated the requirement for cellular proliferation as young and
rapidly dividing cells were found to be more sensitive to viral infection than older
cultures (Nagington et al., 1968). In vivo, the proliferating cells of the newly
regenerating epidermis at 48h post-infection were highlighted by their staining with
the antibody PCNA (chapter 3).
At this stage, there was no difference between a primary and a secondary infection.
These proliferating cells were able to support viral replication with the appearance of
viral antigen, detected at 3-4 days post-infection. The infection spreads laterally and
uniformly along the new epidermis encompassing the entire depth of the epidermis
except for the stratum basale (chapter 3). In a secondary infection the proliferation of
the epidermis, as detected by PCNA, decreased, coinciding with the disappearance of
the viral antigen. The primary orf lesion however, is highly proliferative and this is
reflected in the persistence of the virus with viral antigen still detected on day 22 post¬
infection. The proliferative nature of naturally occurring orf virus infections and the
hypertrophic appearance of the regenerating epidermis have emphasised the effect of
orf virus on epidermal growth. Vaccinia virus encodes an epidermal growth factor
(EGF) related protein (Brown et al., 1985) that is thought to mediate binding of the
virus to skin cells expressing the receptor or to stimulate the growth of uninfected
cells and promote the spread of infection. Extensive molecular analysis of the orf virus
genome failed to locate an EGF gene analogous to that found in vaccinia (Lyttle et
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al., 1994). However a gene encoding a polypeptide with homology to mammalian
vascular endothelial growth factor (VEGF) was identified in the genome of orf vims
(Lyttle et al., 1994). The VEGF of orf vims could be directly responsible for the
extensive vascular endothelial proliferation that characterises human orf virus lesions.
However, this is not a feature of ovine orf lesions. How the VEGF benefits the vims
is unknown, but it is thought that it could act by increasing the flow of metabolites
essential to the virus or by inducing epidermal proliferation indirectly. VEGF is highly
specific for endothelial cells but Yirrell et al., (1994) postulated that orf virus VEGF
may induce epidermal instead of endothelial proliferation in sheep, thereby providing
the vims with a fresh source of proliferating cells in which to replicate. The reduced
epidermal proliferation that is observed in a secondary orf virus infection may occur
as a result of the faster clearance of the vims from the skin, resulting in a lower level
of VEGF released. However, it may be that the two features of the primary orf lesion
that differentiate it from a secondary orf lesion, factor XIIIa+ dendritic cells and
extensive epidermal proliferation, are related.
The factor XIIIa+ dendritic cells of the primary orf lesion were observed to be
clustered directly beneath the proliferating epidermis. Such a close association of
factor XIIIa+ dendritic cells has also been described in the highly proliferative psoriasis
lesions in humans (Cerio et al., 1989). The combined in vitro and in vivo studies
(Nickoloff et al., 1991, Barker et al., 1990, 1991 and Nickoloff et al., 1986) clearly
delineate important, spatially co-ordinated cytokine-controlled reactions between the
TNF producing dermal dendritic cells and the overlying keratinocytes which have
increased IL-8, ICAM-1 and TGFa expression. The increased TGFa is known to
induce keratinocyte proliferation which would account for the hyperplasia of
keratinocytes in psoriatic lesions. The similarity of the primary orf lesion with the
psoriatic lesions of man could be related to the presence of the factor XMa+ dendritic
cells.
Factor XIIIa+ dendritic cells are known to be involved in the initial stages of healing,
possibly by stimulating the proliferation of the epidermal cells and thereby knitting the
edges of the wound together. In orf vims infected skin these proliferating epidermal
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cells support orf virus replication. In a primary orf lesion, the factor Xllla* dendritic
cells that accumulate may produce TNFa which would result in the production of
TGFa by the keratinocytes and the extensive proliferation of the epidermis. The
continued proliferation of the epidermal keratinocytes would provide orf virus with a
fresh source of cells to infect and may increase the spread of the virus along the
epidermis resulting in a more prolonged and severe infection. The increased spread of
the virus and the formation of a network of immature dendritic cells could account for
the more severe primary orf virus infection and also prevent the development of
complete immunity, thus increasing the chances of developing lesions again on re¬
infection with orf virus.
As the function of both populations of CDl'/factor Xllla" and CDF/factor XHIa"
dermal dendritic cells have not yet been determined the sequence of the events at
primary and secondary orf lesions, described above, is merely speculative. More
detailed studies will be required to determine the role of these cells in the response to
orf virus infections and the ability of specific cytokines to regulate the expression of
their surface markers.
In summary
Orf virus represents one of a group of viruses including vaccinia virus. HSV and HPV
that infect the skin, replicating within the keratinocvte cell population. The skin
lesions caused by each of these viruses are all different and the orf lesion that develops
in humans is also significantly different from the orf lesion that develops in sheep.
Although the local, cellular immune response is important in the control of each of
these infections, the differences observed in the lesions will reflect a combination of
the involvement of different components of the immune system and the ability of the
virus concerned to replicate and alter or evade these responses. The importance of
cellular immunity for the control of infections with vaccinia virus, HPV and HSV has
been emphasised by the severity and persistence of the infections that develop when
various components of the cellular immune system are depleted (chapter 1). Thus
studies of orf virus infections in sheep that are immunocompromised in some way may
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increase our understanding of the importance of local, cellular immune effector
mechanisms in the host response to orf virus infections.
In conclusion, there is still much work to be done before the interaction of orf virus
with the local, cellular immune system of the skin can be fully elucidated. The results
presented in this thesis indicate a difference in the dendritic cell response of primary
and secondary orf virus infections that may be related to the differences in the time
course and severity of the lesions. These results also support the increasing
recognition of the importance of dermal dendritic cells in the skin response to
infections. In addition, the ability of orf virus to interfere with the production of the
cytokine GM-CSF by keratinocytes was reported. This indicates the possible
possession by orf virus of virulence factors which may enable the evasion of specific
effector mechanisms and be related to the incomplete immunity generated after an orf
virus infection. This thesis has hopefully provided a basis for future work which will
further characterise the ability of orf virus to interfere with the host response.
Characterisation of these putative virulence factors would add to our knowledge of
the components of the immune system important in combatting orf virus infections,
which may lead to more effective treatment and the development of improved
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ABSTRACT
Four populations of MHC-class EC dendritic cells were characterised within normal
ovine skin. The MHC-class IT dendritic cell accumulation observed in response to
primary and secondary orf virus infections of sheep comprised two of the populations
that normally reside in the ovine dermis. These accumulating dendritic cells lacked the
CD1 antigen and a proportion expressed factor Xffla. The highest number of factor
XIIIa+ dendritic cells accumulated in a primary infection, with small numbers
appearing only transiently in a secondary infection.
Only a few of the dendritic cells underwent proliferation in a primary orf infection,
suggesting that the network forms largely by an influx of cells into the dermis from
the blood. The dendritic cells were not recognised by a panel of monoclonal
antibodies which labelled macrophages and their origin remains unknown.
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INTRODUCTION
Orf, an eruptive and localised skin disease of sheep and goats, is caused by a parapox
DNA virus. The disease which can also affect man, is endemic globally in sheep, being
most prevalent in young lambs and their nursing ewes (1). It is an acute infection in
which the virus enters through abrasions in the skin and replicates within regenerating
epidermal keratinocytes (2). The host response to orf virus infection involves an
accumulation of a large number of neutrophils and lymphocytes adjacent to and
underlying the infected epidermis (3). A characteristic feature of the orf lesion is a
dense accumulation of MHC class IT dendritic cells which have been hypothesised to
form a barrier to viral invasion and a template for subsequent epidermal repair (4).
Jenkinson et al (4) showed that these accumulating dendritic cells do not express
acetylcholinesterase (AchE), a marker expressed by normal ovine epidermal
Langerhan's cells but not by dermal dendritic cells.
This study sought to determine, firstly, whether the dendritic cells accumulating
adjacent to or below orf lesions differed phenotypicailv from the dendritic cells
normally present in uninfected ovine skin; secondly, whether there was any
relationship between these dendritic cells and cells of the monocyte-macrophage




Female Suffolk cross sheep, reared at the Moredun Research Institute were used in all
the experiments.
Group 1. Primary orf virus infection.
Four hysterectomy-derived specific pathogen-free (SPF) lambs were kept in an
environment free from orf virus before and during the experiment When two months
old, ail four animals were given a primary infection with orf virus following the
method described below.
Group 2. Secondary orf virus infection.
Four conventionally reared sheep, aged between 12 and 14 months, were used. Blood
samples were taken from the animals prior to the start of the experiment and analysis
of the sera by ELISA (5) revealed positive titres to orf virus antigen which indicated
previous exposure. The animals were challenged experimentally with orf virus as
outlined below.
Group 3. Control scarification.
Four conventionally reared control sheep aged between 12 and 14 months were
scarified experimentally but not challenged with orf virus.
Viral inoculum
The virus used in the experiment was Scabbymouth, a vaccine produced by the
Commonwealth Serum Laboratory of Australia consisting of live tissue culture
propagated orf virus which has retained virulence.
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Inoculation Procedure:
All 12 animals were scarified on the inner thigh with a single stroke using a 16 gauge
needle. To groups 1 and 2, 0.1ml of the vaccine (107 TCID50/ml) was applied topically
to the abraded skin. To the scarification lines of group 3, 0.1ml of phosphate buffered
saline (PBS) was applied. Skin samples (6mm in diameter), were taken by punch
biopsy from all 12 animals across the scar lines at Oh, 48h, 96h and 170h after
treatment. Extra biopsies were collected from the primary infected animals at days 9,
12,16, 22 and 30 for qualitative observations.
Immunohistochemistry
Each skin specimen was fixed for 2-3h at 4°C in a cacodvlate/formalin solution (6),
then stored for approximately 18h in 0.4M sucrose at 4°C, as described previously
(4). One half of each biopsy was processed to paraffin wax by the St.Marie method
(7) and the other half snap frozen in liquid nitrogen, then stored at -70°C. For
quantitation of dendritic cells by immunohistology, five semi-serial paraffin wax
sections, each lOum thick, were cut from each sample at intervals of at least 50um
and mounted on slides pre-coated with Biobond (British Biocell, Cardiff, UK).
Sections of frozen tissue were cut at 10pm thick in a cryostat for immunostaining
with some of the antibodies (see below).
Using an avidin-biotin immunoperoxidase kit, (Vectastain elite, Vector laboratories
Ltd, Burlinghame, USA) a set of slides from each sheep was immunostained with a
panel of specific antibodies listed below. The sections were incubated with the panel
of antibodies overnight at 4°C and developed following the kit instructions. Briefly,
biotinylated horse IgG anti-mouse immunoglobulin was used as a second stage
reagent, followed by a horse radish peroxidase-labelled avidin-biotin complex. For the
rabbit antiserum against factor Xffla, biotinylated goat anti-rabbit was used as the
second stage reagent. Visualisation and location were achieved by diaminobenzidine
(DAB; Dako Ltd, High Wycombe). For 2 colour analysis a second monoclonal
antibody (mab) was applied after the first had been coloured by DAB, followed by the
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incubations described as above. The second antibody was labelled with alkaline
phosphatase and revealed using a different coloured substrate, Vector New fuschin,
which gives a pink colour. All slides were counterstained in haematoxylin, dehydrated
through graded alcohols and histoclear (National Diagnostics, New Jersey) and
mounted in histomount (National Diagnostics, New Jersey).
Antibodies
Dendritic cell markers
Two monoclonal antibodies (mabs) and one polyclonal antibody preparation were
used for immunohistological characterisation of dendritic cells using previously
optimised concentrations of each of the following: SBU-49.1. an anti-MHC class II
antibody that recognises an epitope common to ovine DR and DQ (8); SBU-T6. an
anti-ovine pan CDl-specific antibody (9,10) and rabbit IgG anti-human coagulation
factor Xllla (1:750 Calbiochem, La Jolla, USA).
Detection ofproliferation
The mab to proliferating cell nuclear antigen (PCNA) clone PC10 (Dako, Ltd), was
used to detect the cells undergoing proliferation. The antibody to PCNA recognises a
phase-specific nuclear antigen that functions as a co-factor for DNA polymerase delta
(11). PCNA levels are increased through the mid G1 phase of the cell cycle, remain
elevated throughout the S phase, then rapidly decrease from G2/M to G1 (12)
Monocyte-macrophage markers
Three mabs reactive with monocyte-macrophages were used; OM-1 , anti-ovine
CDllc (13); IL-A15, anti-ovine/bovine CDllb (14) and IL-A24, anti-ovine/bovine
pi 10/75 antigen which reacts with a subpopulation of dendritic cells as well as
neutrophils, eosinophils, macrophages and some lymphocytes (15).
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Orf virus
The mab, 5E2, specific for an unidentified orf virus protein was used (H.W.Reid,
Moredun Research Institute).
Controls
Negative controls included isotype-ipatched murine mabs specific for border disease
viral epitopes (obtained from G. Entrican, Moredun Research Institute) and rabbit
serum IgG as a control for the factor Xllla-specific antibody.
Positive cell controls for the macrophage markers consisted of cytospins of ovine
alveolar macrophages (prepared by G. Entrican, Moredun Research Institute) fixed in
formaldehde/cacodylate as described above.
Quantification ofdendritic cells
Dendritic cells, defined by previously reported criteria (16), were quantified within a
total area of lmm2 of dermis on five semi-serial sections of each biopsy for normal
skin and at the time points 48h, 96h and 170h after treatment (4) for each of the three
mabs used. The counts were performed on four microscope fields across each section
of skin. Dual staining of dendritic cells with 2 of the 3 mabs was determined by
comparison of serial sections or by the two colour technique described. Counts were
not performed for the mab staining of cells other than dendritic cells or for the
additional sections of primary orf lesions collected at timepoints beyond 170h.
7
RESULTS
The results for each of the monoclonals are described individually and subdivided into




Four populations of phenotypically distinct MHC class IT dendritic cells were
observed in normal skin; their phenotypes are summarised in Table 1. CD1+ dendritic
cells were seen within the epidermis generally at, or immediately above, the stratum
basale and within the dermis clustered at the dermal/epidermal junction or closely
associated with dermal structures such as sweat glands, hair follicles and blood
vessels. A comparison between dendritic cells expressing MHC class II and CD1
antigens in serial sections (Figs la and lb) showed that all CDF dendritic cells
coexpressed class II antigens. Within the epidermis all dendritic cells were CDF and
class IT, but only 50% of the MHC class IT dendritic cells in the dermis were
positive for CD1. A small population of factor XHIa^ dendritic cells were observed
within the dermis, typically at the dermal/epidermal junction (Fig lc) and surrounding
blood vessels, particularly in the papillary dermis. Analysis of serial sections showed
that factor XIIIa+ dendritic cells were CD1" and coexpressed MHC class II.
However, they represented only a small proportion (approximately 15%, Table 1) of
the MHC class IF dendritic cells present within normal ovine skin.
Scarified skin
A significant increase of MHC class IT dendritic cells and factor XUIa^ dendritic cells
from normal skin was observed at 48h following scarification (p <0.05 and p< 0.01
respectively). These dendritic cell populations accumulated transiently at the
dermal/epidermal junction on either side of the abrasion at 48h (Figs 2a, 3a and b).
CDF dendritic cells were absent from the dendritic cell accumulation and were found
only in the undisturbed dermis/epidermis adjacent to the abrasion. At 96h CDF
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dendritic cells had appeared along the boundary of the new epidermis and by 170h
their distribution in the epidermis and dermis had returned to that seen in normal,
uninfected skin.
Primary Orf virus infection
The dendritic cell response at 48h post-infection was similar to the response observed
for scarification, with an increase in MHC class IT and factor XIIIa+ dendritic cells.
From 48h onwards the MHC class IT dendritic cells continued to accumulate
forming a dense network beneath the infected, degenerating epidermis (see Figs 2a
and 4a) which reached a maximum between days 9 to 12 and then decreased
returning to a pre-infection distribution by day 30 (not shown). Factor XIIIa*
dendritic cells accumulated in high numbers at the lesion (Figs 2b, 4b and 4c), forming
a significantly high proportion (53%, p < 0.0001) of the dendritic ceil network at
170h when compared with the equivalent time point in the scarification control group.
Factor XIIIa+ dendritic cells remained in the dermis beneath the lesion, unlike the
MHC class IT dendritic cells which could be seen infiltrating the infected epidermis.
Although 170h post-infection was the last timepoint for cell enumeration, qualitative
analysis thereafter showed that factor XIIIa^ cells persisted until about day 12 and
then declined in parallel with the MHC class IT dendritic cells. The dense
accumulation of dendritic cells was negative for CD1 at all the timepoints studied.
With the onset and spread of infection (from 48h onwards), CD1+ dendritic cell
numbers decreased (Fig 2b), and by 170h these cells were virtually absent from the
skin when compared with the same timepoint of scarified only skin (p < 0.015). On
resolution of infection (day 16, as shown by disappearance of viral antigen) CD1+
dendritic cells reappeared at the epidermal/dermal junction and subsequently within
the thickened epidermis on day 22.
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Secondary orf virus challenge
The MHC class If" dendritic cell response that occurred within the first 96h after a
secondary challenge with orf virus (Fig 2c) was similar to the response observed
during this time following primary infection. The dendritic cell network was densest at
96h after which cell numbers declined as the infection resolved. This is consistent with
previous observations made by Jenkinson et al (4). Factor XUIa" dendritic cells
peaked transiently at 48h, as observed for scarification only controls, and were not
present in the dense network of MHC class EC dendritic cells at 96h, representing
only 1% of the total MHC class IT dendritic cellS present in the section. However, as
the infection started to regress (170h) the numbers of factor Xnia'1' dendritic cells
returned to normal. CD1+ dendritic cells were completely absent from the lesion and
their numbers decreased as the lesion extended into previously unaffected
dermis/epidermis (Fig 2c) At 170h CD1+ dendritic cells were present at the
dermal/epidermal junction of the healing lesion.
Proliferating cell nuclear antigen (PCNA)
Normal skin
PCNA+ cells were present in low numbers in the normal skin of all the animals
studied. Typically the positive cells were observed in the basal layer of the epidermis
and surrounding sweat glands and at the base of hair follicles. These cells did not have
a dendritic cell morphology.
Scarified skin
Intense PCNA staining was observed at 48h post scarification in the epidermal cells
flanking the edges of the newly regenerating epidermis (Fig 5a). The cells infiltrating
the dermis beneath the lesion were negative for PCNA. The newly formed epidermis
also contained some positive cells at 96h, and by 170h the skin resembled the normal
state, with only faintly PCNA-1" cells detectable.
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Primary orf virus infection
At 48h post infection, PCNA staining was similar to that seen at the same time
following scarification only, being focused at the edges of the lesion and in the newly
formed epidermis. The proliferative activity within the epidermis decreased from 96h
when the epidermal cells at the edges of the expanding lesion became vacuolated due
to viral replication and only faint staining with PCNA was detectable. By 170h PCNA
staining began to increase and intense nuclear staining was observed within the
developing epidermal downgrowths (Fig 5b), which increased in size over the next
few days (days 9 to 12, not shown). Positive cells also were present within the dermal
cellular influx (48h onwards). Dual staining of these cells with MHC class II revealed
that a few of the proliferating cells were class IT dendritic cells (Fig 5c). By days 22
to 30 PCNA+ cell numbers decreased and the skin returned to a normal level of pre-
infection PCNA staining.
Secondary orf virus challenge
The pattern of cellular proliferation was similar to the scarification already described,
with positive cells flanking the edges of the lesion at 48h. Proliferation was not
observed at any time point within the dermal influx of dendritic cells, the dense
accumulation of cells at 96h was completely negative for PCNA staining. Epidermal
downgrowths were not observed and the only proliferating cells that were present
were within the healing epidermis (at 170h).
Monocyte-macrophage markers
All three mabs recognised markers on macrophages in the fixed cytospins of alveolar
macrophages (not shown). Within normal skin, the occasional positive cell that had
macrophage-like morphology (round nucleus, lack of marked dendritic processes)
could be detected within the dermis with the antibodies OMI and IL-A15. These cells
were associated typically with dermal structures such as sweat glands. However IL-
A24 did recognise cells with dendritic processes in the epidermis and surrounding the
tops of hair follicles. Some staining with the antibodies IL-A15 and IL-A24 of the
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inflammatory influx generated in response to scarification, primary and secondary orf
virus infections was observed, with the largest number of positive cells occuring in the
primary orf lesion. Under higher magnification these positive cells were seen to be
neutrophils. Neither IL-A24+ dendritic cells nor macrophages was detected. OM1 did
not stain any of the cells present within the inflammatory cell influx.
Orf virus antigen
Orf viral antigen was not detected in normal or scarified skin. In both primary and
secondary infections viral antigen was present in cells adjacent to the damaged
epidermis at 72h. In secondary challenge infections viral antigen was detected only up
to 96h, whereas primary infections had more extensive staining and viral antigen was
still detectable at day 22.
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DISCUSSION
Jenkinson et al (4) showed that the MHC class 11"" dendritic cells involved in the
cutaneous response to orf virus infection share the phenotype of the dermal dendritic
cells observed in normal ovine skin, characterised by the absence of the Langerhans
cell marker AchE. They hypothesised that dermal dendritic cells were likely to
represent a heterogeneous population of cells that may be differentially involved in the
MHC class IT dendritic cell response to orf virus infection.
Our studies show that within normal ovine skin the MHC class n+ dendritic cells
comprise at least four subpopulations of dendritic cells; one is found exclusively
within the epidermis- the Langerhans cell and is AchfT and CD1+. The AchE- dermal
dendritic cells described by Jenkinson et al (4) constitute three subpopulations; CDF
dendritic cells (that represent about 50% of the total) and CD1" dendritic ceils of
which a proportion (approximately 36%) are positive for the marker, factor XHIa.
This marker has been used recently to define human dermal dendritic cells of bone
marrow origin (17,18 and 19). The dendritic cells that gather in response to
scarification and orf virus infection were a CDF population comprising two of the
subpopulations found within the dermis of normal ovine skin. The expression of factor
XHIa by these cells differed between primary and secondary orf virus infections.
In response to the trauma caused by scarification, factor XIIIa+ dendritic cells
increased transiently in number, gathered at the edges of the lesion and possibly play a
role in the initial healing response. Studies in man have shown that factor XHIa is
found regularly in the early stages of repairing lesions, most clearly in evolving scars
(20). Factor XlUa is a transglutaminase involved in the final stages of clot formation
(21) and one theory suggests that factor XHIa is stored within cells for extracellular
release after local injury, crosslinking the fibrin clot to structural protein and helping
to seal the wound (22). In the present study, the diffuse non cell-associated staining
often observed at the edges of the lesion and within the scab could be due to the
deposition of factor XITIa at the scar and may also explain its transient expression.
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Factor Xllla* dendritic cells were present in much higher numbers and persisted for
much longer in the primary orf virus lesion compared with the scarified skin and the
secondary orf lesion. This may have been due to the more extensive nature of the
lesion, or these cells may have a role other than in wound healing. Recently human
factor XIIIa+ -dendritic cells have been identified as coexpressing intracellular
adhesion molecule-1 (ICAM-1) and lymphocyte function-associated antigen (LFA-1).
The presence of these adhesion molecules and the distinctive distribution of these cells
(with the highest concentration being in the skin and mucosal tissues) has led to the
suggestion that they play a central role in skin immune responses (22). Factor Xffla+
dendritic cells have been demonstrated in psoriatic skin lesions as being potent
producers of tumour necrosis factor -a (TNFa) (23) which is implicated in the
increased growth rate of the keratinocytes in the lesions. It was hypothesised that the
ability of these dermal dendritic cells to produce TNFcc could increase lymphocyte
trafficking through the skin by inducing EL-8 and ICAM-1 production by
keratinocytes (23). Thus a possible function of the cells could be the attraction of
neutrophils and T lymphocytes into the skin in response to epidermal damage or viral
replication. High numbers of factor XHIa+ dendritic cells are seen in the verrucous
skin lesions of HIV-1+ patients caused by secondary infections with DNA viruses,
such as varicella zoster virus, herpes simplex virus and molluscum contagiosum (24).
The ability of factor XHIa" dendritic cells to influence keratinocyte growth could
contribute to the process of healing damaged skin. Interestingly, factor XIIIa+
dendritic cells were most numerous adjacent to the epidermal downgrowths which are
characteristic of primary but not secondary orf lesions. As the secondary orf lesion
heals well without the presence of these cells, the high numbers of factor XIEla*
dendritic cells that accumulate in a primary orf lesion may have an immunological role
possibly reflecting fundamental differences in the primary and secondary immune
response to orf virus infection, and contribute to the epidermal proliferation which
characterises the primary lesion.
It is unknown whether the expression of the antigens CD1 and factor XHIa can be
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influenced by cytokines. The differences in the level of expression of factor XTTTa
between primary and secondary responses could be explained by differences in the
local cytokine profiles. The depletion of CD1 from the surrounding dermis may occur
as a direct result of orf virus replication and the induction or suppression of local
cytokines which may regulate CD1 expression. The levels of CD1 return to normal
only when the infection is well into regression. Cerio et al (18) studied dendritic
dermal cells that expressed factor Xllla and concluded that they were bone marrow-
derived, distinct from Langerhans cells and shared some common epitopes with
mononuclear phagocytes. The relationship of the dendritic cell with the monocyte
macrophage lineage is still under debate. The lack of staining of the MHC class 13
dendritic cells with a panel of monoclonal antibodies which recognise markers on
+
macrophages confirms only that these cells are not MHC class II tissue macrophages
but still leaves their origin unknown. It is possible that the network of MHC class II
and CD1" dendritic cells represent an immature population of dendritic cells. The
maturation and subsequent expression of specific markers by these cells may be
dependent upon the production of certain cytokines, which is affected by orf virus
infection thereby maintaining the cells in an immature state.
As the accumulation of cells in response to scarification and secondary orf virus
infection occurs in the absence of any measurable proliferative activity, it is unlikely
+
that the small population of MHC class 13 , CD1" dendritic cells present in normal
ovine skin proliferate locally to form the dense network of dendritic cells. The
regenerating epidermal keratinocytes, positive for PCNA at 48h post-scarification and
infection contain orf virus during the eclipse phase-when no viral antigen is detectable.
From 96h onwards, these cells become vacuolated, PCNA" and contain orf virus
antigen. High proliferative activity is however observed within the dermal influx of
cells in primary orf virus infections. Dual staining revealed that a few of these
-+•
proliferating cells are MHC class 13 dendritic cells. A high proportion of the
remaining proliferative activity is probably due to lymphocyte proliferation. The large
accumulation of MHC class n+ dendritic cells, most likely arises from an influx of
cells from the blood. Whether this number represents recruitment of circulating
15
dendritic cells or a population of precursor cells that develop their dendritic
characteristics after infiltrating the tissues is not known.
In summary, the dendritic cells accumulating in orf virus- infected skin share the
phenotype of the CD1- population of dermal dendritic cells that are found in normal
ovine skin. A proportion of these cells express the marker factor Xllla, the number
varying considerably between primary and secondary responses. Detailed functional
studies are required to determine whether factor Xllla and CD1 are inducible on the
dendritic cells and if expression of the different markers reflects functional differences
between the populations. The information gained from these studies should then
provide an insight into the possible origin and role of the dendritic cell at the site of
the orf virus lesion.
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Table 1. The dendritic ceil populations of normal ovine skin.
Figure 1. Serial sections of normal ovine skin, showing The distribution of (a) MHC
class IT dendritic cells, (b) CD1 dendritic cells and (c) factor XIIIa+dendritic cells,
(x 560)
Figure 2. Changes in the MHC class IT, CDHand factor XHIa" dendritic cell
populations in response to;
(a) mock scarification
(b) primary orf virus infection
(c) secondary orf virus infection
Figure 3. Serial sections of ovine skin 48h post-scarification, showing the
accumulation of; (a) MHC class IT dendritic cells and (b) factor XIIIa+ dendritic cells
at the dermal/epidermal junction of the abrasion. Note the diffuse staining at the edges
of the lesion with factor XHIa. (x 560)
Figure 4. Serial sections of ovine skin 170h post-primary infection with orf virus,
showing the extensive nature of the lesion, with the balloning degeneration of the
epidermis and associated hair follicles and the accumulation of ; (a) MHC class ET
dendritic cells and (b) factor Xffla+ dendritic cells.(x 112)
(c) A high power view of the dendritic nature of the factor Xnia4" cells.(x 560)
Figure 5. The proliferative response of ovine skin
(a) 48h post-scarification, the epidermal keratinocytes involved in the healing process
of the skin are PCNA positive, (x 112)
(b) 170h post-primary infection with orf virus. A large number of intensely PCNA*
cells are seen in the developing epidermal downgrowths, surrounding infected hair
follicles and within the dermal influx, (x 112)
(c) Double staining with MHC class II (pink) and PCNA (brown) shows a
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proliferating MHC class IT dendritic cell within the inflammatory influx.
Immunoperoxidase and alkaline phosphatase, (x 560)
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